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Abstract
Vascular permeability and its regulation are indispensable for normal circulatory 
function and tissue homeostasis. When unregulated, vascular permeability contributes 
significantly to blood vessel related pathologies, such as cancer and diabetic 
retinopathy. Interposed between blood and tissues, endothelial cells become 
structurally and functionally differentiated, to mediate controlled permeability. The 
aim of this thesis work was to develop suitable systems to study two different aspects 
of vascular permeability, endothelial fenestrae formation and tyrosine phophatase- 
based regulation of paracellular permeability.
Transcellular permeability describes the passage of water and macromolecules across 
endothelial cells. A route for transcellular permeability is provided by fenestrae, the 
60 nm circular pores that span the entire thickness of highly attenuated endothelia 
encountered in endocrine or filtrating organs. In an attempt to gain insight into the 
structure and biogenesis of fenestrae I helped set up an in vitro culture system where 
fenestrae could be rapidly induced in cell biological and biochemical quantities. To 
understand the molecular composition of fenestrae I established a biochemical method 
for their enrichment. Subtractive proteomic analysis performed on a subcellular 
fraction enriched in plasma membranes revealed proteins with roles in actin filament 
disassembly, plasma membrane remodeling, endocytosis, and membrane to 
cytoskeleton linkage. One particular candidate, the membrane-cytoskeleton linker 
moesin, was validated as a component of fenestrae by immunocytochemical means. 
Paracellular permeability occurs through tight or adherens junctions that join 
endothelial cells. In order to understand the regulation of paracellular permeability 
through adherens junctions I focused on Vascular Endothelial Protein Tyrosine 
Phosphatase (VE-PTP), a demonstrated phosphatase modulator of the junctional 
protein VE-cadherin. To this end I established transgenic mice with inducible 
expression of wildtype or mutant VE-PTP in endothelial cells. A correlation between 
VE-PTP expression at the RNA level and embryonic defects suggests the potential 
utility of the mice as models of adherens junction dysfunction.
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Chapter 1: Introduction
1.1 Historical Perspective
The concept of the circulatory system as a closed circuit was established by the 
English physician William Harvey (1578-1657). Building on the ideas of Aristotle 
(384-322 BC) and Galen (129-216), in his famous Anatomical Disquisition on the 
Motion o f  the Heart and Blood in Animals, Harvey presented evidence of blood 
flowing outward from the heart, circulating through arteries and veins, and eventually 
returning to the heart [1]. He firmly believed that nothing in nature exists in vain, and 
was confident that the circulatory system was responsible for the delivery of nutritive 
fluid around the body.
The recognition of nutrient supply and waste removal as the ultimate functions of the 
cardiovascular system prevails to this day. A central question within this concept 
concerns the process of material passage between blood and tissues, collectively 
referred to as vascular permeability. In 1953, John Pappenheimer integrated physical 
laws with measurements of capillary permeability in animals, to explain “the invisible 
flow” of material through the vessel [2, 3]. He postulated that the capillary wall was 
rendered permeable to lipid-insoluble molecules through the existence of numerous 
ultramicroscopic pores, in a hypothesis formally known as the Pore Theory [2, 3]. The 
first visualisation of structures that could account for Pappenheimer’s postulates came 
with the application of electron microscopy to the study of blood capillaries. 
Intercellular gaps, attachment belts (interendothelial junctions), fenestrae, and 
caveolae, were recognised as structural features of the endothelium that could be 
linked to its permeability properties [4-6], although their size and frequency did not 
correspond exactly to the pore theory measurements. In an attempt to probe for the 
true permeability properties of each of the observed structures, subsequent studies 
made use of particulate or enzymatic tracers that could be visualised by electron
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microscopy (reviewed in [7, 8]). On the basis of the ultrastructural localisation of 
tracers at various time intervals after their intravascular or interstitial administration, 
size- and charge- restrictive properties were attributed to a variety of structures within 
capillary walls [8]. Freeze-fracture electron microscopy provided the most detailed 
descriptions of the intricate architecture of intercellular junctions and fenestrae [9-11], 
while biochemical isolation studies began identifying the molecular components of 
junctions and caveolae [12-16]. Finally, in the course of the last decade, advances in 
genome sequencing and mammalian genetics have culminated in the engineering of 
transgenic and knockout mice for components or putative modulators of tight 
junctions, adherens junctions, and caveolae, so as to facilitate assessing their 
contribution to permeability [17-20].
1.2 Heterogeneity of the endothelium
1.2.1 Endothelial differentiation and organ function
Precise regulation of blood-tissue interchange is indispensable for fluid homeostasis, 
delivery and uptake of metabolites to and from tissues, and filtration. Accordingly, 
vascular endothelial cells, the primary barrier to free blood-tissue exchange, adopt 
highly specialised features and behaviors to mediate and monitor the flux of 
macromolecules and fluids across the vascular wall. For example, the vascular 
endothelium of the blood-brain and the blood-retinal barriers is fortified by tight 
junction components that restrict access of fluid and blood components to sensitive 
neural tissues [21-23]. To compensate for the need of nutrients, barrier cells are 
equipped with a multitude of membrane transporters that ensure the provision of
14
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glucose and essential amino acids [24-26]. The other extreme of endothelial barrier 
differentiation is that of lymphatic vessels, an extremely permeable endothelium 
whose function is the uptake of extravascular fluid for clearance, transport and return 
to the circulation [27, 28]. Consistent with this function, lymphatic endothelial cells 
have thin walls, loose junctions, and are devoid of surrounding support cells or 
basement membrane [27, 28]. Between the two extremes of hyperpermeable and 
impermeable endothelia, are endothelia in organs requiring abundant but more 
regulated vascular permeability. Organs mediating endocrine, absorptive or filtrating 
functions are supported by a highly specialised vascular endothelium containing 
numerous plasma membrane pores, the fenestrae [8]. Finally, throughout the vascular 
tree, the integrity and continuity o f endothelial sheets is maintained by the presence of 
adherens junctions, or a desmosomal-like structure in the case of lymphatics, which 
hold neighbouring cells attached to one another [29, 30].
1.2.2 An evolutionary perspective on endothelial morphogenesis
Observations on the phylogeny of the vasculature have suggested a progression 
towards a more closed circulatory system in the course of evolution [31]. In primitive 
chordates such as amphioxus, endothelial cells are separated by large gaps, and often 
are devoid of basement membranes, ensuring continuous contact between the blood 
and tissues. In the hagfish, which is often regarded as a primitive vertebrate, 
endothelial cells become more continuous and display intercellular junctions, 
micropinocytotic vesicles, and fenestrae. In advanced vertebrates, such as teleosts and 
mammals, such features become more prominent, while a lymphatic system is also in 
place. It is plausible that increases in the size of organisms demanded a continuous 
vasculature that would maintain sufficient blood hydrostatic pressure to deliver
15
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nutrients and uptake waste, even from the most distal parts of an animal. Local needs 
for sustained permeability could be served by the existence of fenestrae, thus avoiding 
large net losses of fluid. Moreover, the lymphatic system could counteract any fluid 
losses, by returning extravascular fluid back to the circulation.
Interestingly, ffeeze-ffacture analysis of the capillaries in the kidney of the Atlantic 
Hagfish, (Myxine glutinosa) has revealed sparse fenestrae [32], while no fenestrae 
have been found in its thyroid or pituitary glands [31]. Fenestrae are however 
common in the elasmobranchs (subclass encompassing sharks, skates and rays), 
featuring prominently within their kidneys and intestinal capillaries, and in all higher 
vertebrates [31]. Whether fenestrae serve a true filtration function in their primitive 
form, or were adapted to this function through the course of evolution, remains an 
open question.
1.2.3 Morphological classification of permeability
The recognition of different subendothelial structures that could mediate blood-tissue 
exchange has led to the classification of vascular permeability according to the 
pathway followed in traversing the capillary wall. Two modes of permeability have 
been described: paracellular permeability and transcellular permeability (Figure 1.1). 
Paracellular permeability refers to the passage of material through orifices existing 
between cells, or created through opening and closing of tight and adherens junctions. 
Transcellular permeability describes the passage of material across endothelial cells, 
through caveolae, transendothelial channels, vesiculo-vacuolar organelles (W O s), and 
fenestrae. A brief description of tight junctions, caveolae, W O s  and transendothelial 
channels and their connection to permeability will directly follow, while fenestrae and 
adherens junctions will be analysed in detail in the ensuing section.
16
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Figure 1,1 Structures mediating transcellular and paracellular permeability. Material 
passage can occur across the endothelial cell, through caveolae (c), vesiculovacuolar 
organelles (W O ), transendothelial channels (TEC) or fenestrae (f). Alternatively 
materials can pass between adjacent endothelial cells through tight or adherens 
junctions (j). The lumen and tissue fronts of the endothelium and the basement 
membrane (bm) are denoted. (Schematic adapted from Ref. 8)
17
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1.2.3.1 Tight junctions
Tight junctions are junctional complexes of epithelial and endothelial cells [33]. 
Unlike their confinement to the most apical region of interepithelial cell contact, in 
endothelial cells they are found interspersed among adherens junctions (Figure 1.2) 
[33]. Tight junctions were identified by ultrathin section electron microscopy as so- 
called kissing points of plasma membranes [9]. Freeze-ffacture replica electron 
microscopy further detailed them as pairs of tight junction strands in apposing plasma 
membranes, which, when associated, led to the obliteration of the intercellular space 
[10]. Tight junction strands consist of the transmembrane proteins occludin, junctional 
adhesion molecule (JAM), and members of the claudin family [33, 34]. Peripheral 
membrane proteins such as ZO and other PDZ domain-containing proteins participate 
in the linkage of tight junction strands with the cytoskeleton [33, 34]. Athough 
initially regarded as completely impermeable barriers, the observation of clefts within 
tight junctions, that could accomodate 6 A channels, established their role in 
paracellular permeability [35-37]. Tight junctions are preferentially developed in 
arteries versus veins [33], and consistent with their restrictive properties they are a 
prominent feature of the blood-brain and blood-retinal barriers [21, 23].
1.2.3.2 Caveolae
Caveolae, also referred to as plasmalemmal vesicles, are 60-80 nm-wide flask-shaped 
invaginations of the plasma membrane, originally identified in endothelial and 
epithelial cells [4, 38] and subsequently recognised in many cell types [39]. The 
observation of vesicles at either front of the endothelium, as well as intracellularly, led 
to the hypothesis of quantal transport of substances across the capillary wall, termed 
transcytosis [40, 41]. Vesicles loaded with a certain amount of plasma components
18
Figure 1.2 Intercellular junctions. Transmission electron micrograph and 
corresponding schematic of the main types of junctions between skin epithelial cells. 
Tight junctions are composed of transmembrane proteins that are linked to the actin 
cytoskeleton, and result in the obliteration of the intercellular space. Adherens 
junctions are formed by homophilic interactions between proteins of the cadherin 
family, that are transmembrane and associate with the actin cytoskeleton. An 
approximately 20 nm space between adjacent cells is permitted by such junctions. 
Desmosomes consist of transmembrane proteins anchored to intermediate filaments, 
however are absent from most endothelia. (Reproduced from Ref. 126)
19
Chapter 1: Introduction
were assumed to bud off one side of the endothelium, shuttle through the cell, and 
eventually release their cargo at the opposite endothelial front [40, 41]. Transcytosis is 
thought to take place both in a non-specific fashion, by means of size or charge 
selectivity, and a receptor-mediated fashion, as in the case of albumin or low density 
lipoprotein (LDL) [42-44]. In addition to transcytosis, a number of other functions 
have been proposed for caveolae, including cell signaling, endocytosis, and cholesterol 
trafficking, [3*-)]. Combinations of caveolin proteins constitute the main structural 
components of caveolae, with caveolin-1 and caveolin-2 forming oligomers in 
endothelium, and epithelium [45]. A distinguishing feature of endothelial caveolae is 
the presence of a diaphragm spanning their orifice, a constituent of which is the protein 
PV-1 [16, 46]. Consistent with a role in transcellular permeability, observed caveolae 
surface densities are inversely proportional to the endothelial thickness, and among 
different organs, display the lowest frequency in brain capillaries [8].
1,2.33 Vesiculo-vacuolar organelles (W O s)
Originally identified in tumor blood vessels, W O s were subsequently observed in the 
venular endothelium supplying the skin, the skeletal muscle and other tissues [47. 48]. 
W O s were described as a bunch of grape-like clusters of membrane-lined vesicles 
and vacuoles. Over 100 of such vesicles and vacuoles collectively comprise an 
interconnected structure that traverses the endothelial cytoplasm. Within the structure, 
open communication is thought to exist between vesicles and vacuoles, albeit in some 
cases where it is restricted by the presence of a diaphragm. Labelling for caveolin 1 
[49], coupled to the feature of the diaphragm are suggestive of a relationship to 
caveolae. The larger size and greater heterogeneity of most vesicles was deemed 
representative of multiple fused caveolae [50, 51] . A role for W O s in transcellular
20
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permeability was inferred from studies showing an accumulation of macromolecular 
tracers within their compartments in the vasculature of tumors [47, 48]. However, 
minimal entry of tracers in W O s was observed for normal endothelium [47, 48].
1.2.3.4 Transendothelial channels
Transendothelial channels, were first identified in muscle capillaries [52], and 
subsequently observed in many fenestrated endothelia [8]. Frequently referred to as 
fused vesicles, or fused fenestrae, transendothelial channels contain two diaphragms 
that are morphologically similar to those identified in fenestrae, caveolae, and W O s  
[8, 53]. Moreover, the diaphragms harbour the protein PV-1, a common feature 
between the diaphragms of fenestrae and caveolae [54]. In light of their sparse 
distribution, the significance of transendothelial channels is a matter of controversy. 
Whether they constitute a distinct unit involved in transcellular permeability, or are 
merely short-lived intermediates in the formation of other diaphragmed structures, 
remains an open question.
1.3 Fenestrae
1.3.1 Morphology and architecture
Endothelial fenestrae were first observed in 1950 by Gautier, Bernhard, and Oberling,
during their ultrastructural studies of glomerular capillaries [55]. Their work was
validated by a number of others working in the same system [5, 56, 57], and later
generalised to other organs [6, 58]. Named after the latin word for window, fenestrae
have been described as transcellular circular pores with an average diameter of ~ 60
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Figure 1.3 Schematic representation of fenestrated endothelium. Fenestrae are found 
only at the most attenuated regions of endothelial cells where the nucleus and 
organelles are excluded and the distance from apical to basal plasma membrane is as 
little as 40 nm. They occur in groups and are arranged in a near-linear fashion with 
precise spacing between them. Inset shows the fenestral pore to be 60 nm in diameter, 
with an effective size of 5-6 nm when apertured by a diaphragm. The basement 
membrane underlying the fenestrated endothelium is indicated. (Schematic adapted 
from Ref. 59)
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nm [6, 59], though they can be as large as ~ 150 nm within the liver sinusoidal 
endothelium (Figure 1.3) [60]. Fenestrae are encountered in the most attenuated 
regions of the microvascular endothelium, where the cell profile is as little as 40 nm, 
and span the entire thickness of the cell without disrupting the continuity of the cell 
membrane [59]. The substances that traverse the pore never encounter the contents of 
the cytoplasm, and are transported in a rapid and presumably energy-efficient manner. 
This is in contrast to transcytosis, which involves the coupling of energy-rich 
endocytic and exocytic events. In most vascular beds fenestrae contain a diaphragm 
composed of approximately 8 radial fibrils converging in a central knob, which further 
dissects the pore into 5-6 nm openings (Figures 1.3 and 1.4 ) [ 11], Fenestrae are known 
to occur in clusters of approximately 50-100, termed ‘sieve plates’, that are encircled 
by a microtubule-rich border [61]. Within a sieve plate, fenestrae are found in a near 
linear arrangement with precise spacing between each pore [59, 62], implying the 
presence of a complex intracellular scaffolding to support such order. Whether 
individual fenestrae, or the sieve plates, are stable structures that persist throughout the 
lifetime of a differentiated cell or dynamic structures that are rapidly turned-over, is 
currently unknown.
1.3.2 Chemical and molecular composition
Palade and the Simionescus pioneered the study of fenestrae composition by
demonstrating that cationised ferritin (CF) preferentially deposited within a glycocalyx 
visible on the luminal aspect of the fenestral diaphragm [63, 64]. Capitalizing on this 
initial observation, they used the CF interaction as a probe for the molecular nature of 
fenestrae, by monitoring its disappearance following treatment with enzymes of 
defined specificity. Sensitivity to proteases and certain glycosidases as well as affinity
23
Figure 1.4 Fenestral diaphragms. Quick-freezing and deep-etching of rat kidney 
peritubular capillaries revealed intertwining fibrils bridging the pore and converging 
into a central mesh. A luminal view of diaphragms is shown. Magnification: 
120,000x. (Reproduced from Ref. 11)
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for lectins suggested that acidic glycoproteins and proteoglycans could account for CF- 
decorated anionic sites on the diaphragms [64, 65]. However, the differential 
sensitivity to heparinase and heparitinase in the fenestral diaphragms of the intestine 
and choriocapillaris respectively [64, 66], together with variable results in lectin 
binding studies in these tissues [65, 67], highlight organ-specific differences in the 
glycocalyx composition: heparan sulfate proteoglycans presumably form part of the 
diaphragms in the intestine, while heparin and N-acetylglucosamine-rich glycoproteins 
are thought to localise on the diaphragms of the choriocapillaris. Moreover, binding of 
CF to fenestral diaphragms is absent altogether in the bone marrow and the fetal liver 
[68], while it is highly variable in the fenestrated neovasculature of tumors [69]. 
Lastly, a differential distribution in the CF labelling was observed between the luminal 
and abluminal aspects of intestinal and pancreatic fenestrae [70], CF that was 
interstitially microinjected following basal lamina digestion with collagenase, failed to 
label the abluminal aspect of fenestral diaphragms, demonstrating the existence of 
polarity within each fenestra [70].
Recent studies identified an endothelial cell-specific protein, Plasmalemmal Vesicle 1
Protein (PV-1) as the first known component of the fenestral diaphragm [54]. PV-1 is
a 60 kDa Type II transmembrane glycoprotein, believed to form coiled-coil
homodimers that constitute the primary structural component of the diaphragm [71].
It should be noted that PV-1, and the diaphragm are not unique to fenestrae but also
reside within endothelial cell caveolae and transendothelial channels [16, 54].
Intriguingly, studies on the permeability properties of fenestrae identified a
discrepancy between the predicted and the actual passage of water and solutes, even
when the area occupied by the diaphragm was taken into account [72]. They further
concluded that fenestrae diaphragms may support an overlying glycocalyx, or
underlying basal lamina, containing a dense fiber matrix. Scattered information exists
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for the presence of sterols [73], furin proteases [74], and Ca pumps [75, 76], on or in 
the vicinity of fenestrae, but awaits validation.
1.3.3. Fenestrae role in transcellular permeability
Attempts to investigate the permeability properties of fenestrae were initiated by 
Clementi, Palade, Simionescu, and Pino using tracer perfusion studies. Horseradish 
peroxidase (~ 4 nm in diameter) proved to be readily permeable through diaphragmed 
fenestrae of the intestinal mucosal capillaries, pancreatic capillaries and the ocular 
choriocapillaris. Larger tracers such as ferritin (~ 11 nm in diameter), or dextrans and 
glycogens, were variably permeable, depending on the location of the fenestrated 
vascular bed in the organism [41, 77-79]. These findings fit remarkably well with data 
developed by Bearer and Orci, who determined that the presence of a diaphragm 
transected the 60 nm fenestrae into multiple channels of approximately 5 nm in 
diameter [11]. Whether permeability through fenestrae is a passive process or is 
facilitated by specific molecular interactions between components of the pore and 
traversing substances remains an open question.
Though somewhat speculative, future studies in this area may benefit by examining the 
structure and function of the nuclear pore, a remarkably analogous structure consisting 
of two lipid bilayers fused to create a seamless circular opening. Transport of 
molecules between the cytoplasm and the nucleoplasm is chaperoned by proteins of 
the nuclear pore that first recognize specific export or import signals on potential cargo 
molecules, and then act as shuttling factors in a process regulated by the GTPase Ran 
[80]. So far, selectivity within the fenestrae has only been shown with respect to 
molecular charge, as inferred from studies demonstrating the particularly high affinity
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Figure 1.5 Fenestrated endothelium of the choriocapillaris. The capillary bed 
supplying supplying nutrients and removing waste from the outer retina is extensively 
fenestrated. The close association of diaphragmed fenestrae with Bruch’s membrane 
(BM) and microvilli of retinal pigmented epithelium (RPE) is shown. (Courtesy of 
Eunice Cheung and Steve Samuelsson, Eyetech Research Centre)
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of cationic substances for fenestral diaphragms [63, 64], and the strikingly low 
permeability to negatively charged albumin [81]. Although there is sparse direct 
evidence of a major physiological role for fenestrae, several functions can be safely 
attributed to them simply on the basis of their physical properties and their distribution 
within normal vasculature and during neovascular disease. Fenestrae are postulated to 
mediate the bi-directional exchange of water, solutes and small macromolecules 
between blood and tissues. More specifically, fenestrae are believed to function: in the 
filtration of blood within the choroid plexus that gives rise to cerebrospinal fluid [82]; 
in the access of endocrine hormones to the bloodstream, such as the release of steroid 
hormones by the adrenal cortex [83]; in the supply of nutrients to, and removal of 
waste from, the outer retina by the underlying choriocapillaris (Figure 1.5) [84]; in the 
ultrafiltration of blood to create primary urine within the kidney glomerulus (Figure 
1.6) [85]; in the filtration of potentially hazardous substances in the blood at the liver 
sinusoids [60].
1.3.4 Biogenesis and regulation
The inability to maintain fenestrated endothelium in tissue culture and the difficulty in 
quantifying and manipulating the appearance of fenestrae both in vivo and in vitro 
have greatly hampered the study of their biogenesis. Up until recently, the induction 
of fenestrae in cultured endothelial cell lines has been reported to yield numbers that 
are 3-4 orders of magnitude lower in density than normally observed in vivo. 
Nevertheless, a small number of key studies published throughout the last 3 decades 
have highlighted several extracellular and intracellular determinants that may be 
involved in the differentiation program of a fenestrated endothelial cell.
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Figure 1.6 Scanning electron micrograph from a freeze-fractured glomerulus. A view 
through the lumen of a fenestrated glomerular capillary is shown. The endothelium 
appears to have a colander-like structure that permits passage of materials from the 
blood to the glomerular capsule. (Courtesy of Steve Gschmeissner, Cancer Research 
UK)
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1.3.4.1 Endothelial cell micro-environment
Fenestrated microvessels are in constant contact with extracellular matrix, both in the 
form of routine basal lamina or, in some cases, elaborate, thickened matrix such as the 
basement membrane of the kidney glomerulus or the multi-lamellate Bruch’s 
membrane, which separates pigmented retinal epithelium from the choriocapillaris. 
Extracellular matrix could simply provide a structural scaffold to facilitate the extreme 
shape changes and cell attenuation that accompanies the fenestrated phenotype. 
However, a more active, instructive role for the extracellular matrix has been proposed 
to explain, for example, the presence of fenestrae only in the regions of the 
choriocapillaris that are immediately adjacent to Bruch’s membrane [78]. In vitro 
experiments examining the effects of a variety of extracellular matrices suggest that 
fenestrae formation is supported by specific matrix components, which mimic the 
situation observed in vivo [8 6 , 87].
1.3.4.2 Signal transduction pathways
The first attempts to reprogram the fenestrae differentiation program in cultured 
endothelial cells relied upon the use of potent and relatively non-specific initiators of 
intracellular signaling cascades on isolated bovine adrenal cortex endothelial cells. 
Phorbol myristate acetate (PMA), an activator of Protein Kinase C isoforms and a 
potent differentiation agent for some cell types, promoted a change in the shape of 
endothelial cells accompanied by a 5-fold increase in the frequency of diaphragmed 
fenestrae (~ 6  fenestrae/ 100pm2) [8 8 , 89]. Similarly, treatment of cultures with 
retinoic acid led to a 3-fold increase in the surface density of fenestrae, while 
transforming growth factor p led to a 7-fold decrease in their density [90]. The 
physiological relevance of these signaling pathways remains to be established.
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The angiogenic growth factor, Vascular Endothelial Growth Factor (VEGF) is the 
strongest candidate for a signaling protein that induces fenestrae formation [91]. 
VEGF is an endothelial specific mitogen and motogen, and was originally identified as 
a vascular permeability factor, approximately 50,000 times more potent than histamine 
[53]. Although VEGF is greatly down regulated after the completion of embryonic 
vasculogenesis and angiogenesis, it is continuously and highly expressed in epithelial 
cells adjacent to fenestrated endothelium [92]. Moreover, fenestrae have been 
observed in the neovasculature of tumors and in the normally continuous endothelium 
of the retina during diabetic microangiopathy, both pathological situations that are 
functionally linked to the local upregulation of VEGF [51, 93]. In fact, in vivo studies 
have demonstrated that VEGF can induce fenestrae within 10 minutes in the 
continuous endothelium of skeletal muscle and skin, when applied topically or injected 
intradermally [69], and in vitro studies using capillary endothelial cells showed a 
modest but significant ability of VEGF to promote fenestrae biogenesis [94].
1.3.4.3 Cytoskeleton
The importance of cytoskeletal remodeling in fenestrae biogenesis has been suggested 
from in vitro studies examining the effect of agents that disrupt actin microfilament 
assembly on highly fenestrated liver sinusoidal endothelial cells [95, 96]. Using a 
variety of microfilament disruption agents, a 2 to 3 - fold increase in fenestrae numbers 
was achieved within 30-60 minutes. The physiological relevance of this data was 
indirectly supported by experiments showing that a dominant negative version of the 
small GTP-binding protein Rac could block VEGF-driven fenestrae formation during 
corneal angiogenesis [97]. The authors postulated that inhibition of fenestrae 
formation was a result of interfering with the actin cytoskeleton, without however
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presenting evidence of microfilament reorganisation. The multitude of signalling 
cascades affected by both VEGF and Rac, demand a cautious interpretation of such 
results, as a cytoskeleton-independent mechanism would be equally plausible [97].
The cytoskeleton may also be playing a role in short-term fenestrae dynamics. A 
number of studies have reported an alteration in liver fenestrae diameter in response to 
hormones or drugs (reviewed in [60]). One mechanism proposed to explain these 
observations implicated the presence of an actomyosin contractile apparatus 
surrounding and regulating each fenestra [98].
1.3.4.4 Concepts for fenestrae formation
The limited amount of experimental data can be accommodated in several conceptual 
models (not mutually exclusive) for fenestrae biogenesis:
1.3.4.4.1 Caveolae give rise to fenestrae
Fenestrae and caveolae share structural features, common tissue distribution, a
relationship to the VEGF signaling cascade, and a common putative role in the
regulation of vascular permeability. In one of the earliest hypotheses for fenestrae
formation, investigators postulated that caveolae may give rise to fenestrae in a process
involving fusion of a budding caveolar vesicle with the adjacent plasmalemma [7].
The discovery that PV-1 was common to the diaphragms that reside in both fenestrae
and caveolae of endothelial cells further supported this model [54]. Current evidence,
however, emphasises more differences than similarities in the nature of the two
organelles. General compositional differences between the two organelles were first
highlighted in tracer perfusion studies showing that caveolar diaphragms (also referred
to as stomatal diaphragms) lacked anionic sites amongst other molecular determinants
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that were present within the fenestral diaphragm [63, 64]. Furthermore, exclusion of 
the main structural component of caveolae, caveolin-1 , from fenestrae in vivo and in 
vitro [94], and the recent finding that knockout mice completely lacking caveolae still 
have fenestrae [99], provide compelling evidence for distinct origins of caveolae and 
fenestrae. However, the existence of a common structural precursor that differentiates 
to give rise independently to fenestrae and caveolae still remains a valid point for 
consideration.
13.4.4.2 The role o f  the diaphragm in fenestrae formation
The presence of a diaphragm in fenestrae is variable; it is found in the fenestrated 
capillaries of the intestine, the choriocapillaris, the choroid plexus and endocrine 
organs, while it is absent from the more permeable microvessels of the kidney 
glomerulus and the liver sinusoids [8 , 60, 100]. Diaphragmed fenestrae, however, do 
initially appear within the vessels of developing fetal glomerulus and liver [85, 101], 
which has raised speculation on a role for the diaphragm in fenestrae biogenesis, in 
addition to its putative role in gating the pore. Achieving a precise circular opening 
and facilitating the extreme membrane curvature at the rim of fenestrae, where apical 
and basal plasma membranes come together, could be functions of the protein-rich 
diaphragm.
1.3.4.4.3 Apical-basal plasma membrane fusion following actin displacement
Data demonstrating that actin microfilament disassembly triggers fenestrae biogenesis
have spawned a model whereby removal of the actin-rich cortex beneath the plasma
membrane is required to allow close apposition and fusion of apical and basal plasma
membranes [95]. Cortical actin removal has been shown to be an important
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prerequisite to membrane fusion during exocytosis, while removal of organelle-bound 
actin has been suggested to accelerate yeast vacuole membrane fusion [102, 103]. 
Whether the cytoskeleton also plays an instructive role in fenestrae formation remains 
to be established.
1.4 Adherens Junctions
1.4.1 Morphology and architecture
The distinction between the various types of intercellular junctions was first made by 
Farquhar and Palade through their work on intestinal epithelial cells [9]. In contrast to 
tight junctions {zonula occludens) where the intercellular space appeared completely 
obliterated, adherens junctions {zonula adherens or intermediary junction) allowed a 
2 0 0 A-wide space between adjacent epithelial cells (Figure 1 .2 ). Electron dense 
cytoplasmic material and a fibrillar network were observed along the depth of 
adherens junctions, which varied in length between 0.2 and 0.5 pm. The same 
structure, albeit less well-defined, was subsequently observed in endothelial cells 
[104]. Moreover, in contrast to the orderly succession of the different types of 
intercellular junctions in epithelial cells, a mosaic pattern of adherens and tight 
junctions is present along the length of the interendothelial area of contact [33].
1.4.2 Molecular Composition
The main molecular constituents in all adherens junctions are transmembrane proteins 
of the cadherin family (Figure 1.7) [105]. The extracellular regions of the proteins can
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Figure 1.7 Molecular organisation of endothelial cell-cell junctions. (A) Overview of 
the main types of junctions between endothelial cells, along with their transmembrane 
and membrane-associated components. VE-PTP, an endothelial specific-phosphatase 
that associates with VE-cadherin through the extracellular domains and catalyses its 
tyrosine dephosphorylation, is indicated. (Reproduced from Ref. 121) (B) Detailed 
view of the composition of endothelial adherens junctions. VE-Cadherin molecules 
associate through their extracellular domains in cis or in trans. The intracellular 
domain of VE-cadherin is linked to proteins of the catenin family, p i20, and others. 
Catenins link the complex to the actin cytoskeleton. (Reproduced from Ref. 109)
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mediate calcium-dependent homophilic adhesion, while the cytoplasmic tails associate 
with the actin cytoskeleton, resulting in the formation of stable junctions [105]. VE- 
cadherin is specifically expressed in endothelial cells [106], and its correct localisation 
is essential for the formation of adherens junctions [107]. Endothelial cells also 
express N-cadherin, and VE-cadherin-2, but neither of them localises to the adherens 
junction [33].
The VE-cadherin extracellular domain consists of five cadherin-like repeats arranged 
in a rigid, rod-like structure (Figure 1.7, B) [108]. Cadherins are thought to associate 
through their extracellular domains both in cis, within the same cell, and in trans, 
between adjacent cells, though the precise regions responsible for each arrangement 
have not been elucidated [33, 109]. The intracellular domains of classic cadherins are 
highly homologous, and bind p-catenin and plakoglobin (y-catenin) through their 
carboxy-terminal region [33, 109]. P-catenin and y-catenin, in turn bind to a-catenin, 
which through its binding to a-actinin and vinculin, anchors the complex to the actin 
cytoskeleton [33, 109]. In addition to catenins, p i20, another member of the 
armadillo family of proteins has been found to associate with VE-cadherin [33, 109]. 
p i20 appears to interact with the juxtamembrane region of VE-cadherin, and in 
contrast to catenin proteins does not participate in the linkage with the cytoskeleton. 
ZO-1, nestin, and afadin have been variably found to associate with adherens 
junctions, though their relevance to the complex is not as clear [3 3 ].
VE-cadherin is also present in lymphatics, linked to plakoglobin and p0071, and 
through them to desmoplakin, and vimentin, in a desmosomal-like structure termed 
complexus adhaerentes [33, 110].
36
Chapter 1: Introduction
1.4.3 Contribution to paracellular permeability
Adherens junctions are ubiquitous components of the vascular endothelium [33]. VE- 
cadherin is expressed early on during embryonic development and persists through 
adulthood [106, 111]. An essential role for VE-cadherin in vascular development was 
highlighted by the inability of mice with targeted disruption of the VE-cadherin gene 
to remodel their immature vascular plexi [112]. Embryonic lethality at 9.5 days of 
gestation precluded any analysis of the effects of VE-cadherin inactivation in vascular 
permeability.
Evidence from in vivo and in vitro studies has underlined a clear role for VE-cadherin 
in paracellular permeability. A key study demonstrated the breakdown of the 
endothelial barrier upon intravenous administration of a monoclonal antibody against 
VE-cadherin in a mouse [107]. Physical gaps within the vasculature, interstitial 
edema, and a number of inflammatory cells in the heart and lungs were evident upon 
ultrastructural examination. The effect was deemed specific for adherens junctions as 
the antibody induced the redistribution of VE-cadherin in cultured cells, without 
affecting tight junctions. In vitro evidence suggests that VE-cadherin is the end-target 
for a number of known permeability mediators: VEGF, thrombin, and histamine lead 
to a modulation of VE-cadherin with a concomitant increase in paracellular 
permeability [113-116].
The precise morphological changes accompanying the increase in permeability 
through junctions are unknown. Nevertheless, it appears that even subtle effects that 
strengthen or weaken the interactions between the molecular components of the 
complex can be sufficient in perturbing the endothelial barrier integrity. Such changes 
are not necessarily mirrored in the distribution of VE-cadherin itself, as evidenced by 
the increased paracellular permeability in P-catenin null endothelial cells, which
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otherwise display correct localisation of VE-cadherin and only altered distribution of 
a-catenin [17].
A more vigorous mechanism of junctional disorganisation may be in place during 
leukocyte extravasation in the course of an immune response [117]. Despite not being 
classified under paracellular permeability, the extent of leukocyte permeation through 
the capillary wall is a measure of endothelial integrity. In a pathway triggered by the 
leukocyte adhesion to intercellular adhesion molecule-1 (ICAM-1) [118], VE-cadherin 
is transiently removed from endothelial junctions, presumably to facilitate the passage 
of invading leukocytes, after which the adherens junction reassembles [119].
In addition to its role in paracellular permeability, VE-cadherin is implicated in a 
variety of cellular functions through interactions with intracellular signaling pathways 
[33, 120, 121]. Its effect in contact inhibition of cell-growth can be attributed to the 
sequestering of p-catenin at the plasma membrane, the recruitment of the phosphatase 
DEP-1/CD148 at sites of VEGFR-2, or the prevention of Src-homology-2(SH2)- 
domain-containing protein from activating the mitogenic RAS signaling pathway. Its 
role in apoptosis is thought to occur via the activation of the phosphatidylinositol 3- 
kinase (PI3K) pathway, while its role in the reorganisation of the actin cytoskeleton is 
attributed to its interaction with Tiam, a guanosine exhange factor for the small 
GTPase Rac. These and other roles for VE-cadherin have been extensively reviewed 
[33, 120, 121], and will not be analysed further in this section. Given the multitude of 
biological roles proposed for adherens junction components, it is not inconceivable 
that their effects on permeability are also exerted indirectly, through a modulation of 
transcription or signaling cascades. Along these lines, the conditional inactivation of 
the p-catenin gene in endothelial cells, leads to an increased number of fenestrae in 
vivo [17].
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1.4.4 Regulation
The regulation of VE-cadherin function can occur at many different levels [122]. 
Control at the stage of gene expression [123-125] will not be discussed, and instead 
this section will focus on regulation at the post-translational level that is likely to play 
a role in the dynamic and rapid changes taking place during a permeability response.
1.4.4.1 Linkage to cytoskeleton
VE-cadherin is intimately linked to the cytoskeleton through a number of different 
ways, a-catenin is a key player in this interaction, as it can associate with 
microfilaments directly, or indirectly through its binding to vinculin, a-actinin, or 
afadin, that in turn contain binding sites for actin [33, 126, 127]. The importance of F- 
actin binding was highlighted in experiments with E-cadherin, revealing that a crucial 
step in the biogenesis of adherens junctions was the cytoskeletal anchoring, and 
subsequent stabilisation of the cadherin-catenin complex, appearing as a distinct 
punctum of fluorescence by light microscopy [127, 128]. Conversely, junction 
formation and eventual sealing of neighbouring cells were both absent in cells lacking 
the cytoskeletal adaptor a -catenin [128]. A role for small GTPases in this process has 
been suggested through evidence for the ability of the Rac effector IQGAP to disrupt 
the P-catenin/ a-catenin interaction, unless prevented by associating with Rac [129]. 
Dissociation of VE-cadherin from the actin cytoskeleton has indeed been observed 
under some conditions that increase junctional phosphorylation and permeability, as 
inferred from its partition into the Triton X-100-soluble fraction [116, 130].
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1.4.4.2 Intracellular trafficking
Newly synthesised cadherins are thought to be transported from the Golgi apparatus to 
the plasma membrane through a pathway that requires an association with P-catenin 
[131]. Once they have reached the membrane, endocytosis is regarded as the 
mechanism regulating their local availability [132, 133]. VE-cadherin internalisation 
has been observed in response to a variety of stimuli including conditions leading to 
endothelial barrier dysfunction [109, 134-136].
Experiments on the prototype member of the family, E-cadherin, were the first to 
highlight a role for p i20 in regulating cadherin levels and cell-adhesion [137]. A role 
for p i20 in retaining VE-cadherin at the plasma membrane, and maintaining barrier 
function, was subsequently suggested through experiments that altered its levels in 
vitro [108, 138, 139]. In the absence of pl20, VE-cadherin internalises and co- 
localises with early endosomes, while the process can be inhibited altogether by the 
addition of lysosomal inhibitors [140], or rescued by replenishing the levels of p i20 
[108, 139]. Interestingly, Hakai, an E3 ubiquitin ligase was found to bind E-cadherin 
and enhance its endocytosis after displacing p i20 [141]. In addition, p i20 was found 
to bind the motor protein kinesin and facilitate the delivery of adhesion complexes 
from vesicular pools to the plasma membrane [142]. Two different mechanisms were 
proposed to explain the role of pi 20 in the regulation of VE-cadherin: protection from 
endocytosis, and promotion of cell-surface trafficking [109, 143].
Finally, a role for the actin cytoskeleton in the internalisation of cadherins has been 
suggested through studies with the small GTPases Rac and ARF6  [144, 145], while 
both clathrin-dependent [145] and clathrin-independent [146] endocytosis have been 
implicated.
40
Chapter 1: Introduction
1.4.4.3 Cleavage by proteases
Proteolytic cleavage is yet another mechanism recognised in the regulation of adherens 
junction levels [33]. Shedding of the extracellular domain of E-cadherin can occur 
through cleavage by metalloproteases [147], while the release of its intracellular 
domain has been shown for presenilin/gamma-secretase cleavage [148]. Proteolytic 
digestion of VE-cadherin has been observed, though so far only in the context of 
endothelial apoptosis and leukocyte extravasation [149, 150].
1.4.4.4 The role of phosphorylation
Tyrosine phosphorylation is a well recognised mechanism for the regulation of cell­
cell contacts. A correlation between enhanced tyrosine phosphorylation of the 
cadherin-catenin complex and junctional destabilisation has been established [151], 
while confluent endothelial cells in culture are accompanied by a decrease in the 
tyrosine phosphorylation of their junctional components [130]. Serine/threonine 
phosphorylation has been reported for E-cadherin [152], and p i20 [153], however 
given the lack of experimental evidence for its significance in VE-cadherin function, 
this section will focus on the more extensively studied tyrosine phosphorylation.
1.4.4.4.1 Protein tyrosine kinases
A variety of inflammatory and permeability mediators, including histamine, thrombin, 
and VEGF, lead to an increase in paracellular permeability through their stimulatory 
actions on receptor protein tyrosine kinases (RPTKs) or G-protein-coupled receptors 
[113, 114, 116]. Following receptor activation, the VEGF-signaling cascade that leads 
to an increase in permeability is thought to involve Src tyrosine kinases [154, 155],
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which are known to concentrate at adherens junctions [156]. Thrombin, on the other 
hand, is postulated to exert its effects by displacing the protein tyrosine phosphatase 
SHP2 from the cadherin-catenin complex [157].
It is noteworthy that VEGF-, histamine-, or thrombin-driven tyrosine phosphorylation 
and endothelial barrier disruption, could each be manifested in a separate way. A 
discrepancy exists between the observations on the effects of histamine on adherens 
junctions, and those of thrombin: the former cause an increase in the phosphorylation 
of VE-cadherins and catenins, with a concomitant decreased association between the 
complex and the cytoskeleton [116], akin to a situation of low cell density [130]; the 
latter also results in an increased tyrosine phosphorylation of junctional components, 
but this time with a decrease in the interaction within the VE-cadherin-catenin 
complex, and also a marked change in the cell-surface pattern of VE-cadherin [113]. 
The effect of VEGF is less clear, as two different studies of junctional perturbation, 
report both disruption and preservation of the adherens complex association with the 
cytoskeleton [114,158].
VE-cadherin, catenins, and p i20 can all be modified by phosphorylation, while VE- 
cadherin itself harbors nine tyrosine residues in its intracellular domain [14]. It 
appears that a complex mechanism is in place, and each response most likely reflects a 
combination of different phosphorylation changes that are possible within the realm of 
permutations available for each molecule and for each cell type. The different patterns 
of phosphorylation could in turn reflect different regulatory mechanisms, as discussed 
above.
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1.4.4.4.2 Protein tyrosine phosphatases
The continuous changes accompanying protein tyrosine phosphorylation, demand the
presence of phosphatases to balance out the actions of kinases. Indeed, a number of
protein tyrosine phosphatases (PTPs) have been found to associate with the cadherin-
catenin complex, including SHP-2, RPTPk, RPTPp/C, LAR, SHP-1, RPTPp, PTP1B
[33]. Vascular Endothelial protein tyrosine phosphatase (VE-PTP) is a recently
characterised phosphatase present specifically in endothelial cells (Figure 1.7, A)
[159]. It is the homologue of human protein tyrosine phosphatase p (HPTPp), and a
member of subclass III of receptor-type PTPs, bearing seventeen fibronectin III (FN
III) repeats on its extracellular portion, and a single catalytic domain in the
cytoplasmic tail [159, 160]. In contrast to other known phosphatase-substrate
interactions, VE-PTP was found to associate with VE-cadherin via the membrane-
proximal extracellular domains, while no interaction was detected between VE-PTP
and p-catenin [161]. Through triple transfection experiments, VE-PTP was shown to
reverse the VEGF-mediated tyrosine phosphorylation of VE-cadherin, and to increase
the endothelial barrier function [161]. Mutations in the catalytic domain of VE-PTP
abolish its ability to reverse the effects of VEGF on VE-cadherin phosphorylation and
on the endothelial barrier function (personal communication; Professor Dietmar
Vestweber, Max-Planck-Institute for Molecular Biomedicine, Munster, Germany),
suggesting a direct role of phosphatase activity in the regulation of permeability
through VE-cadherin. Akin to the function of its mouse homologue, HPTPp
expression is upregulated in a parallel fashion to an increase in membrane PTPase
activity in Human Umbilical Vein Endothelial Cells (HUVECs) displaying contact
inhibition of cell growth [162]. A substrate for HPTPp remains unidentified at present.
Phosphatase recruitment on cadherin-catenin complexes could mediate additional
functions besides simply the dephosphorylation of junctional components. DEP-
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1/CD 148 is another member of the Type III family of receptor protein tyrosine 
phosphatases [160], also expressed in endothelial cells, albeit non-exclusively [163]. 
It has been found to codistribute with VE-cadherin at interendothelial junctions [163], 
and recently also to dephosphorylate VEGFR-2, when the latter is in complex with 
VE-cadherin [164]. Dephosphorylation was dependent on the presence of both VE- 
cadherin and p-catenin, but not p i20 [164], and could represent part of a feedback 
mechanism whereby VE-cadherin mediates attenuation of VEGF signaling, its own 
activator.
The importance of maintaining a balance between kinases and phosphatases within a 
cell was underlined in a mouse model with targeted inactivation of the gene encoding 
DEP-1 [165]. Mice died before embryonic day 11.5, with defects in vascular 
development characterised by enlarged primitive vessels, impaired vascular 
remodeling, and increased endothelial proliferation. Loss of function of VE-PTP has 
not been reported to this day.
1.5 Permeability in disease
Pathological vascular permeability refers to the unregulated extravasation of fluid, 
plasma proteins, and in extreme situations, also cells, from the blood to the tissues. 
Such permeability accompanies conditions of acute or chronic inflammation, and 
neovascular disease. At the cellular level, breakdown of the endothelial barrier is 
manifested as an induction or a modulation of pre-existing structures mediating 
physiological permeability.
Tumors exhibit high vascular permeability, in association with angiogenesis [53]. 
Unusually large intercellular gaps [166], W O s [47], and fenestrae [167, 168] have all
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AFigure 1.8 Pathological vascular permeability. Abundant endothelial fenestrae are in 
a tumor vessel as seen by TEM (A) (Reproduced from Ref. 174). Intercellular opening 
(between arrows) in lining of a tumor vessel viewed by TEM (B) (Reproduced from 
Ref. 166) (Bar = 1 pm)
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been observed in the neovasculature of tumors (Figure 1.8), and consistent with their 
permeability properties can account for the extravasation of plasma proteins and 
interstitial edema. Intercellular gaps are also the sites of entry of tumor cells into the 
vasculature, providing the gateway for metastasis to other tissues [155].
Chronic inflammatory diseases such as rheumatoid arthritis and psoriasis are also 
associated with increased neovascularisation and hyperpermeability. [169, 170]. 
Leukocyte infiltration is a common element of both diseases, and presumably occurs 
through disrupted junctions. In addition, psoriatic lesions have been shown to be 
extensively fenestrated [171].
Upregulation of VEGF is a central component in the hyperpermeability manifestations
in tumors, rheumatoid arthritis, retinopathies, and inflammatory skin disorders [53].
Since VEGF is a potent modulator of tight junctions [172], adherens junctions [155],
W O s [51], and fenestrae [69, 173], while a combination of the different endothelial
specialisations is usually involved in the hyperpermeability response, distinguishing
among their individual contributions is a challenge. Moreover, the actions of VEGF as
an endothelial mitogen and motogen, are difficult to isolate from its effects on leakage,
as angiogenesis and permeability appear to occur in conjunction. As often happens in
diseases that affect the differentiation program of cells, neovascular disease shares
many common features with the early vascular system of the brain, prior to the
establishement of the blood-brain barrier [22]. Nonetheless, VEGF is capable of
inducing rapid changes in permeability, as demonstrated by the formation of fenestrae
in normally non-fenestrated vascular beds within minutes of application [173].
Since VEGF is downregulated in most adult tissues [92], with the exception of sites
undergoing angiogenic remodeling, it presents an attractive therapeutic target. A
recent study showed that an inhibitor of VEGF was able to suppress the presence of
tumor endothelial fenestrae and lead to the regression of tumor vessels [174]. More
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focused therapeutic targeting on specific VEGF isoforms [175] or specific attributes of 
endothelial substructures, could potentially enhance the efficacy of treatments.
1.7 Convergence of pathways and outline of thesis
The focus of this thesis is divided among two components of the endothelial barrier, 
fenestrae and adherens junctions. Despite the obvious morphological and functional 
differences between the two membrane specialisations, a number of common elements 
can be recognised.
First of all, VEGF acts as a common denominator between fenestrae, adherens 
junctions, and also a number of other structures involved in physiological and 
pathological vascular permeability. Acknowledged as a potent permeability factor, 
VEGF can regulate the gating properties of junctions, and is most likely involved in 
both the biogenesis and the maintenance of fenestrae. Binding to different receptors, 
activation of different intracellular pathways, and interaction with separate signaling 
cascades could all contribute to the expression of unique phenotypes, starting with a 
single growth factor. Secondly, the actin cytoskeleton appears to have a central role in 
establishing both types of endothelial specialisations. Well-accepted determinants of 
cell shape, actin microfilaments can promote the formation of adherens junctions and, 
as I will argue in this thesis, inhibit the formation of fenestrae. Regulatory functions, 
in addition to structural scaffolding, have been attributed to cytoskeletal components 
of adherens junctions. Equivalent roles for microfilaments in fenestrae are not 
unlikely, though at the moment remain speculative in absence of substantial 
experimental evidence.
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The studies presented in this thesis were aimed at providing insight into areas of 
knowledge deficit, in the fields of fenestrae and adherens junction biology. With 
information almost exclusively at the morphological and ultrastructural level the 
development of novel tools to enable biochemical and cell biological investigations of 
fenestrae was deemed critical. On the other hand, the extensively characterised 
properties of adherens junctions in vitro seemed best complemented by in vivo studies 
assessing the consequences of junction modulation on the endothelial barrier. Thus, a 
structural and functional analysis of vascular permeability was undertaken, the 
ultimate goals of which were to drive the molecular characterisation of fenestrae, and 
the creation of an in vivo model to study paracellular permeability modulation by 
phosphatases. The ensuing chapters present the systematic approach pursued in 
establishing an in vitro model for fenestrae formation and devising biochemical 
methods for the isolation of fenestrated plasma membranes, which resulted in the 
identification of fenestrae protein candidates through subcellular proteomics, and the 
characterisation of a novel fenestrae sieve plate component. The last chapter describes 
the creation of a transgenic mouse model for the study of endothelial barrier 
dysfunction, through conditional overexpression of wildtype or mutant versions of the 
adherens junction phosphatase VE-PTP.
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2.1 Reagents
All chemicals were purchased from Sigma-Aldrich and Fluka, unless otherwise 
indicated. All culture media and related products were obtained from Invitrogen, 
unless otherwise stated. All restriction endonucleases were purchased from New 
England Biolabs. Phosphate Buffered Saline without calcium or magnesium (PBS), 
Luria-Bertani (LB) medium, LB-agar, Ethylene Diamine Tetraacetic Acid (EDTA), 
trypsin/versene, and Leibovitz L-15 medium were provided by CRUK or Eyetech 
Research Center central services. L-glutamate and penicillin/streptomycin were 
provided by CRUK central services or purchased from Invitrogen. Oligonucleotides 
were provided by CRUK oligonucleotide synthesis service or purchased from Proligo, 
unless otherwise indicated.
2.2 Bacterial culture
2.2.1 Preparation of electrocompetent cells
5 ml from an overnight culture of XL-1 blue bacteria (Stratagene), were added to 800 
ml of LB medium and grown at 37°C with shaking to an OD5 9 5  of 0.6. The culture 
was incubated for 30 minutes on ice and centrifuged at 5,000rpm for 20 minutes at 
4°C using a JA-10 rotor of an Avanti J-E centrifuge (Beckman Coulter). The pellet 
was washed twice with 800 ml ice-cold water, once with 400 ml ice-cold 10% 
glycerol, and was finally resuspended in 1 volume ice-cold 10% glycerol. Aliquots of 
the preparation were stored at -80°C.
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2.2.2 Transformation
50-500 pg DNA was added to 80 pi of electrocompetent cells in a 1 mm 
electroporation cuvette (Bio-Rad). Mixtures were incubated on ice for 10 minutes and 
transformations were performed at 200ft, 25pF, and 1.8kV. Bacteria were incubated 
with 400 pi SOC medium at 37°C for lhour, and then centrifuged at full speed in a 
microcentrifuge. Pellets were resuspended in 100 pi LB medium, plated on agar 
plates containing Ampicillin (75 pg/ml) and incubated overnight at 37°C.
2.2.3 Cryopreservation
Bacterial cultures were stored as 50% glycerol stocks at -80°C
2.3 Mammalian tissue culture
2.3.1 Isolation of mouse embryonic fibroblasts
14.5 day old embryos were dissected from the extraembryonic membranes in 
Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen). The liver was 
discarded, the head was removed for genotyping and the remainder of the embryo was 
incubated with 1 ml of trypsin/versene for 45 minutes on a shaker set at 37°C. The 
embryo was dissociated by pipetting up and down five times, using a plastic Pasteur 
pipette, and then split between two 60 mm dishes.
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2.3.2 Maintenance of mammalian cell lines
Cell Line Species Origin Passage No Culture conditions
bEND5 mouse
brain
endothelioma
13-25
DMEM high glucose with sodium pyruvate, 
10%FBS, 4mM L-glutamate, 
penicillin/streptomycin, 5pM p-mercaptoethanol, 
non-essential amino acids. 37°C incubator with
Py4.1 mouse
ear and tail 
hemangiomas
DMEM high glucose with sodium pyruvate, 2%FBS, 
penicillin/streptomycin. 37°C incubator with 
10%CO2
NIH 3T3 
(ATCC)
mouse embryo
DMEM high glucose with sodium pyruvate, 10% 
FBS, 4mM L-glutamate, penicillin/streptomycin, 
1.5g/L sodium bicarbonate. 37°C incubator with 
5%C02
HUVEC
(Cascade
Biologies)
human
umbilical
vein
3-5
M200, low supplement growth serum, 
penicillin/streptomycin (Cascade Biologies). 37°C 
incubator with 5%C02
SVEC4-10
(ATCC)
mouse lymph node 3-5
DMEM high glucose with sodium pyruvate, 10% 
FBS, 4mM L-glutamate, penicillin/streptomycin, 
1.5g/L sodium bicarbonate. 37°C incubator with 
10%CO2
TetO-VE-PTP
MEF
mouse embryo 2-3
DMEM high glucose with sodium pyruvate, 10% 
FBS Tet system approved (Clontech), 4mM L- 
glutamate, 2 x penicillin/streptomycin, 1.25 pg/ml 
Fungizone. 37°C incubator with 10%CO2
MEF 3T3 Tet- 
O ff cell line 
(Clontech)
mouse embryo 3
DMEM high glucose with sodium pyruvate, 10% 
FBS Tet system approved (Clontech), 4mM L- 
glutamate, penicillin/streptomycin. 37°C incubator 
with 10%CO2
All cell lines were trypsinised using trypsin/versene solution. Alternatively cell lines 
were trypsinised using lx  Trypsin EDTA solution (Invitrogen), apart from bEND5 
and Py4.1 cells which required lOx Trypsin EDTA solution (Invitrogen), diluted 1:1 
with DMEM.
Cells were thawed by diluting the contents of an ampule in 9 volumes of medium, 
sedimenting the cells at 300g and resuspending the pellet in the appropriate volume of 
complete medium. Cells were frozen in 10% DMSO, 20% Fetal Bovine Serum 
(FBS), and 70% of complete medium, and were stored in liquid nitrogen.
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2.3.3 Transient transfection of mammalian cell lines
Mouse embryonic fibroblasts (MEFs), isolated from 14.5 day embryos were 
transfected using either Superfect (Qiagen) or Fugene (Roche). For transfections with 
Superfect, cells were seeded onto glass coverslips on the day before transfection at a 
density equivalent to lxlO5 cells per well of a 24-well plate. The next day the cells 
were transfected in serum free DMEM without antibiotics. 1 pg DNA and 5 pi 
Superfect were incubated with the cells for 3 hours, after which complexes were 
replaced with normal medium. Cells were fixed 24 hours post transfection. For 
transfections with Fugene, the same density of cells was seeded and grown overnight, 
and then transfected in DMEM without antibiotics. 0.2 pg DNA and 0.6 pi Fugene 
were incubated with the cells, and without replacing the medium, cells were fixed 24 
hours post transfection. MEF 3T3 Tet-Off cells were transfected using Superfect 
(Qiagen) as described above. In all experiments, an expression plasmid encoding 
Green Fluorescent Protein (GFP) was transfected in parallel as a control for 
transfection efficiency.
2.3.4 Suppression of Tet-Off constructs by doxycycline
MEF 3T3 Tet-Off cells transfected with Tet-VE-PTP responder constructs, or MEF 
cells from TetO-VE-PTP transgenic animals (TetO-VE-PTP MEF) transfected with 
pTetOn (Clontech), were incubated in medium containing 2 pg/ml Doxycycline 
(Sigma) in order to suppress the expression of the VE-PTP transgene.
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2.3.5 Fenestrae induction in endothelial cells
Coverslips and dishes were coated with 1% gelatin (Sigma) solution in PBS for 30 
minutes at room temperature. Endothelial cells were seeded on the day before 
induction at a density equivalent to 1.5xl06 cells per 100 mm dish. The next day, 
cultures were induced at 60-70% confluency, using Cytochalasin B (Sigma) at 10 pM 
for 2 hours, Latrunculin A (Molecular Probes) at 2.5 pM for 3 hours, or a combination 
of recombinant mouse VEGF (R&D systems) at 75 ng/ml for 6-72 hours and 10 pM 
Cytochalasin B for 2 hours. Cells were processed for biochemistry or morphology 
immediately after the end of the induction.
To inhibit protein synthesis during fenestrae formation, cells were incubated with 10 
pg/ml Cycloheximide (Sigma) for 30 minutes, and then induced with VEGF (75 
ng/ml) for 6  hours and Cytochalasin B (10 pM) for the last 2 hours.
2.4 DNA techniques
2.4.1 Preparation of genomic DNA
Mammalian tissues were digested in 0.5 ml of lysis buffer (100 mM Tris HC1 pH 8.5, 
5 mM EDTA, 0.2% SDS, 200 mM NaCl, 0.5 mg/ml proteinase K), shaking at 55°C 
overnight. Digested tissues were centrifuged to remove any undigested parts, mixed 
with 0.5 ml isopropanol, and DNA was sedimented by centrifuging at 21,000g for 8  
minutes at 4°C. After one wash with 70% Ethanol, DNA was allowed to dry and was 
finally resuspended in 100 pi of 0.2 x TE buffer (10 mM Tris pH8.0, 1 mM EDTA).
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2.4.2 Preparation of plasmid DNA
Plasmid DNA was purified from overnight cultures, grown at 37°C in LB containing 
Ampicillin (75 pg/ml), using Qiagen plasmid mini kits, QIAfilter plasmid midi, or 
maxi kits according to the manufacturer’s instructions.
2.4.3 Ethanol precipitation of DNA
DNA. solutions were mixed with 0.1 volumes 8M LiCl and 3 volumes cold Ethanol. 
Glycogen was often added to facilitate visualisation of the precipitate. The mixture 
was placed at -20°C for 20 minutes; DNA was centrifuged at 21,000g for 20 minutes, 
washed twice with 70% Ethanol, air-dried and resuspended in TE buffer.
2.4.4 Quantitation of DNA
DNA solutions were placed in a quartz cuvette (1 cm path length) and the absorbance 
of the mixture was read at 260 nm and 280 nm using a Spectrophotometer. The OD260 
of 1, corresponding to 50 pg/ml double stranded or 33 pg/ml single stranded DNA, 
was used as a reference for DNA concentration calculations. The OD260/280 ratio was 
used as an estimate for purity of the preparation. A ratio of 1.6-1.9 was considered 
acceptable.
2.4.5 Restriction enzyme digestion
For small scale diagnostic digests, 0.5 pg of DNA was incubated in the appropriate 
buffer with 5-10 U of restriction endonuclease in a total volume of 20 pi. The
reaction was incubated at the appropriate temperature (25°C or 37°C) for 1-2 hours.
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For large scale digests, 5 pg of DNA was incubated in the appropriate buffer with 20- 
30 U of restriction endonuclease in a total volume of 70 pi. The reaction was 
incubated for 2-3 hours at 25°C or 37°C. Following digestion, enzymes were 
inactivated by incubating at 80°C for 20 minutes.
2.4.6 Polymerase chain reaction (PCR)
Primers were 20-22 nucleotides in length, usually with two GC-basepairs at the 3’- 
end, and annealing temperatures of approximately 55°C. The annealing temperature 
specific to each primer was calculated using the following formula: Tm = 3 x (sum of 
GC-basepairs) + 2 x (sum of AT-basepairs). Reactions were carried in a Peltier 
thermal cycler (MJ Research PCR Machine).
To genotype the TetO-VE-PTP strain, a combination of 3 primers were used in each 
reaction: TG primer recognised a sequence only present in the transgene, GE primer 
recognised a sequence only present in the endogenous copy of the gene, and CO 
primer recognised a region common to both the transgene and the endogenous 
versions of VE-PTP.
GE: 5’-CTGCCACGGCCCTTGAGCATCG-3’
TG: 5 ’ -CTCGGT ACCCGGGTCG AGT AGGC-3 ’
CO: 5 ’ - ACGCTC AGTGTT ATCC AC AAGGCCG-3 ’
2 pi of genomic DNA preparation from mouse tail were mixed with 40 pmols GE 
primer, 40 pmols TG primer, 80 pmols CO primer, and 15 pi Mega Mix Blue (Helena 
Biosciences). The reaction conditions were as follows:
56
Chapter 2: Materials and methods
Segment 1 1 cycle 94°C for 4 minutes
Segment 2 35 cycles 94°C for 40 seconds
64°C for 1 minute 
72°C for 1.5 minute 
Segment 3 1 cycle 72°C for 3 minutes
Tie2-tTa mice were genotyped using the following PCR primers (provided by Dr. 
Urban Deutsch, Theodor Kocher Institute, Bern, Switzerland):
HHFW1: 5 ’ -CGAT ACC AT AC AT AGGT GG AGG-3 ’
rtTAREVl: 5’-AATGGCTAAGGCGTCGAGCAAAG-3’
10 pmol of each primer were mixed with 2 pi tail DNA and 15 pi Mega Mix Blue 
(Helena Biosciences), and run according to the following PCR scheme:
Segment 1 1 cycle 94°C for 5 minutes
Segment 2 35 cycles 94°C for 30 seconds
63°C for 45 seconds 
72°C for 1 minute 
Segment 3 1 cycle 72°C for 8 minutes
TetO-LacZ responder strains (nZL2 and TRE-LacZ 2717) were genotyped using the 
following PCR primers (provided by Dr. Urban Deutsch):
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LacZFW4: 5’-CCGTCACGAGCATCATCCTC-3’
LacZREV4: S’-GACGAAACGCCTGCCAGTATTTAG-S’
13 pmol of each primer were mixed with 2 pi tail DNA and 15 pi Mega Mix Blue,
and run using the same reaction conditions as in the Tie2-tTA PCR, only with an
annealing temperature of 60°C.
2.4.7 DNA sequencing
Primers of about 18 nucleotides were designed to amplify a region within the gene of 
interest or the vector sequence surrounding the gene. Reactions were carried out 
using 500 ng of a given plasmid, 3-4 pmol of primer, and 8 pi of fluorochrome 
labelling mix (CRUK), in a total volume of 20 pi. PCR conditions were the 
following:
Segment 1 25 cycles Denaturation at 96°C for 10 seconds
Annealing at 50°C for 5 seconds 
Extension at 60°C for 4 minutes
Following amplification, DNA was ethanol precipitated, electrophoresed and 
visualised. SDS-PAGE electrophoresis and visualisation were performed by CRUK 
Sequencing Service. Sequence analysis and alignment was performed using the 
software programs Mac Vector (Accelrys) and Sequencher (Gene Codes Corporation). 
The following oligonucleotides were used to sequence TetO-VE-PTP plasmids:
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Bluescript T3: 5 ’ - AATTAACCCTC ACT AAAGGG-3 ’
Bluescript T7: 5 ’ -GT AAT ACG ACT C ACT AT AGGGC-3 ’
Bluescript M13Fwd: 5’-GTAAAACGACGGCCAGT-3’
VEP-A5: S’-ACCTTCAGATTTGAGACTTCCATG^’
VEP-S3: 5 ’ -C AGT GAT ACC AGC AG AT AC AGC-3 ’
VEP-S4: 5’-GTGTCTGCATTCAGACAGGACG-3’
VEP-S5: 5 ’ -CT GT AT GT GGT G ACT C AC AGT G-3 ’
VEP-FW2: 5 ’ -GGTTC AGCG AC ACC AACGG AG-3 ’
VEP-FW4: 5 ’ -CCT CTT GCCT GAG AAT CG AGG-3
FWD-R/A: S’-CATCCGTCACTTTCACTACAC^’
Qligo(+):
5 ’ -CGCGGCCGCTCT AG AGTTT AAACGGCGCGCCTT AATT AAAG AT CTG-3 ’ 
All YEP primers were provided by Dr. Urban Deutsch.
2.4.8 DNA agarose gel electrophoresis
Agarose gels were prepared by dissolving 0.6-2% agarose in TAE buffer (40 mM Tris 
Base pH8.0, 20 mM glacial acetic acid, 1 mM EDTA). Ethidium bromide was added 
to a final concentration of 0.5 pg/ml. DNA was mixed with lOx BlueJuice™ gel 
loading buffer (Invitrogen) and electrophoresed at 5-20 V/cm in TAE buffer. A 100 
bp or 1 kb DNA ladder (Invitrogen) was loaded in an adjacent well for comparison.
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2.4.9 Gel purification of DNA fragments
Gel slices containing relevant DNA fragments were excised and stripped of agarose 
and contaminants using a gel extraction and nucleotide removal kit (Qiagen).
2.4.10 Cloning
2.4.10.1 Cohesive-end ligation
Restriction digests for the insert and vector were performed. The vector fragment was 
also dephosphorylated with 0.5 U/pg DNA of alkaline phosphatase (CIP, New 
England Biolabs), for 1 hour at 37°C, to prevent recircularisation in the case of 
compatible ends. Following purification, vector and insert were ligated using 200-300 
ng total DNA with a 2-4 fold molar excess of insert, and 400 U T4 DNA ligase (New 
England Biolabs) in 15 pi total volume. The reaction was carried out overnight at 
15°C. 1 pi of the ligation reaction was used to transform E.coli as described above.
2.4.10.2 Blunt-end ligation
Restriction digests of vector and insert were performed as above. Fragments were 
incubated with T4 DNA polymerase (New England Biolabs) at 1-2 U/pg DNA, 
200pM dNTP mix (Ultrapure, Pharmacia), and 0.1 mg/ml BSA, at 12°C for 20 
minutes so as to form blunt ends. The polymerase was inactivated by incubating at 
75°C for 10 minutes, and the vector was dephosphorylated with alkaline phosphatase 
as above. Following purification, vector and insert were ligated as described above, 
only using 2-fold molar excess of vector.
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2.5 RNA techniques
2.5.1 RNA isolation
Total RNA was isolated from cells or tissues using the RNeasy mini kit (Qiagen). 3- 
5xl06 MEF cells were lysed in 350 pi RLT buffer (Qiagen) by pipetting, and the 
contents loaded on to 1 RNeasy mini column. 11.5 day old embryos were snap-frozen 
and immediately homogenised in 800 pi RLT buffer using a mortar and pestle. The 
lysate was passed through a QIAshredder spin column (Qiagen) and split between two 
RNeasy mini columns. RNA purification was carried out according to the 
manufacturer’s instructions, with the additional step of on-column DNA digestion 
performed using the RNase-Free DNase Set (Qiagen). RNA was eluted in water and 
any remaining DNA was removed from the samples by treating 5 pg RNA with 1U of 
rDNase I (DNA-^ree, Ambion) in a total volume of 50 pi for 1 hour at 37°C. rDNase 
I was inactivated by supplementing the reaction with DNase Inactivation reagent, and 
RNA was snap-frozen and stored at -80°C.
2.5.2 RNA quantitation
RNA solutions were placed in a quartz cuvette (1 cm path length) and the absorbance 
of the mixture was read at 260 nm and 280 nm using a Spectrophotometer. The OD2 6 0  
of 1, corresponding to 40 pg/ml RNA, was used as a reference for calculations. To 
obtain an accurate OD2 6 0 /2 8 0  ratio, RNA was diluted in 10 mM TrisHCl pH 7.5. A 
ratio of 1.9-2.1 was expected for a pure preparation.
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2.5.3 RNA agarose gel electrophoresis
1.2% agarose gels were prepared in TBE buffer (45 mM Tris-borate pH 8.0, 1 mM 
EDTA) containing ethidium bromide at a final concentration of 0.5 pg/ml. RNA was
'T’W
mixed with lOx BlueJuice gel loading buffer (Invitrogen) and electrophoresed at 5- 
20 V/cm in TBE buffer. Sharp and distinct ribosomal RNA bands, with the 28S 
ribosomal RNA band of double intensity to the 18S RNA band, were an indication of 
intact RNA.
2.5.4 RT-PCR
Reverse transcription of RNA was performed using 1 pg RNA and a two-step reaction
Til
using Superscript RNase H' Reverse Transcriptase (Invitrogen): RNA, 1 pi Oligo 
(dT)i2 -i8 (Invitrogen), 1 pi 10 mM dNTP (Invitrogen), in a total volume of 12 pi, were 
heated to 65°C for 5 minutes in a thermal cycler. After cooling on ice, the reaction 
was supplemented with 4 pi 5x First-Strand buffer, 2 pi 0.1 M DTT, 1 pi 
RNaseOUT™ (Invitrogen), and heated to 42°C for 2 minutes. Finally, 1 pi 
Superscript™ II was added, and the reaction was incubated at 42°C for 50 minutes. 
The enzyme was inactivated by heating for 15 minutes at 70°C.
To specifically look at TetO-VE-PTP transgene, primers were designed to amplify a 
region extending to the transcribed exogenous promoter sequence which was also 
absent from the endogenous copy of the gene:
rt-te3: 5 ’ - AT GC ACT AGT GGCGCCT GTCG-3 ’
rt-revl: 5,-ACTTGCTCTGCCACTCCAGTCTGC-3’
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The housekeeping gene p97 was selected as an internal control, and was amplified 
with primers that spanned an intron, so as to distinguish between cDNA and any 
genomic DNA contaminant:
P97.RT.1859S: 5’-ACGGCAAGCTGCCCCCTGTG-3’
p97.RT.2321 A: 5’-CATAGCCGATGGATTTGTCTGC -3’
For each PCR reaction, 2 pi cDNA was mixed with 15 pi Mega Mix Blue (Helena 
Biosciences), 40 pmol of each TetO-VE-PTP primer, and 1 pmol of each p97 primer. 
The reaction conditions were the same as for genotyping TetO-VE-PTP mice.
2.5.5 Real time quantitative PCR (Taqman)
Reverse transcription of RNA was performed using 300 ng RNA and the following 
reaction mix (ABI): 1 x RT buffer, 5.5 mM MgC^, 500 pM of each dNTP, 2.5 pM 
random primers, 0.4 U/pl RNase Inhibitor, 1.25 U/pl Multiscribe Reverse 
Transcriptase, supplemented with Nuclease-Free water (Ambion) to a total volume of 
60 pi. cDNA synthesis was carried out in a thermal cycler according to the following 
scheme:
Segment 1 1 cycle 25°C for 10 minutes
Segment 2 1 cycle 42°C for 60 minutes
Segment 3 1 cycle 95°C for 5 minutes
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Taqman cocktails were prepared using lx  PCR master mix (ABI), 5 pi cDNA, 250 
nM of each primer, and 500 nM of probe, in a total volume of 25 pi. The following 
primer/probe sets (ABI) were used:
Endogenous VE PTP Fwd: 5’- CCA CCG GCC CTT GAG CAT-3’
Endogenous YE PTP Rev: 5’- CCA GCC AGG GCA CTT CTG-3’
Endogenous VE PTP Probe: 5’- CGC TCA ACA AGT GGT AC-3’
Transgene VE PTP Fwd: 5’- GCA TGC AAG CTT CAC ATA TGC-3’
Transgene VE PTP Rev: 5’- CCA GCC AGG GCA CTT CTG-3’
Transgene VE PTP Probe: 5’- CGC TCA ACA AGT GGT AC-3’
Total VE PTP Fwd: 5’- TAA CAC TGA GCG TCG TGC AGA-3’
Total VE PTP Rev: 5’- CTA GAG ACC CTG GAC TCC AAC AG-3’
Total VE PTP Probe: 5’- CAG AGC AAG TGA AAT GTA-3’
Tie2-tTA Fwd: 5’- ACG GCG CTC TGG ATA TGG-3’
Tie2-tTA Rev: 5’- TTC CAA GGG CAT CGG TAA AC-3’
Tie2-tTA Probe: 5’- CGA CTT CGA GTT TGA GCA-3’
For VE-PTP, endogenous primer/probe sets were designed to only amplify the 
endogenous VE-PTP copy, transgene primer/probe sets to only amplify the transgene 
copy, while total VE-PTP primer/probe sets were non-discriminatory between the two 
versions.
GAPDH served as the internal control in all reactions, and was amplified with rodent 
GAPDH primers and probe (ABI).
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Reactions were loaded on Prism Optical tubes (ABI) and run in the ABI Prism 7700 
Sequence Detection System using the following cycling conditions:
Segment 1 1 cycle 50°C for 2 minutes
Segment 2 1 cycle 95°C for 10 minutes
Segment 3 40 cycles 95°C for 15 seconds
60°C for 1 minute
Results were analysed using the SDS 7900HT Software 2.2 (ABI).
2.6 Protein techniques
2.6.1 Protein concentration determination
Protein concentrations were determined using the Bio-Rad Protein Assay (Bio-Rad) in 
microtiter plates. Samples diluted in water, and bovine serum albumin (BSA) 
standards diluted in water and sample diluent, were incubated with Bio-Rad Protein 
Assay reagent for 5 minutes at room temperature and the absorbance was measured in 
a Spectrophotometer at OD595. Standard curves were created based on the absorbance 
of BSA standards and were used to assign protein concentrations to samples. The 
Detergent Compatible Bio-Rad Protein Assay was used for proteins in buffers 
containing high concentrations of detergent, and was carried out in a similar fashion, 
with sample or standard absorbance measured at OD795.
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2.6.2 Protein precipitation
Proteins were precipitated overnight in 80% acetone (v/v) at -80°C and subsequently 
centrifuged for 30 minutes at 21,000g at 4°C. The pellet was resuspended in the 
desired volume of buffer.
2.6.3 Plasma membrane isolation using cationic colloidal silica
All steps in the procedure were performed on ice or in centrifuges pre-cooled to 4°C.
Cells grown on 150 mm dishes were washed twice with PBS containing calcium and
magnesium (Invitrogen), and once with coating buffer (20 mM MES, 135 mM NaCl,
0.5 mM CaCb, 1 mM MgCh, pH 5.5). Cells were then coated with 8 ml of a 1%
cationic colloidal silica solution (kind gift of Professor Donna Stolz, University of
Pittsburg) in coating buffer for 2 minutes. After one wash with coating buffer, cells
were coated again, for 1 minute, with 8 ml of 1 mg/ml polyacrylic acid (Aldrich)
solution in coating buffer, adjusted to pH 6.0-6.5. Cells were washed once with
coating buffer and once with lysis buffer (2.5 mM Imidazole pH 7.0, supplemented
with Complete EDTA-free protease inhibitor tablets, Roche), prior to incubation in
lysis buffer for 15 minutes. The lysis buffer of induced cells was supplemented with
2.5 pM latrunculin A, to maintain the fenestrated phenotype during the incubation
period. Cells were scraped in a total of 2 ml lysis buffer and lysed by 20 strokes in a 7
ml Dounce tissue grinder with a tight pestle (Wheaton). Lysis was ensured by
examining the cells by Phase-Contrast Microscopy. Silica-coated plasma membranes
and nuclei were sedimented at 900g for 10 minutes. To obtain internal membranes,
the supernatant was centrifuged at 100,000g for 30 minutes in a TLA 100.3 rotor of an
Optima TLX Ultracentrifuge (Beckman Coulter). The pellet of plasma membrane and
nuclei was resuspended in 1 ml of lysis buffer, supplemented with 20 pi of Benzonase
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grade II (Merck BDH), and homogenised with 1 ml of 100% Nycodenz in lysis buffer 
in a dounce tissue grinder. The homogenate was layered onto a 0.5 ml cushion of 
70% Nycodenz in lysis buffer, and was supplemented with another layer of 2 ml lysis 
buffer, prior to sedimenting at 60,000g for 30 minutes in a SW55 Ti rotor of an 
Optima L-80 Ultracentrifuge (Beckman Coulter). The pellet containing silica-coated 
plasma membranes was washed 3 times with lysis buffer and proteins were 
solubilised by boiling silica-coated membranes in silica lysis buffer (3.4% SDS, 120 
mM Tris pH 6.8) for 15 minutes. Residual silica was sedimented at 21,000g, and the 
supernatant containing solubilised plasma membranes was snap-frozen and stored at - 
80°C.
For quality control purposes, samples were removed from various fractions during the 
course of the purification and were solubilised in silica lysis buffer. Whole cell 
lysates were prepared by washing a 150 mm dish twice with PBS, scraping and 
sedimenting the cells at 300g, and finally lysing the pellet in 300 pi silica lysis buffer. 
Equal amounts of solubilised cellular fractions were supplemented with DTT and 
glycerol (EM Science), to a final concentration of 0.1 M and 5%, respectively. They 
were then separated by SDS-PAGE gel electrophoresis.
2.6.4 Differential extraction of cells
Cells grown on 60 mm dishes were briefly washed with PBS and were then incubated 
for 30 minutes on ice with 0.5 ml of extraction buffer (10 mM Tris pH 8.0, 150 mM 
NaCl, 2 mM EDTA, Complete EDTA-free Protease inhibitor tablets, Roche, and 
0.1%, 0.2%, 0.5%, or 1% Triton X-100, EM Science). Cells were scraped, and 
insoluble material was pelleted by centrifugation for 30 minutes at 21,000g at 4°C. 
Detergent soluble material was acetone precipitated, and pellets recovered from either
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the precipitated soluble material, or from the insoluble material were resuspended in 
the same volumes of lx  SDS sample buffer, to be separated by SDS-PAGE gel 
electrophoresis.
Alternatively, to visualise insoluble material by immunofluorescence, cells grown on 
60 mm dishes were incubated for 3 minutes on ice with 3 ml of extraction buffer. 
Detergent soluble material was removed; cells were washed twice in PBS, and fixed 
for immunofluorescence
2.6.5 Immunoprecipitation
Cells grown on 100 mm dishes were briefly washed with PBS and were then 
incubated for 30 minutes on ice with 1 ml of immunoprecipitation buffer. The 
following immunoprecipitation buffers were used:
IP buffer 1: 20 mM Tris HC1 pH 7.5, 0.1% Triton X-100 (EM Science), 10%
glycerol (EM Science), Complete EDTA-free Protease inhibitor tablets (Roche)
IP buffer 2: 10 mM HEPES pH 7.5, 150 mM NaCl, 0.1% NP-40, 1 mM DTT,
Complete EDTA-free Protease inhibitor tablets (Roche)
RIP A buffer: 10 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100 (EM Science), 
0.5% SDS, 5% sodium deoxycholate, Complete EDTA-free Protease inhibitor tablets 
(Roche)
Differential extraction buffer: 10 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 
Complete EDTA-free Protease inhibitor tablets (Roche), 0.1% Triton X-100(EM 
Science).
Cells were scraped, and insoluble material was pelleted by centrifugation for 30 
minutes at 21,000g at 4°C. Protein concentration of the supernatant was measured 
and 500 pg of the lysate was incubated overnight at 4°C with 5 pg of antibody.
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Protein G sepharose 4 Fast Flow (Amersham Biosciences) beads were washed 3 
times with immunoprecipitation buffer and incubated with the lysate, at a dilution of 
1:20 for lh  at 4°C. Immunocomplexes and beads were separated by centrifugation at 
16,000g for 5 minutes at 4°C. The beads were washed 3 times with 
immunoprecipitation buffer and immunocomplexes were eluted by boiling for 10 
minutes with 40 pi of 2x SDS sample buffer, to be separated by SDS-PAGE gel 
electrophoresis.
2.6.6 One-dimensional SDS-Polyacrylamide gel electrophoresis
Gels were poured at a thickness of 1 to 1.5 mm using the Bio-Rad Mini gel assembly 
kit and acrylamide solutions from National Diagnostics. The separating gel was 
prepared as follows:
final
acrylamide
concentration
ProtoGel (ml) Resolving buffer (ml)
deionised H20  
(ml)
6% 2 2.5 5.39
8% 2.67 2.5 4.72
10% 3.33 2.5 4.06
12% 4 2.5 3.39
15% 5 2.5 2.39
100 pi of 10% APS (Sigma) and 10 pi TEMED (Sigma) were added per 10 ml of gel 
solution to enhance polymerisation.
The stacking gel was prepared by mixing 1.3 ml ProtoGel, 2.5 ml ProtoGel Stacking 
Buffer, 6.1 ml deionised H2 O, and the same amounts of APS and TEMED as above.
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SDS sample buffer was prepared as a 6x stock solution, containing 0.35 M Tris HC1 
pH 6.8, 10% SDS, 0.6 M DTT, 30% glycerol, and 0.012% bromphenol blue. Samples 
were boiled in lx  or 2x sample buffer at 95°C for 5 minutes prior to loading on the 
gel.
Gels were run in Tris-glycine buffer (25 mM Tris, 250 mM glycine pH 8.3, 0.1% 
SDS) at 70-180 V.
2.6.7 Western Blotting
Following electrophoretic separation, proteins were blotted onto Hybond™ 
(Amersham Biosciences) nitrocellulose membranes using a semi-dry blotter (Bio- 
Rad). Membranes and pieces of Whatman paper were pre-soaked in transfer buffer 
(80 ml methanol, 32 ml Tris-glycine buffer, 0.4 ml of 10% SDS solution, in a total 
volume of 400 ml) for 20 minutes. After a brief incubation of the gel in transfer 
buffer, gel and membrane were sandwiched between six pieces of Whatman paper, 
with the membrane facing the anode of the electroblotting apparatus. Transfer was 
carried out at 120 mA per gel for 1 hour (1 mm thick gels) or 1.5 hour (1.5 mm thick 
gels). Blots were incubated with blocking buffer (5% non-fat dry milk in PBS) for 2 
hours at room temperature or overnight at 4°C. The primary antibody was diluted in 
blocking buffer and applied for 1-2 hours at room temperature or overnight at 4°C. 
The following primary antibodies were used: mouse anti-GS28 (1:100; BD
Biosciences), rabbit anti-PVl (1:1000; CRUK), rat anti-MECA-32 (1:500; 
Developmental Studies Hybridoma Bank), mouse anti-tubulin (1:5000; Sigma), 
mouse anti-actin (1:2000; clone AC-74; Sigma), mouse anti-caveolin 1 (1:1000; BD 
Biosciences), goat anti-moesin (1:1000; Santa-Cruz), mouse anti-moesin (1:1000; BD 
Biosciences), goat anti-radixin (1:1000; Santa-Cruz), mouse anti-ezrin (1:1000;
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Sigma), rabbit anti-p-Moesin (1:1000; Santa-Cruz), rabbit anti-cofilin (1:1000; 
Cytoskeleton), mouse anti-annexin II (1:1000; BD Biosciences), goat anti-enolase 
alpha (1:100; Santa-Cruz), goat anti-hnRNP K (1:100; Santa-Cruz), rabbit anti-merlin 
(1:1000; gift of Dr. Wallace Ip, University of Cincinnati), mouse anti-GM130 (1:250; 
BD Biosciences), rat anti-VE-cadherin (1:1000; BD Biosciences). After 3 five- 
minute washes in blocking buffer, Horseradish peroxidase (HRP) conjugated 
secondary antibodies were diluted in a similar fashion and applied for 1 hour at room 
temperature: sheep anti-mouse IgG (1:1000; Amersham Biosciences), donkey anti­
rabbit Ig (1:1000; Amersham Biosciences), goat anti-rat (1:1000; Amersham 
Biosciences), rabbit anti-goat (1:2000; Jackson Immunoresearch). Blots were washed 
2 times in blocking buffer and finally once in PBS. The product of the HRP reaction 
was detected by enhanced chemiluminescence (Amersham Biosciences). Quantitation 
of the density of bands was performed using Scion Image for Windows (Scion 
Corporation).
2.6.8 Proteomics
2.6.8.1 Isoelectric focusing and two-dimensional SDS-PAGE electrophoresis 
(CRUK)
Proteins eluted from silica-coated plasma membranes were TCA/acetone precipitated 
using the 2-D Clean-Up Kit (Amersham Biosciences) and then resuspended in 8M 
Urea, 2% CHAPS, 5% Glycerol, 65 mM DTT, 0.5% IPG buffer pH 3-10 (Amersham 
Biosciences), by shaking for 60 minutes at room temperature. 50 pg of protein was 
subjected to isoelectric focusing (IEF) on 13 cm Immobiline™ Dry Strip gels pH 3-11
T W
(Amersham Biosciences) using an IPGphor Isoelectric Focusing System
(Amersham Biosciences). Following IEF, IPG strips were incubated in SDS-PAGE
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equilibration buffer containing 50 mM Tris-Cl pH 8 .8 , 6 M Urea, 30% glycerol, 2% 
SDS, bromophenol blue. Strips were first incubated in reducing equilibration buffer 
containing 65 mM DTT for 15 minutes, and then in alkylating equilibration buffer 
containing 25 mg/ml iodoacetamide for another 15 minutes. Following equilibration, 
SDS-PAGE electrophoresis was performed on 1.5 mm thick 10% polyacrylamide 
gels, using a Hoefer™ SE 600 standard vertical system (Amersham Biosciences). 
Gels were fixed for silver staining in a solution of 5% acetic acid and 30% ethanol for 
1 hour. Following rinsing, sensitisation for 1 minute in 1.3 mM sodium thiosulphate 
(STS), and another round of rinsing, gels were incubated in 12 mM AgNC>3 for 2 
hours at 4°C, in a light-protected environment. Gels were rinsed, and the staining 
developed by incubation in a solution of 0.3 M K2 CO3 , 0.25 ml/1 formalin, and 1. 6  
mM STS for 10 to 20 minutes. The reaction was stopped by incubating for 30 
minutes in 33 mM Tris pH8.0 and 2% acetic acid.
2.6.8.2 Isoelectric focusing and two-dimensional SDS-PAGE electrophoresis 
(Charles River Proteomics)
Proteins eluted from silica-coated plasma membranes were acetone precipitated and 
solubilised in 40 mM Tris pH 10.4, 7M Urea, 2M Thiourea, and 1% proprietary 
detergent (Cellular and Organelle Membrane Solubilising Reagent; Sigma), reduced 
with tri-butylphosphine, and alkylated with 10 mM acrylamide for 90 minutes at room 
temperature. Following a second round of acetone precipitation, the pellet was 
solubilised in 7M Urea, 2M Thiourea, and 2% CHAPS, and 40 pg of protein was 
subjected to IEF on 11 cm pH 3-10 immobilised pH gradient (IPG) strips (Proteome 
Systems, Sydney, NSW, Australia). Following IEF, IPG strips were equilibrated in 
6 M urea, 2% SDS, 50 mM Tris-acetate buffer (pH 7), 0.01% bromophenol blue and
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subjected to SDS polyacrylamide gel electrophoresis on 6-15% Gel Chips™ 
(Proteome Systems). All gels were stained in Sypro® Ruby (Molecular Probes) and 
imaged by CCD camera on a fluorescent imager (Alpha Innotech)
2.6.8.3 Protein digestion, MALDI analysis, and Bioinformatic database search 
(Charles River Proteomics)
Protein spots were automatically detected and excised using the Xcise apparatus 
(Shimadzu Biotech). Gel pieces were washed twice with 150 pi 25 mM ammonium 
bicarbonate pH 8.2, 50% acetonitrile, then dehydrated by the addition of 100% 
acetonitrile and air dried. Trypsin (Promega) in 2 mM of 20 pg/mol ammonium 
bicarbonate was added to each gel piece and incubated at 30°C for 16 hours. The 
peptides were extracted by sonication. The solution was automatically desalted and 
concentrated using Zip Tips (Millipore) on the Xcise apparatus, and spotted onto the 
Axima (Kratos) MALDI target plate. Peptide mass fingerprints of tryptic peptides 
were generated by matrix assisted laser desorption/ionisation time-of-flight mass 
spectrometry (MALDI-TOF-MS) using an AximaCFR (Kratos).
Spectra were automatically analysed by the BioinformatlQ integrated suite of 
bioinformatics tools (Proteome Systems). Protein identifications were assigned by 
comparing peak lists to a database containing theoretical tryptic digests of NCBI and 
Swiss Prot sequence databases. Protein identification was evaluated based on percent 
coverage, MOWSE score, number of peptide matches, peak intensity, and match of 
isoelectric point (pi) and molecular weight with the location of the protein on the 2D 
gel.
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2.7 Morphology
2.7.1 Histology
Mouse eyes dissected in PBS, were either directly embedded in Tissue-Tek ™ OCT 
compound (Sakura) on dry ice, or embedded after a 5 minute fixation step at room 
temperature in 4% paraformaldehyde (PFA) in PBS. 10 pm thick sections were cut 
along the PO (pupil to optic nerve) horizontal plane, mounted on slides and stored at - 
80°C.
2.7.2 Immunolabelling
2.7.2.1 Immunohistochemistry on fixed or unfixed mouse sections
Slides were permeabilised in -20°C methanol for 10 minutes, and blocked for 30 
minutes in blocking solution (10% Donkey or Goat Serum (Sigma), 0.5% Triton X- 
100, 1% BSA (Sigma), PBS) in a humidity chamber. The following primary 
antibodies were used: goat anti-moesin (1:25; Santa-Cruz), rabbit anti-ezrin (1:100; 
Upstate), rat anti-MECA-32 (1:100; Developmental Studies Hybridoma Bank), rat 
anti-mouse CD31 (1:300; clone MEC 13.3; BD Biosciences). 80 pi of primary 
antibody solution was applied to each slide for 1 hour at room temperature in a 
humidity chamber. The slides were washed 3 times, for five minutes each time, in 
blocking solution lacking serum. The same procedure was followed for secondary 
antibodies Alexa488-conjugated goat anti-rabbit or anti-rat IgG (1:1000; Molecular 
Probes), Alexa633-conjugated goat anti-rat IgG (1:500; Molecular Probes), and Cy3- 
conjugated donkey anti-goat IgG (1 pg/ml, Jackson Immunoresearch). As negative 
controls, the primary antibodies were omitted with secondary antibody incubations
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performed in the usual way. After three washes, the slides were mounted using 
Vectashield with DAPI (Vector Laboratories Inc.)
2 .1 2 2  Immunofluorescence on coverslips
Cells on coverslips were fixed either in -20°C methanol for 8 minutes or in room 
temperature 4% PFA for 15 minutes. For PFA fixed cells, fixation was followed by 5 
washes in PBS and a 3 minute permeabilisation step in PBT (0.1% Triton X-100, 
PBS). Coverslips were blocked for 15 minutes in blocking solution (10% Goat or 
Donkey Serum (Sigma), 0.2% Fish Skin Gelatin (Sigma), PBS). Primary antibodies 
used on PFA fixed cells were diluted in blocking solution as follows: rat anti-MECA- 
32 (1:100; Developmental Studies Hybridoma Bank), mouse anti-tubulin (1:500; 
Sigma), mouse anti-actin (1:200; clone AC-74; Sigma), mouse anti-caveolin 1 (1:100; 
BD Biosciences), rabbit anti-caveolin (1:100; BD Biosciences), goat anti-moesin 
(1:50; Santa-Cruz), mouse anti-moesin (1:100; BD Biosciences), goat anti-radixin 
(1:25; Santa-Cruz), rabbit anti-ezrin (1:100; Upstate), mouse anti-ezrin (1:100; 
Sigma), rabbit anti-p-Moesin (1:100; Santa-Cruz), rabbit anti-cofilin (1:100; 
Cytoskeleton), mouse anti-annexin II (1:100; BD Biosciences), goat anti-enolase 
alpha (1:100; Santa-Cruz), goat anti-hnRNP K (1:100; Santa-Cruz), goat anti-nm23 
H2 (1:100; Santa-Cruz), rabbit anti-merlin (1:100; gift of Dr. Wallace Ip, University 
of Cincinnati). Primary antibodies used on methanol fixed cells were diluted in 
blocking solution as follows: rabbit anti-PV-1 (1:100; Cancer Research UK), rabbit 
anti-VE-PTP (1:300; Cancer Research UK), mouse anti-GM130 (1:100; BD 
Biosciences) Following 15 minutes in blocking solution, coverslips were inverted 
over 50 pi of primary antibody solution on a piece of parafilm, incubated for 30 
minutes at room temperature, and finally washed 3 times, for five minutes each time,
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in blocking solution lacking serum. The same procedure was pursued for the 
following secondary antibodies: Alexa488-conjugated goat anti-rat, anti-mouse, or 
anti-rabbit IgG (1:1000; Molecular Probes), Alexa633-conjugated goat anti-rat or 
anti-mouse IgG (1:500; Molecular Probes), Alexa 546-conjugated goat anti-rabbit IgG 
(1:500; Molecular Probes), Cy3-conjugated donkey anti-goat IgG (1 fig/ml; Jackson 
Immunoresearch), Cy3-conjugated donkey anti-rat IgG (0.5 pg/ml; Jackson 
Immunoresearch). To visualise F-actin, Alexa 546-, Alexa 488-, or Alexa 633- 
conjugated phalloidin (1:50; Molecular Probes) was included in secondary antibody 
preparations of methanol or PFA fixed cells. Alexa 488-conjugated DNase I (1:500; 
Molecular Probes) was employed to detect G-actin on PFA fixed cells. As negative 
controls, primary antibodies were omitted with secondary antibody incubations 
performed in the usual way. After 3 five-minute washes in blocking solution lacking 
serum, coverslips were mounted on slides using MOWIOL (Calbiochem) with 
DABCO (Sigma).
2.1,23 Peptide Competition
Peptide competition of the mouse anti-moesin antibody was performed by incubating 
the antibody with the peptide against which it was raised (moesin peptide; BD 
Biosciences) or an irrelevant peptide (SNAP-25; BD Biosciences) at a 10,000 : 1 
molar ratio of peptide to antibody. Complexes were incubated for 4-5 hours at room 
temperature with gentle rotation, and centrifuged at 100,000g for 1 h at 16°C in a TLA 
100.3 rotor of an Optima TLX Ultracentrifuge (Beckman Coulter). The supernatant 
was used for immunofluorescence as described above.
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2.7.2.4 Live cell labelling for Scanning Electron Microscopy
Cells on coverslips were immediately transferred to ice, and were incubated for 30 
minutes with blocking solution (Leibovitz L-15 medium, 0.2% glycine, 1.5% FBS) 
prior to immunolabelling with primary antibody in antibody diluent (L-15 medium, 
1% BSA, 0.25% Fish Skin Gelatin) for 30 minutes. The following primary antibodies 
were used: rabbit anti-PVl (1:400; CRUK), rat anti-mouse PEC AM (1:100; clone 
MEC 13.3; BD Biosciences). The cells were washed three times in L-15 medium and 
incubated for 45 minutes with secondary antibodies diluted in antibody diluent as 
follows: EM goat anti-rabbit IgG 10 nm Gold (1:40; BBIntemational), EM goat anti­
rat IgG 5 nm Gold (1:40; BBIntemational). Following three washes in L-15 medium, 
cells were fixed for 2 hours in 3% glutaraldehyde and 1% PFA in 0.08 M sodium 
cacodylate buffer (pH 7.4).
2.7.2.5 Immunolabelling for wholemount TEM
Cells grown on glass coverslips containing grids (see section 2.1.52) were fixed with 
0.5% glutaraldehyde for 15 minutes at room temperature, then washed twice with 
PBS for 10 minutes. Aldehydes were quenched with 50 mM glycine for 5 minutes. 
Cells were permeabilised with 0.05% Triton X-100 in PBS for 5 minutes and 
incubated in block (10% Donkey serum, 1% BSA, PBS) for 45 minutes). Primary, 
secondary, and tertiary antibodies were diluted in block as follows: rat anti-MECA- 
32 (1:10; Developmental Studies Hybridoma bank), biotin-conjugated donkey anti-rat 
(1:200; Jackson ImmunoResearch), FluoroNanogold-streptavidin Alexa Fluor®* 488 
(1:20; Nanoprobes). Cells were incubated with the primary antibody for 45 minutes, 
then washed 3 times with PBS, for 10 minutes each time. The same procedure was 
followed for the secondary and tertiary antibodies. Cells were fixed overnight with
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2.5% glutaraldehyde and processed using HQ silver enhancement solutions 
(Nanoprobes) according to the manufacturer’s instructures. Following enhancement, 
cells were processed for visualisation by wholemount TEM.
2.7.3 p-galactosidase staining of tissues
Embryos were dissected in ice-cold PBS, and fixed with a solution of 2% 
formaldehyde, 0.2% glutaraldehyde, in PBS (In Situ p-galactosidase staining kit, 
Stratagene). 10.5 and 11.5 day old embryos were fixed for 1 and 1.5 hours, 
respectively, at room temperature with gentle rocking. After 5 washes in PBS, 
embryos were stained in X-Gal solution (In Situ (3 -galactosidase staining kit, 
Stratagene) overnight, at 37°C. Embryos were washed 5 times in PBS, postfixed 1 
hour at room temperature with 4% PFA, washed 3 times with PBS and mounted.
2.7.4 Light Microscopy
Images were captured using the following instruments and software packages:
1) LSM510 laser scanning confocal microscope (Zeiss); LSM 510 Software (Zeiss)
2) TCS SP2 spectral confocal microscope (Leica); Leica confocal software version
2.5
3) Widefield DMRA4 microscope (Leica); orca ER2 camera (Hamamatsu); 
Metamorph Software (Universal Imaging Corporation)
4) MZFL III Fluorescence Stereomicroscope (Leica); Retiga Camera (Q-Imaging); 
OpenLab 3.1.7 (Improvision, Inc.)
Digital images were processed using Adobe Photoshop 7.0 (Adobe Systems Inc.)
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2.7.5 Electron Microscopy
2.7.5.1 Scanning Electron Microscopy (SEM)
Cells on coverslips were fixed in 2% PFA (EM grade; Electron Microscopy Sciences), 
2.5% glutaraldehyde (Sigma), 0.1 M Sodium Cacodylate for 1 hour at room 
temperature, and maintained in 2% PFA, 0.1 M Sodium Cacodylate (pH 7.4) 
thereafter. When ready for processing they were washed twice in 0.1 M Sodium 
Cacodylate, and post-fixed in 1% Osmium tetroxide (Agar Scientific Ltd.) in 
cacodylate buffer. After two washes in distilled water, they were dehydrated through 
a series of ethanol solutions, 5 minutes in each: 50%, 60%, 70%, 80%, 90%, 100%, 
100%. Drying was achieved by immersing in Hexamethyldisalazane (HMDS; Sigma) 
for 5 minutes, twice, and placing on Whatman paper.
Cells fixed after live cell labelling were postfixed with 1 % aqueous Osmium tetroxide 
for 1 hour, washed once in water, and dehydrated through an ascending ethanol series, 
5 minutes in each: 50%, 70%, 90%, 100%, 100%, 100%. Drying was achieved using 
HMDS as above.
Coverslips were mounted on 10 mm stubs (Agar Scientific Ltd.) using carbon 
adhesive mounts (Agar Scientific Ltd.) and silver dag (Agar Scientific Ltd.) was 
added to one edge. The specimens were coated with gold in a Polaron SC7640 High 
Resolution Sputter Coater, or carbon in a Gattan 681 Ion Beam Coater, and examined 
under a JEOL JSM-6700 Field Emmission Scanning EM.
2.7.5.2 Wholemount Transmission Electron Microscopy (TEM)
Formvar grids for wholemount TEM were prepared by coating 400 mesh nickel grids 
(Gilder; Electron Microscopy Sciences) using 0.5% Formvar (Ted Pella, Inc.) in
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ethylene dichloride (Electron Microscopy Sciences). Grids were placed on coverslips, 
then carbon coated in a BAF 400 D High Vacuum Freeze-Etching System (Balzers) 
and UV-sterilised prior to their use in cell culture.
Cells were fixed in 1.25% glutaraldehyde (Electron Microscopy Sciences) and 2.5% 
PFA (Electron Microscopy Sciences) in 0.1 M Sodium Cacodylate buffer, for 1 hour 
at room temperature, or overnight at 4°C. Following three five-minute washes in 0.2 
M sodium cacodylate, cells were postfixed in 1% Osmium tetroxide (Electron 
Microscopy Sciences) in cacodylate buffer for 30 minutes. After another 2 washes in 
0.2 M sodium cacodylate, and 2 washes in distilled water, cells were dehydrated in an 
ascending ethanol series. This consisted of one five-minute incubation in 50%, 70% 
and 85%, ethanol, and two five-minute incubations in 95% and 100% ethanol. 
Coverslips were immersed in HMDS for 3 minutes and air-dried. Grids were 
examined under a JEOL 1010 TEM equipped with an AMT digital capture system.
2.7.5.3 TEM of thin sections
Intact monolayers, scraped monolayers, or cellular fractions from the silica isolation 
protocol were fixed in 2.5% glutaraldehyde, 2% PFA in 0.1 M Sodium Cacodylate 
buffer for 20 minutes, and stored in 2% PFA, 0.1 M Sodium Cacodylate buffer until 
processed. For silica-isolated material, agar tubes were prepared by dipping 5 pi glass 
pipettes into agar (Electron Microscopy Sciences) pre-warmed to 65°C, and cooling 
them down over ice. Silica isolated fractions were placed into the agar tubes and 
sealed with warm agar. Scraped or intact monolayers, and tubes containing cellular 
fractions were washed with 0.2 M Sodium Cacodylate for 10 minutes and postfixed 
with 1% Osmium tetroxide in 0.1 M Sodium Cacodylate for 1 hour. After two 10- 
minute washes with 0.2 M Sodium Cacodylate, and one wash with distilled water,
80
Chapter 2: Materials and methods
specimens were dehydrated through an ascending acetone series of 50%, 70%, 85%, 
95%, and 100%. Incubations lasted 7 minutes, while 95% and 100% acetone steps 
were performed twice. Specimens were infiltrated for 45 minutes with a mixture of 2 
parts acetone and 1 part frozen spurs resin, and then for 60 minutes with a mixture of 
1 part acetone and 2 parts frozen spurs resin. Finally, they were infiltrated with 100% 
fresh spurs resin overnight at room temperature. Resin was polymerised by 
incubating overnight at 60°C. 70-100 nm thick sections, cut using an Ultracut UCT 
(Leica), were placed onto 200 or 300 mesh copper grids (Gilder; Electron Microscopy 
Sciences). Grids were stained with uranyl acetate (Ted Pella, Inc.) for 20 minutes and 
Reynolds stain (made with Lead Nitrate, Ted Pella, Inc. and Sodium Citrate, Sigma) 
for 2 minutes prior to examination under the TEM.
2.7.5.4 Stereology for Electron Microscopy
20 to 30 SEM images were captured at a magnification of 10,000. Starting from an
arbitrary position on the coverslip and systematically random sampling along one
direction, an image was captured every 200 pm. Images in which cellular structures
occupied less than 50% were dismissed. A grid (2 cm x 2 cm squares with 150 points
of intsersection) was overlaid on each image, and the number of grid points falling on
any cellular structure, versus the number of grid points falling on sieve plates (more
than 10 fenestrae in a group), were counted. Fenestrae abundance was estimated as
follows: fraction of plasma membrane covered with fenestrae =
number of grid points falling on sieve plates 
number of grid points falling on any cell structure
To measure the density of fenestrae, the number of fenestrae per pm2 among 10 
random sieve plates was calculated; this multiplied by the fraction of plasma
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membrane covered with fenestrae yielded an estimate of the density of fenestrae per 
pm2 plasma membrane.
For fenestrae quantitation using wholemount TEM, images were captured at a 
magnification of 25,000. 12 images were obtained per nickel grid, and 3 nickel grids 
were examined per experiment. Images were opened in Adobe Photoshop 7.0, and a 
15 mm grid with 169 points was overlaid on each image. The abundance of fenestrae 
was calculated as in the stereological approach for SEM.
2.8 Generation of transgenic mice
2.8.1 Construction of transgene cassettes for TetO-VE-PTP
The following steps were taken to generate the vector that would harbour the 
responder transgene cassettes:
1) plasmid pRL-null (Promega) was digested with Nhel and Notl to remove the 
luciferase gene, blunted and religated to produce pSIl.
2) An XhoI/BamHI fragment of pSIl, containing a multiple cloning site, an 
artificial intron, and an SV40 late poly (A) signal, was cloned into 
XhoI/BamHI-digested pBluescript® II KS (Stratagene) to produce pSI2.
3) The operator sequences from pUHC 13-3 [176] were removed by an Xhol/Sall 
double digest and cloned into Xho/Sall-digested pSI2 to produce pSI3.
4) An oligo containing a series of rare restriction sites 
(GGGCCCGCGGCCGCTCT AG AGTTT AAACGGCGCGCCTT AATT AAA 
GATCTGTCGAC) was digested with Apa/Sall and cloned into Apal/Xhol- 
digested pSI3 to produce pSI4.
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Full-length VE-PTP was excised from pCMV6-XL4 (Genebank AF067196) using 
Not I, and cloned into the multiple cloning site of pSE420 (Invitrogen), in reverse 
orientation with respect to the vector’s open reading frame. VE-PTP cDNA was 
released from the resulting vector by a BssHII digest, and cloned into Mlul-digested 
pSI4, to yield pSI5, a plasmid harbouring the cDNA of VE-PTP under the control of 
the tetracycline response element.
To construct a plasmid with only the extracellular domain of VE-PTP expressed as a 
soluble protein under the control of the tetracycline response element, the following 
steps were taken: A 300 bp fragment from an Accl/Xbal digest of pFLAG-CMV-1- 
V-sol FN17 (provided by Dr. Urban Deutsch, Theodor Kocher Institute, Bern, 
Switzerland) was ligated to the 8 kb fragment from an Accl/Xbal digest of pCMV6- 
XL4 VE-PTP FN17Fc (provided by Dr. Urban Deutsch). The resulting plasmid was 
cut with Pmll and Nhel, and the 3.2 kb fragment was ligated to the 5.5 kb fragment of 
pSI5, digested with Pmll and Xbal, to yield pSI9.
To construct a plasmid with the phosphatase trapping mutant of VE-PTP under the 
control of the tetracycline response element, pCMV-FLAGl VE-PTP R/A [159] 
(provided by Dr. Urban Deutsch) was digested with Nhel/Xba I and the resulting 1.3 
kb fragment was ligated to the 9kb fragment of the Nhel-digested pSI5 to yield pSIlO.
2.8.2 Injection of TetO-VE-PTP transgenes into mouse oocytes
Transgenes TetO-VE-PTP, TetO-VE-PTP EC, and TetO-VE-PTP R/A were linearised 
by digesting 50 pg of the respective plasmids pSI5, pSI9, and pSIlO, with BssHII. 
The 6-7 kb transgenes were separated from the vector on a 1% Agarose Gel in TBE 
without ethidium bromide. The marker lane and part of the lane containing the 
digestion products were cut and stained in a solution of 0.5 pg/ml Ethidium Bromide
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in TBE for 30 minutes, to avoid exposure of the DNA to UV light. Using the 
position of the transgene in the stained gel as a landmark, the relevant portion of the 
unstained gel was excised and gel-purified. Eluates were ethanol precipitated and 
resuspended in EB buffer (10 mM TrisHCl pH 8.5). A further round of purification 
was achieved by diluting the DNA in 2.4 ml of 10 mM TrisHCl pH 8.0, 1 mM EDTA, 
adding 3.0 g of ultrapure CsCl, and ultracentrifuging in a SW50.1 rotor at 20°C for 48 
hours at 40,000 rpm. Fractions containing the DNA were pooled and dialysed over 48 
hours at 4°C, against a large volume of injection buffer. The solution was filtered 
through a 0.2 pm filter, and adjusted to a concentration of 1 ng/pl.
0.5 day old mouse embryos were collected from the oviducts of superovulated, mated 
C57BL/6 or (C57BL/6 x CBA) female mice. Using a glass holding pipette between 
80 and 120 pm in diameter, 1-2 pi of the DNA solution was microinjected into the 
pronuclei of the one-cell embryos prior to the 1st division. Once microinjected, 
healthy eggs were transferred into the oviducts of 0.5 day pseudopregnant surrogate 
female mice. Approximately 20-30 microinjected eggs were transferred into each 
pseudopregnant recipient.
2.8.3 Breeding and maintenance of mouse colony
TetO-VE-PTP transgenic mice were maintained in C57BL/6 or mixed (C57BL/6 x 
CBA) background. Experimental crosses were performed using driver Tie-2tTA, and 
TetO-LacZ responder nZL2, TRE-LacZ 2717 strains, all provided by Dr. Urban 
Deutsch.
For timed-matings, the morning of vaginal plug formation was counted as 0.5 dpc. 
Tails were removed for genotyping pups and adult mice, and yolksacs were used to 
genotype embryos as described above.
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3.1 Background
Endothelial fenestrae were first described in 1950 [55], but their composition, 
function, and biogenesis remain mostly unknown. Their small size coupled to the 
lack of specific markers renders their study dependent on ultrastructural methods. In 
vitro studies which normally provide ease of manipulation and characterisation, have 
historically not been an option, as cells that have fenestrae in vivo become 
dedifferentiated and lose the fenestrated phenotype when placed in culture [87, 94]. 
As a result, the study of fenestrae has been restricted primarily to in vivo and ex vivo 
descriptive and morphological analyses, which not only are complex to conduct, but 
also provide limited information.
In the course of the past three decades, fenestrae have been observed in tissue culture, 
through attempts to create more physiological culture conditions for endothelial cells. 
The first observation of fenestrae in vitro came from cloned endothelial cells that 
mimicked the three-dimensional appearance of capillaries in vivo, when grown in 
tumor-conditioned medium [177]. Subsequently, low levels of fenestrae induction 
have been achieved by culturing endothelial cells on epithelial cell -  secreted 
extracellular matrix [8 6 , 87, 94] or treating them with Vascular Endothelial Growth 
factor (VEGF) [94], a potent permeability mediator implicated in fenestrae formation 
in vivo [69, 92]. Fenestrae formation has also been stimulated by factors of less 
evident physiological relevance such as phorbol myristate acetate (PMA) [8 8 , 89], 
retinoic acid [90], and the microfilament disruption agents cytochalasin B and 
latrunculin A [61, 95, 96, 178]. The maximum number of fenestrae attained in cloned 
endothelial cells was between 0.05 and 0.2 fenestrae per pm2 [8 6 , 88-90, 94], which is 
orders of magnitude lower than what has been documented for fenestrated capillary 
beds in vivo, and insufficient for cell biological or biochemical studies. The greatest
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numbers of fenestrae seen to date were in fenestrated primary liver sinusoid 
endothelial cells which could be made to expand their number of fenestrae by 2-3 fold 
[61, 95, 178]. Such cells, however, can only be maintained in culture for a few days, 
and attempts to immortalise them have failed to preserve fenestrae [179].
The limited scientific observations on fenestrae to date, have highlighted the need for 
a systematic approach to dissect and sequentially analyse these organelles. In a screen 
of numerous endothelial cell lines, using a combination of several published induction 
protocols, our laboratory identified an endothelial cell line that was susceptible to 
fenestrae induction in large quantities. My aim was to explore the optimal conditions 
for induction that would empower the molecular characterisation of fenestrae. This 
chapter describes the optimisation of this in vitro culture system for fenestrae 
biogenesis and the development of quantitative ultrastructural methods, with a focus 
on the modulation of the cytoskeleton.
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3.2 Results
3.2.1 In vitro model for fenestrae formation
Following systematic screening through a panel of cloned endothelial cell lines 
cultured on a gelatin extracellular matrix and induced with PMA, VEGF-A, 
Cytochalasin B, and Latrunculin A, in various combinations or on their own, the 
bEND5 brain endothelioma cell line [180] was identified as competent for the 
formation of fenestrae. The presence of fenestrae was assessed using Scanning 
electron microscopy (SEM) (Figure 3.1), or wholemount Transmission Electron 
Microscopy (TEM) (Figure 3.2). Under basal conditions, no or very few fenestrae 
were observed on the plasma membrane of bEND5 cells (Figures 3.1, A and 3.2, A). 
After induction, the majority of the peripheral plasma membrane was perforated by 
numerous fenestrae that occured in sieve plates and were highly ordered: they 
displayed remarkably consistent pore diameters, linear arrangement and equidistant 
spacing (Figures 3.1, B, and 3.2, B-C).
To obtain a quantitative assessment of fenestrae numbers, a stereological approach 
was developed (Figure 3.3). The first step in this method involved the acquisition of 
SEM or TEM images by means of systematic random sampling. Next, all areas 
within each image were given the same opportunity to be sampled by randomly 
overlaying a grid lattice of about 150 points (intersection of gridlines). Counting the 
number of points falling on fenestrated areas of the plasma membrane (sieve plates), 
and dividing the value by the number of points falling on any area of the cell, gave an 
estimation of the fraction of plasma membrane that was fenestrated. Finally, to 
compare these numbers with measurements in previous in vivo or in vitro studies, the 
density of individual fenestrae within fenestrated areas was calculated by counting the
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Figure 3.1 In vitro fenestrae under SEM. bEND5 cells untreated (A) or induced 
with 75 ng/ml VEGF for 24 hours and 10 pM Cytochalasin B for 2 hours (B). A 
large number of vesicles (arrowheads) are present on the continuous plasma 
membrane of untreated cells (A). The plasma membrane of induced cells is 
perforated by numerous fenestrae that appear as regularly arranged discontinuities 
with a diameter of 70 nm (arrows) (B). (Bar = 1 pm)
Figure 3.2 In vitro fenestrae under TEM. bEND5 cells untreated (A) and induced 
for 3 hours with 2.5 pM Latrunculin A (B) examined using the wholemount TEM 
method. A continuous plasma membrane in untreated cells (A) is replaced by 
numerous well-ordered fenestrae upon induction (B). A trace of the diaphragm 
spanning each fenestra (arrows) can be seen (arrowhead). Sections through induced 
cells, cut along the plane of the monolayer, and examined under TEM, reveal the 
abundance of fenestrae (C). Fenestrae can be seen ‘en face’ (arrows) and in cross- 
section (arrowheads). (Bar = 500 nm)
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Figure 3.3 Stereology applied to fenestrae quantitation. (A) SEM images were acquired 
by systematic random sampling, then printed, and sieve plates were marked (yellow line). 
A grid lattice was randomly overlaid on each image and the number of grid points falling 
on sieve plates, versus those falling on any cellular structure, were counted. The 
abundance of fenestrae was estimated based on the following calculation: Fraction of the 
plasma membrane occupied by fenestrae = grid points falling on sieve plates / grid points 
falling on any cell area. The number of fenestrae per area of plasma membrane, was 
calculated as follows: no. of fenestrae per pm2 of plasma membrane = no. of fenestrae 
per pm2 of sieve plate area x fraction of plasma membrane occupied by sieve plates. (B, 
C) Differential interference contrast (DIC) images of bEND5 cells untreated (B), or 
induced with 2.5 pM Latrunculin A for 3 hours (C), reflect the cell density during random 
sampling for stereology. (Bar =100 pm)
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Figure 3.4 Quantitation of fenestrae induction. bEND5 cells were grown on gelatin 
and treated with VEGF (75 ng/ml) for 6 , 16, 25, 40, or 90 hours, with the addition of 
Cytochalasin B (10 pM) for the last 2 hours of each time point. The number of 
fenestrae was assessed by SEM. Data points represent the average of 30 images 
captured per time point.
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number of fenestrae occuring in an area of known dimensions, such as a square of the 
grid lattice that fell within a sieve plate. Multiplying the number of fenestrae per pm 2 
of sieve plate area by the fraction of plasma membrane coverage, gave an estimation 
of the number of fenestrae per pm of total cell plasma membrane. In order to 
minimise ambiguities in the quantitation, due to similarities between sparse single 
fenestrae and vesicular profiles, a number of counting criteria were set: Fenestrae 
were only considered if they occurred in sieve plates; Sieve plates were defined as 
groups of more than 1 0  fenestrae, that had some degree of order, and resided in 
attenuated regions near the edges of cells.
To validate the quantitative potential of the model, a time-course of induction was 
performed using a protocol found early on to be the most effective. That consisted of 
incubating with VEGF-A (75 ng/pl) over a period of 90 hours, with the addition of 
Cytochalasin B (lOpM) for the last 2 hours of each time-point assessed (Figure 3.4). 
The maximum number of fenestrae was reached after 24 hours in culture, and 
represented a 40-fold induction compared to the untreated control, with 4.5 fenestrae 
per pm2, analogous to hundreds or thousands of fenestrae per cell. A number of 
variations to the original protocol were attempted, including the omission of either 
VEGF-A or Cytochalasin B from the induction cocktail. Cells treated only with 
VEGF showed low induction over background, whereas cells treated only with 
Cytochalasin B for 2 hours attained similar induction levels to cells that had received 
the combined treatment (data not shown).
3.2.2 Identifying the optimal parameters for induction
3.2.2.1 The effect of cytoskeletal disruption
The dissection of the relative contributions of VEGF-A and Cytochalasin B in a
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preliminary analysis of fenestrae formation prompted more in depth studies on the 
effect of cytoskeletal disruption in our system. Two separate actin filament disruption 
agents, Cytochalasin B (10 pM) and Latrunculin A (2.5 pM), were assessed in terms 
of their fenestrae-promoting potentials by SEM. Cytochalasin B belongs to a family 
of mold metabolites that inhibit the elongation of actin filaments by binding to their 
barbed, fast growing end with high affinity (Kd ~ 10'7 -10' 8 M) [181, 182]. It is 
thought to prevent monomer addition without decreasing the concentration of 
polymerised actin [183]. Latrunculin A belongs to a family of marine sponge toxins
n
which act by forming 1:1 complexes with actin monomers (Kd ~ 10’ M), and thereby 
decreasing the concentration of actin filaments [184-186].
To isolate primary from secondary events in fenestrae formation, the focus was on the
early events, using a short induction protocol (Figure 3.5). Both agents were able to
stimulate induction on the order of 1 0 0 -fold compared to the untreated control,
attaining levels of 3.5 to 5 fenestrae per pm . Fenestrae started forming as early as
after 20 or 30 minutes of treatment with Cytochalasin B, reached a maximum at 2
hours, and declined in number at 3 hours of treatment. Latrunculin A led to a higher
maximum number of fenestrae after 3 hours of treatment when compared to
Cytochalasin B. The initial slope of the induction curve resembled that of
Cytochalasin B, however comparatively more fenestrae started to form with
incubations over 30 minutes. Incubations longer than 3 hours didn’t lead to any
further increase in the number of fenestrae, but the viability of the cells was
considerably reduced. As expected, given the biological variation inherent in the
system, numbers of fenestrae were not reproduced exactly between different
experiments (Figure 3.5). However, induction of fenestrae between treated and
untreated cells was always statistically significant, and therefore, albeit not being
absolute measurements, numbers of fenestrae per pm2 are useful for comparative
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Kinetics of fenestrae induction by microfilament disruption
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Figure 3.5 Short time course of fenestrae induction by microfilament disruption 
agents. bEND5 cells were grown on gelatin, treated with Cytochalasin B (10 pM) or 
Latrunculin A (2.5 pM) for a variety of time points, and the number of fenestrae 
quantified by SEM. Data points represent averages of two experiments, with 20 
images taken per time point in each experiment. Error bars represent the standard 
deviation between the two experiments. For the 120 minute time point of the 
Latrunculin A treatment, data was available from only one experiment, therefore the 
standard deviation could not be calculated.
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purposes.
Assessing the morphology of whole cells by SEM at a lower magnification suggested 
that Latrunculin A led to a more extreme phenotype. A greater proportion of the total 
cells in the population were responsive to Latrunculin A treatment than to 
Cytochalasin B, with over 80-90% of cells forming fenestrae. Within those, the 
majority of their surface area was fenestrated, with the exception of the nuclear area 
and some thick cytoplasmic areas separating sieve plates (Figure 3.6), similar to the 
pattern observed in extensively fenestrated endothelia in vivo [1 0 0 ].
In an attempt to understand fenestrae biogenesis, early points in the induction time- 
course were examined more closely. Overall, cells changed from having no fenestrae, 
to having few isolated sieve plates (Figure 3.7, A), and finally large sieve plates 
covering the majority of their surface. A number of intermediates were consistently 
spotted, sometimes overlapping in distant time points, which can be explained by the 
lack of a fully synchronised response of all the cells in the treated population. Often, 
depressions of plasma membrane were observed (Figure 3.7, B), reminiscent in shape 
to sieve plates and most probably with the submembranous cytoskeleton disrupted. In 
what looked to be a more advanced stage of the aforementioned depressions, sieve 
plates with fenestrae-like structures that did not span the cytoplasm of the cell were 
identified (Figure 3.7, C). Finally, fenestrae were often observed near unidentified 
membrane invaginations (Figure 3.7, D). Whether this close geographical proximity 
was due to a causal relationship between those structures and fenestrae, or was merely 
a chance event, was difficult to interpret.
3.2.2.2 The effect of endothelial cell subtypes
Following the identification of Latrunculin A as the most efficient inducer of
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Figure 3.6 Fenestrae under low power SEM. The entire plasma membrane of a bEND5 
cell induced with 2.5 pM Latrunculin A for 3 hours is fenestrated, apart from the nucleus 
(star) and cytoplasmic spacers (arrowheads) between sieve plates. (Bar = 1 pm)
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■Figure 3.7 Intermediates observed by SEM in early time points of a time-course of 
fenestrae induction with 2.5 pM Latrunculin A: Small sieve plates (arrowheads) (A), 
depressions of large patches of the plasma membrane (star) adjacent to thick areas of 
the cell (arrowheads) (B), fenestrae with apparent incomplete perforation (arrows) (C), 
diaphragmed vesicles (arrows) clustered near flat fenestrated areas (star) (D). (Bar = 1
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fenestrae, a panel of endothelial cell subtypes was revisited and assessed for their 
fenestrae-forming potentials under optimal conditions. Three mouse endothelial lines 
(bEND5, Py4.1, SVEC4-10) and one human primary endothelial line (HUVEC) were 
cultured on gelatin-coated grids, treated with Latrunculin A for 3 hours, and examined 
by wholemount TEM (Figure 3.8). bEND5 [180] and Py4.1 [187] cells are 
endotheliomas, originating from Polyoma middle T transformed brain endothelial 
cultures and Polyoma middle T transgenic mice, respectively. SVECs are lymph node 
endothelial cells infected with SV40 virus [188]. HUVECs were selected because of 
their widespread use as a primary cell strain. Quantitation of the response in each cell 
line showed that only Polyoma middle T -  containing bEND5 and Py4.1 cells were 
susceptible to fenestrae formation. SVECs showed no indication of fenestrae, and 
HUVECs produced only very few (Figure 3.9).
Interestingly the response of bEND5 and Py4.1 cells differed both in the magnitude of 
induction, and in the levels of fenestrae observed in the uninduced state. bEND5 cells 
harboured greater numbers of fenestrae overall, but contained some background 
fenestrae even in the absence of induction. Py4.1 cells formed lower absolute 
numbers of fenestrae, but showed a greater relative induction than bEND5 cells, due 
to the complete absence of fenestrae in the uninduced state. Py4.1 cells were 
subsequently found to be also responsive to Cytochalasin B, albeit inconsistently and 
to a much lower extent than bEND5 cells (data not shown).
3.2.3 Actin microfilaments under the light microscope
In parallel to the SEM analysis, bEND5 cells subjected to Cytochalasin B and 
Latrunculin A time-courses were stained with fluorescently-labeled phalloidin to 
determine the state of actin microfilaments (Figures 3.10 and 3.11). Untreated cells
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Figure 3.8 Comparison of fenestrae formation in different endothelial cell subtypes 
using wholemount TEM. bEND5, Py4.1, SVE and HUVE cells were treated with 
2.5 pM Latrunculin A for 3 hours. Abundant fenestrae are present in bEND5 (A) 
and Py4.1 (B) treated cells. No fenestrae are present in SVE cells (C), while rare 
fenestrae (arrowheads) are detected in HUVECs (D). (Bar = 1 pm)
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Figure 3.9 Quantitation of fenestrae induction in different endothelial cell subtypes. 
bEND5, Py4.1, SVE, and HUVE cells were treated for 3 hours with vehicle (V) or 2.5 
pM Latrunculin A (Lat), and assessed using wholemount TEM. The number of 
fenestrae was estimated as a fraction of the plasma membrane area occupied by sieve 
plates. HUVECs were only treated for 2.5 hours as they displayed reduced viability 
with prolonged exposure. Data points represent the average of two experiments, with 
36 images captured per sample in each experiment. Error bars represent standard 
deviation between the two experiments.
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Figure 3.10 Actin microfilaments in bEND5 cells treated with 10 pM 
Cytochalasin B. Cells were fixed after different times of treatment and actin 
microfilaments were visualised using Alexa546-conjugated phalloidin. Confocal 
sections at the level of stress fibers (short arrow) revealed a reduction in stress 
fiber content within the first 2 0  minutes, and a persistence of cortical actin 
(arrowhead) until about 60 minutes of treatment. At 120 minutes, individual actin 
bundles (long arrow) were spread around the cytoplasm. (Bar = 8  pm)
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Figure 3.11 Actin microfilaments in bEND5 cells treated with 2.5 pM 
Latrunculin A. Cells were fixed after different times of treatment, and actin 
microfilaments were visualised using Alexa 546-conjugated phalloidin. Confo- 
cal sections at the level of stress fibers (short arrow) revealed a reduction in stress 
fiber content within the first 2 0  minutes, with complete disruption of the network 
at 60-120 minutes. Individual actin foci (long arrow) and small filaments 
(arrowhead), were present after 120-180 minutes of treatment. (Bar = 8  pm)
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contained an extensive network of stress fibers spanning their cytoplasm. However, 
dramatic changes in the organisation of filamentous actin were observed within as 
early as 10 minutes of treatment with either agent. Cells treated with Cytochalasin B 
(Figure 3.10) exhibited a gradual decrease in the amount of stress fibers between the 
time points of 10, 20, and 30 minutes, with cortical actin remaining in place until 
about 60 minutes of treatment. At 120 minutes, the disassembled filamentous actin 
was concentrated in aggregates throughout the cytoplasm, while large areas remained 
microfilament-deficient. In cells treated with Latrunculin A (Figure 3.11) the 
disruption of stress fibers was faster, and the cortical cytoskeleton was dismantled 
within the first 20 minutes. Overall cells had more and larger microfilament-depleted 
areas, and the majority of actin remnants appeared irregularly arranged in short 
filaments within the cytoplasm. The appearance of microfilament-depleted areas 
under light microscopy, correlated well with the emergence of fenestrae under 
scanning electron microscopy, and suggested a relationship between the two 
processes.
In an attempt to explain the differential induction of endothelial cell subtypes by 
Latrunculin A, the actin cytoskeleton of all four cell types was stained with phalloidin 
(Figure 3.12). In all cases, the cytoskeleton was highly disrupted, confirming the non- 
discriminatory effect of the drug, and showing that actin microfilament disassembly 
alone is not sufficient for fenestrae induction. Close observation, however, of bEND5 
and Py4.1 cells, highlighted a potentially significant difference: the latter had greater 
amounts of cortical actin in the steady state (Figures 3.12, A and 3.12, C). Notably, 
this correlated with their decreased susceptibility to fenestrae formation compared to 
bEND5 cells, a discrepancy particularly apparent during induction with Cytochalasin 
B, the less potent of the two cytoskeletal disruption agents.
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Figure 3.12 Actin microfilaments in different endothelial cell subtypes. bEND5 (A, B), 
Py4.1 (C, D), SVE (E, F), and HUVE (G, H) cells were untreated (A,C,E,G) or induced 
for 3 hours with 2.5 pM Latrunculin A (B,D,F,H). Epifluorescent images of Alexa 546- 
conjugated phalloidin, showed microfilament disruption in all treated cell types. (Bar = 8
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3.2.4 Immimolabelling for the diaphragm marker PV-1
Fenestrae induced in bENDS or Py4.1 cells appeared morphologically similar to 
fenestrae described in vivo. Observed under high power, they had a consistent 
circular diameter of about 70 nm and were usually spanned by a diaphragm. One 
feature of diaphragmed fenestrae in vivo is the protein PV-1, a shared component of 
the diaphragms of fenestrae and caveolae, and the only known constituent of fenestrae 
to date [16, 54]. Immunogold labelling using an antibody against PV-1 was 
performed on bENDS cells induced for 3 hours with 2.5 pM Latrunculin A. PV-1 
labelling was found to concentrate on sieve plates, and specifically on the diaphragms 
of fenestrae (Figure 3.13, A, C-D). In contrast, immunogold labelling for Platelet 
Endothelial Cell Adhesion Molecule (PECAM) showed no preference for any 
particular region of the cell, and was distributed in fenestrated and non-fenestrated 
areas alike (Figure 3.13, B). The poor morphology of the imaged cells reflected a 
compromise reached to satisfy the distinct and conflicting requirements of cell 
immunolabelling and ultrastructural preservation.
Previous studies had described fenestrated endothelia as extremely attenuated cells, 
with a central prominence containing the nucleus [100]. Microtubule-rich 
cytoplasmic areas were seen to extend from the nuclear area to the cell periphery; and 
between them encircle fenestrae sieve plates [61]. Given the extreme attenuation of 
the endothelium, the existence of intracellular organelles in areas other than the 
central prominence was deemed highly unlikely. These observations coupled to the 
immunoreactivity for PV-1 within diaphragmed fenestrae, formed the basis of a light 
microscopy assay, developed by K. Deinhardt in the laboratory (see Appendix I). By 
indirect immunofluorescence, she showed that in induced cells, PV-1-positive areas 
could be readily distinguished from the remainder of the cell, as they were negative
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Figure 3.13 SEM and wholemount TEM Immunolabelling. bEND5 cells, induced 
with 2.5 pM Latrunculin A for 3 hours, were labeled for PV-l(A) and PECAM (B), 
and visualised using 10 nm and 5 nm gold conjugated secondary antibodies, 
respectively, under SEM backscatter mode. PV-1 is seen to localise specifically on the 
diaphragm of fenestrae (A), while PECAM is distributed throughout the surface of the 
cell (B). Latrunculin-induced bEND5 cells were labeled for PV-1 and visualised 
using a fluoronanogold-conjugated secondary antibody by means of wholemount 
TEM (C,D). A low magnification view shows labelling concentrated in fenestrae 
sieve plates (C) and a high magnification view shows multiple gold particles within 
the region of the fenestral diaphragm (D). (Bar = 200 nm)
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for any organelle or cytoskeletal marker. Moreover, microtubules and organelles 
were confined to areas between PV-1-positive areas, while PECAM was present 
throughout the plasma membrane, consistent with ultrastructural observations. The 
observations from light microscopy were further validated by a correlative 
microscopy study (Amy Snodgrass, unpublished observations), whereby the same PV- 
1 positive fenestrae patches imaged under the light microscope could be identified as 
fenestrae sieve plates with nanogold-labeled diaphragms using wholemount TEM.
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3.3 Discussion
3.3.1 A versatile model to study fenestrae biogenesis
Traditionally, cell biologists have used experimental model systems to further their 
understanding of organelles. Ultrastructural observations on alterations to the golgi 
apparatus during mitosis laid the foundations for establishing an in vitro model of 
golgi disassembly and reassembly in Hela cells [189, 190]. Initial morphological 
observations within the model were strengthened by thorough quantitative analyses 
and immunoelectron microscopy studies that validated a marker for mitotic golgi 
membranes. This gave rise to the successful isolation of golgi membranes, which 
coupled to the ability to mimic the processes of disassembly and reassembly in a cell- 
free assay, paved the way for the identification of membrane intermediates and 
important components in the pathway.
Akin to understanding other membranous organelles, my approach on the study of 
fenestrae was centered on establishing a model system that would mimic, as closely as 
possible, the situation observed in capillary beds in vivo. By means of combining 
different endothelial cell types and induction stimuli, an in vitro culture system for 
fenestrae formation was developed, conferring a number of advantages over previous 
approaches: 1) Fenestrae were formed in an endothelial cell line that could be
maintained for tens of passages; 2) The induction protocol was fast and easy; 3) A 
relatively high-throughput stereological approach could be applied to its 
ultrastructural characterisation; 4) High levels of fenestrae were sustained; 5) A 
great induction over the uninduced state of the cell was achieved; 6 ) In combination 
with immunoreactivity for PV-1, it could be used as a light microscopy assay for 
fenestrae formation.
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In the most efficient combination, that of bEND5 cells treated with Latrunculin A, 
fenestrae were induced 100-fold at levels of up to 5.3 fenestrae per pm2. This 
favorably compared to previous reports of in vitro studies where adrenal cortex 
endothelial cells or HUVECs, induced with VEGF, phorbol esters, or retinoic acid, 
attained maximal levels of only 0.187 fenestrae per pm2 [8 6 , 88-90, 94]. Studies 
using primary liver endothelial cells with existing fenestrae and the cytoskeleton 
disruption agent swinholide A had reported fenestrae levels of up to 9.1 per pm , 
however, this represented a less than 3-fold induction, as the untreated control 
contained over 3 fenestrae per pm [96]. Moreover, this enhancement of a phenotype 
was only possible in freshly-isolated endothelial cells from the liver sinusoids as 
attempts to immortalise them rendered them no longer susceptible to fenestrae 
formation [179]. Comparisons to the numbers of fenestrae observed in vivo are more
•y
complicated, as reported levels of fenestrae vary between as low as 0.58 per pm 
[191] and as high as 60 per pm [1 0 0 ], depending on the capillary bed investigated 
and even more on the methods of detection and quantitation employed.
3.3.2 Actin remodeling as a driving force for fenestrae formation
The role for actin remodeling in sustaining or increasing the number of fenestrae had 
been highlighted in studies involving fenestrated endothelial cells from the liver 
sinusoids [61, 95, 96, 178] and isolated kidney glomeruli [192], and was exploited in 
our system for the formation of de novo fenestrae. The most widely used drugs, 
Cytochalasin B and Latrunculin A, both target the actin cytoskeleton, but achieve 
disruption through different mechanisms. In agreement with the studies on liver 
sinusoidal endothelial cells [95], Latrunculin A was more potent at inducing fenestrae 
than Cytochalasin B. As previously suggested [95], the fact that two drugs with
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different mechanisms of action, both led to the induction of fenestrae, supports the 
notion of fenestrae formation being linked to microfilament disassembly and not some 
secondary effect of the drug. Moreover, in our culture model, the different extent to 
which microfilament disassembly was achieved with either agent, correlated with the 
magnitude of the response in terms of fenestrae formation: treatment with latrunculin 
A resulted in greater disruption and also in more fenestrae.
The kinetics of fenestrae induction through cytoskeleton disruption were rapid, with 
fenestrae being visible within the first 20 minutes of treatment. The rapid fenestrae 
formation suggested that in this particular system, protein synthesis is unlikely to play 
a role. The components required for fenestrae formation most likely are already 
present in the cell and merely rearranged to form pores. The increase in fenestrae 
formation observed over time can be explained by a progression in the levels of actin 
disruption, resulting in the enlargement of small fenestrae patches within given cells 
and in a greater number of cells responding within the population. Further support for 
the notion that certain tissue endothelia are equipped for rapid fenestrae formation 
comes from in vivo studies showing that VEGF can induce fenestrations in certain 
normally non-fenestrated anatomical sites, within 10 minutes of topical application or 
intradermal injection [69].
The mechanism by which actin remodeling drives fenestrae formation is unclear. One 
hypothesis to explain our observations is consistent with the view of actin as a 
structural barrier for fusion. According to such a model, disruption of the 
cytoskeleton would be required to bring the apical and basal plasma membranes of the 
cell in close proximity to one another so as to allow the necessary steps of membrane 
fusion to take place. Actin removal has been implicated in exocytosis and yeast 
vacuole membrane fusion from in vitro studies showing that persistence of an actin 
coat surrounding the organelle in question acts as a physical impediment for the
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recruitment of tethering factors and in turn for the close apposition of membranes 
[102, 193-196]. However, high concentrations of actin depolymerising agents have 
been shown to inhibit all phases of exocytosis [194, 195], while actin remodeling in 
yeast has been divided into an actin depolymerisation phase during docking, followed 
by a repolymerisation phase at the terminal stage of membrane fusion [193]. To 
explain the latter, actin has been postulated to contribute to the trafficking and 
aggregation of organelles and to coordinate the spatial restriction of particular 
fusogenic proteins to fusion sites [103, 193, 197, 198]. Whether the cytoskeleton is 
not just a physical barrier but also plays an active role in the process of fenestrae 
formation, remains to be established.
3.3.3 The role of signaling cascades
VEGF and PMA were less efficient than cytoskeleton disruption agents in fenestrae 
induction. Moreover, a comparison of different growth factors of the VEGF family, 
along with fibroblast growth factor (FGF), showed significant, though low fenestrae 
induction compared to the untreated control, with a trend towards FGF being the most 
potent inducer (data not shown). The observation that VEGF, a mediator of fenestrae 
formation in vivo [69, 92] and in vitro [94], was modestly effective in our system is 
interesting. A potential explanation for the lack of a response to VEGF, is the view of 
endothelioma cells producing their own complement of the growth factor [199] and 
thus being self-sufficient and saturated. Alternatively, a component in the VEGF 
signaling pathway downstream of the VEGF receptor could be activated in these cells, 
obviating the need for an exogenous growth factor.
A connection between the physiological inducer of fenestrae and the cytoskeleton has 
been suggested in a recent study which showed that a dominant negative version of
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the small GTP-binding protein Rac could block VEGF-induced fenestrae formation in 
a corneal pocket angiogenesis assay [97]. Although direct evidence was absent, this 
was interpreted as a consequence of preventing the reorganisation of the cytoskeleton 
[97]. Futhermore, studies conducted in our laboratory established that the observed 
VEGF-driven induction of fenestrae could be abolished by pretreatment of cells with 
the actin filament stabilizing drug phalloidin (K.Deinhardt, unpublished observation).
3.3.4 Cellular predisposition guides fenestrae formation
Actin remodeling appears to be necessary for fenestrae formation, however it is not 
sufficient. Only a subpopulation of endothelial cells tested was able to respond to 
Latrunculin A by forming fenestrae, although microfilaments were disrupted in all 
cases. Thus, it would seem prudent to search for common features among induction 
competent endothelial cells.
One possible feature is the existence of a primed cytoskeleton in the responding cell 
lines. Interestingly, this notion is supported by evidence that jasplakinolide, a marine 
sponge peptide that induces actin polymerisation in a variety of cell types [200-203], 
resulted in actin disruption and fenestrae formation in bEND5 cells (data not shown), 
an effect previously observed only in liver sinusoid endothelial cells [96].
Another common feature could be related to the origins of the responding cell lines, as 
both bEND5 and Py4.1 cells, were derived through transformation with polyoma virus 
[180, 187]. Polyoma middle T antigen has been shown to associate with cellular 
membranes [204] and target a variety of cellular effectors including src tyrosine 
kinases (reviewed in [205]). Pathways downstream of activated tyrosine kinases may 
account for some of the resulting susceptibility through intersecting with the 
cytoskeleton. The importance of oncogene specificity in the response is underlined by
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the inability of SVECs, endotheliomas derived from transformation with the virus 
SV40 [188], to form fenestrae upon the same stimulation. Furthermore, Polyoma 
middle T endotheliomas injected into mice or chick embryos, have been shown to 
produce hemangiomas consisting of discontinuous endothelial cells and accompanied 
by extesive hemorraging, though the presence of fenestrae has not been directly 
addressed [187, 206] [207].
It is noteworthy that not all endotheliomas derived from polyoma middle T infection 
are capable of forming fenestrae, as eEND or sEND cells are very weakly responsive 
(data not shown). In addition, within the positively predisposed endotheliomas, 
bEND5 cells have an increased susceptibility in comparison to Py4.1 cells. Tissue- 
specific differences related to the origin of endotheliomas and different genetic 
alterations during the establishment of the cell lines, could contribute to the observed 
variation. bEND5 cells were derived by Polyoma middle T infection of endothelial 
cell cultures from the brain microvasculature [180], one of the tissues rarely 
associated with fenestrae formation. Py4.1 cells, were obtained from neonatal 
hemangiomas of Polyoma middle T transgenic mice [187, 208], while the weakly 
responsive eEND and sEND lines were derived from hemangiomas of chimeric 
embryos, that had been generated using Polyoma middle T infected ES cells [209]. 
Another contributor to the endothelial cell predisposition to form fenestrae could 
involve the protein PV-1 [16, 54, 71]. PV-1 has been recognised as a structural 
component of the diaphragms of fenestrae and caveolae, and was recently deemed to 
be necessary and sufficient for diaphragm formation [210]. Nonetheless, PV-1 does 
not appear to be necessary and sufficient for fenestrae formation. Our data suggests 
that PV-1 is certainly not sufficient, as both bEND5 and Py 4.1 cells harbor high 
levels of PV-1 in steady state conditions with no fenestrae. Moreover transfection of 
PV-1 in HUVECs does not result in fenestrae formation [210].
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Regarding the necessity of PV-1, there are scattered, contradictory reports. Stan et al. 
reported a correlation between the number of fenestrae and the levels of PV-1, in 
untreated or PMA-induced, endothelial cells [210]. A similar correlation was seen in 
our system, where bEND5 had higher amounts of PV-1 than Py 4.1 cells, while no 
PV-1 was detectable in SVE cells (data not shown). The level of PV-1 in HUVE cells 
could not be determined as the antibodies used did not recognize the human version of 
the protein, while wholemount TEM did not provide the desired resolution to assess 
the presence of diaphragms in the few fenestrae that were formed. Indirect support 
for a role of PV-1 in fenestrae formation comes from observations during the 
development of fenestrated vasculature in vivo: The non-diaphragmed fenestrated 
capillaries of the liver sinusoids and the kidney glomerulus contain a diaphragm 
during organ development, before 17 days of gestation [101] and transiently during 
the first two postnatal weeks [85], respectively. In addition, neovasculature stemming 
from liver sinusoids after transplantation of pseudoislets contained diaphragmed 
fenestrae [211]. On the other hand, no diaphragms were reported during novel 
fenestrae formation in liver sinusoid endothelial cells in vitro [95, 96], arguing against 
a necessary role for PV-1.
An attempt to directly test this hypothesis was shown through the use of PV-1 siRNA 
to suppress PMA-induced fenestrae formation in HUVECs [210]. No fenestrae were 
observed upon silencing, however, the fact that cells were examined after at least 3 
days of treatment, combined with the low level of fenestrae induction achieved by 
PMA (0.000079 per pm2) prevented drawing accurate conclusions. Our system may 
provide a means for manipulating PV-1 expression in the future, so as to obtain a 
definitive answer to this question.
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3.3.5 Dissecting the complex membrane dynamics that lead to 
fenestrae formation
In the course of optimizing the induction protocol, a number of membrane structures 
were encountered, many of which could represent intermediates in the process of 
fenestrae formation. Although the ‘fenestrae forming centre’ reported in liver 
sinusoidal endothelial cells [96] was never observed, I frequently came across areas 
of cytoplasmic depression (Figure 3.7, B) with structures reminiscent of partially 
fused fenestrae (Figure 3.7, C).
One model of membrane fusion that could fit these observations is the stalk 
hypothesis [212-215]. According to the stalk hypothesis an ordered series of events 
take place, starting with close apposition of two bilayers and mixing of their proximal 
monolayers, followed by stalk formation and hemifusion intermediates, and 
terminating with fusion pore formation [212-215]. Areas of visible cytoplasmic 
depression are likely to be sites of future sieve plate occupancy, with cortical actin 
potentially disrupted, and the distance between apical and basal plasma membranes 
reduced. When the two bilayers are found in sufficient proximity, mixing of 
components can result in hemifusion intermediates, potentially resembling the 
incomplete perforations of Figure 3.7. The arrangement of such invaginations is 
characterised by the order and symmetry present in sieve plates; however, the putative 
fenestrae predecessors appear devoid of fully-formed pores. Fenestral pore formation 
could start with the appearance of a narrow fusion pore that subsequently dilates, and 
opens to the correct diameter of a fenestra.
Membrane fusion according to the stalk hypothesis would require the presence of 
fusion co-factors such as Rab GTPases and SNAREs [215, 216]. Whether ubiquitous 
components of the fusion machinery are present on or around fenestrae, as in the case
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of caveolae [217, 218], remains to be established. Interestingly, Ca pump-ATPase 
and Ca2+Mg2+ ATPase have been reported to localise on hepatic sinusoidal endothelial 
fenestrae [75, 76] and have been implicated in the regulation of fenestrae contraction 
and dilatation [98, 219, 220]. Transient calcium fluxes are postulated to trigger fusion 
by activation of target proteins [216, 221, 222], therefore such calcium pumps could 
also participate in membrane fusion during fenestrae formation, by regulating 
intracellular and extracellular calcium levels. Consistent with such a role for local 
calcium gradients, the assembly of the nuclear pore complex, a structure that shares 
remarkable similarity to fenestrae, can be inhibited by the calcium chelator BAPTA 
[223].
An alternative mechanism for membrane fusion could involve an endocytic process 
whereby a vesicle forms as an invagination at the site of future fenestrae on the cell 
surface, and eventually fuses its membrane with the apposing plasma membrane once 
close proximity between the two has been reached. Future studies aimed at arresting 
the process at various stages, and examination of the intermediates by TEM, should 
help distinguish among the numerous possibilities.
This chapter presented the establishment of the first in vitro culture model for de novo 
fenestrae induction in quantities sufficient for cell biological and biochemical studies. 
This has enabled me to systematically dissect and attack different aspects of the 
biological problem, starting with the isolation of fenestrated plasma membranes and 
the characterisation of their molecular components, which will be described in the 
next chapter.
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4.1 Background
The molecular composition of fenestrae is for the most part a mystery. The only 
known constituent of a subset of fenestrae to date is the protein PV-1, a shared feature 
of the diaphragms of fenestrae and caveolae [54]. Fenestrae of the liver sinusoids and 
the kidney glomerulus are devoid of diaphragms [60, 85], therefore remain without a 
single known molecular component. Attempts to characterise the structure so far have 
focused on the diaphragm itself, and showed it consists of multiple PV-1 dimers in 
close proximity to each other [71]. Cross-linking studies in cells rich in caveolae 
were unable to identify new proteins associated with PV-1 [71], and detergent 
extraction studies showed PV-1 to partition separately from other caveolae 
components [224], underlining the need for alternative approaches. Accordingly, to 
gain insight into the molecules that may constitute the rim of the pore, or the fenestrae 
sieve plate, I took advantage of the in vitro induction system and pursued a sub- 
cellular proteomic analysis.
The choice of a proteomic comparison as a suitable method to identify fenestrae- 
specific components was made on the following assumption: Fenestrae induction, 
albeit independent of protein synthesis in our system, involves a recruitment of novel 
components to the plasma membrane. To eliminate the non-specific effects of the 
induction, to minimize the protein complexity of the mixture to be analysed, and 
above all to focus on the subcellular fraction where the relevant changes occur, the 
first step was to isolate plasma membranes from other parts of the cell.
The prime difficulty in isolating plasma membranes on the basis of their physical 
properties lies in the similarity of their density to that of other subcellular fractions 
[225]. Furthermore, conventional methods for cell disruption lead to the 
vesicularisation of the membrane, and the remodeling of many surface microdomains
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[225]. The challenges above demanded a rapid approach that would purify 
fenestrated plasma membranes and at the same time preserve their structural integrity. 
An unbiased affinity purification method based on the physico-chemical properties of 
the plasma membrane as a whole, rather than on the presence of particular antigens, 
was selected as the most appropriate. The method relies on the high affinity of 
cationic colloidal silica for negatively charged plasma membranes [226-230]; upon 
binding of silica, plasma membranes acquire a unique density that can be used to 
separate them from the remainder of the cell. The prediction was that silica would be 
attracted to fenestrated areas of the membrane due to their particularly high 
concentrations of negative charge [63], but also would stabilise the membrane 
substructure by firmly holding the negative charges in place. Silica-coating is 
reported to prevent vesicularisation of the fragmented plasma membrane, and to 
maintain spatiotemporal protein and lipid relationships without modifying any of the 
components as silica is chemically inert [218, 227, 231, 232].
This chapter describes how non-fenestrated and fenestrated states of the endothelial 
plasma membranes were captured, isolated and subjected to a biochemical analysis 
using 2D-gel electrophoresis and mass spectrometry. A subtractive analysis of non­
fenestrated versus fenestrated plasma membrane proteomes highlighted differences 
that are expected to shed light on the molecular architecture of fenestrae.
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4.2 Results
4.2.1 Isolation of plasma membranes
In order to purify plasma membranes from the remainder of the cell, a modification of 
the cationic colloidal silica plasma membrane isolation (Figure 4.1) was applied to 
bEND5 and Py 4.1 cells that had been untreated, or induced with 2.5 pM Latrunculin 
A for 3 hours.
4.2.1.1 Biochemical analysis
To ensure enrichment for plasma membrane components, the progress of the isolation
procedure was followed biochemically, by retaining samples from various steps in the
procedure. Equal amounts of protein from each fraction were separated by SDS-
PAGE electrophoresis and assessed for the presence of particular organelle markers
by western blotting (Figure 4.2). A comparison of equal protein amounts between
whole cell, plasma membrane and nuclei, and plasma membrane fractions showed a
progressive enrichment for plasma membrane markers such as VE-cadherin and PV-1.
Densitometric analysis of bands corresponding to VE-cadherin and PV-1 revealed
enrichment between 5 and 40 fold in the plasma membrane fraction versus whole
cells, in a number of independent assays. Golgi markers such as GM130 showed
depletion between 2 and 20 fold. In addition, no signal for plasma membrane markers
was detected in the internal membrane fraction, suggesting that there is no or minimal
loss of plasma membranes in the supernatant of the first low-speed centrifugation
step. Plasma membranes co-sedimented with nuclei as predicted, according to their
unique new density. It should be noted that the procedure does not result in the
isolation of pure plasma membranes, but rather of a fraction that is enriched in plasma
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Figure 4.1 Schematic of the cationic colloidal silica isolation protocol. Cells are 
coated on the dish with a solution of cationic colloidal silica, which is neutralised 
by a subsequent coating with sodium polyacrylate. Cells are then lysed in a 
hypotonic buffer using a dounce homogeniser, and the various subcellular 
components are separated by centrifugation. A low-speed pellet containing 
nuclei and silica-coated plasma membranes is further fractionated by an 
ultracentrifugation step through a Nycodenz gradient to obtain a pellet of silica- 
coated plasma membranes.
A
uninduced induced
GM130
PV-1
$  &
m m
/  /  <5* * o
/  /
>5? jS* ,gr  4?
/
uninduced induced
GM130
VE-Cadherin
Figure 4.2 Biochemical analysis of cationic colloidal silica plasma membrane 
isolation. lOpg of protein from each subcellular fraction of bEND5 (A) and Py4.1
(B) cells was subjected to SDS-PAGE electrophoresis and Western Blotting using 
antibodies to the indicated proteins. Enrichment for the plasma membrane 
markers PV-1 and VE-cadherin, and depletion for the Golgi marker GM130 is 
seen in the plasma membrane fractions of bEND5 and Py4.1 cells, under 
uninduced or Latrunculin A-induced conditions.
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membranes. Markers for Golgi and other organelles were still present in the final 
fraction (Figure 4.2 and data not shown), albeit at much lower concentrations than in 
the starting material. This can be accounted for by the incomplete cell lysis brought 
about by dounce homogenisation, as observed when disruption was monitored by 
phase-contrast microscopy. Some whole (or cytosol-depleted) cells that are silica- 
coated are therefore expected to co-purify with the dense plasma membranes. 
Spinning through a metrizimide cushion, resulted in a small plasma membrane 
enrichment, that was however associated with the caveat of a great reduction in total 
yield: approximately l/8 th of the amount of starting material was recovered in the
fraction of plasma membrane and nuclei, and of this only half remained in the plasma 
membrane fraction after the metrizimide gradient centrifugation.
4.2.1.2 Morphological analysis
Preliminary ultrastructural studies on fenestrated plasma membranes suggested that 
fenestrae remained intact after using mild conditions to release cells from the culture 
vessel (Figure 4.4, A). This confirmed the biochemical stability of fenestrae in the 
absence of a substratum or cell culture medium. In an attempt to validate the 
preservation of fenestrae in the course of the silica isolation protocol, thin sections 
from fixed plasma membrane pellets were examined under TEM. Low magnification 
images from plasma membrane pellets of uninduced and induced bEND5 cells 
showed that silica-coated plasma membrane sheets, appearing as ‘beads on a string’, 
were the predominant element in the fractions (Figure 4.3). Occasionally whole cells 
were encountered in the pellets (Figure 4.4, B), consistent with the biochemical data 
and the phase-contrast microscopy observations. High magnification images of 
plasma membranes from uninduced cells revealed the presence of caveolae attached
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Figure 4.3 Ultrastructural examination of plasma membrane pellets. Silica 
coated plasma membrane sheets (arrows) are the predominant structure in 
pellets from untreated (A) and Latrunculin A-treated (B) endothelial cells. 
(Bar = 2 pm)
Figure 4.4 Ultrastructural examination of subcellular structures. Fenestrae in 
Latrunculin A-induced bEND5 cells can be maintained biochemically after release 
from the substratum (A). Fenestrae en face denoted by arrows, and fenestrae in 
cross-section denoted by arrowheads (A) Examples encountered in fractions of the 
silica isolation protocol are shown in B, C, and D. Whole cell contaminant of the 
plasma membrane pellet (B). The nucleus is denoted by a star, and the plasma 
membrane by arrowheads. Plasma membrane sheets (arrows) of untreated cells
(C), and Latrunculin A-induced cells (D). Caveolae are isolated intact along with 
the plasma membranes of untreated cells (C, inset). The size of the silica pellicle 
(arrowhead) masks any underlying membrane ultrastructure and precludes 
visualisation of fenestrae in plasma membranes of induced cells (D).
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to the cytoplasmic aspect of the isolated membrane sheets (Figure 4.4, C, inset), 
confirming previous reports in the literature [231, 232]. Both caveolae, and 
intracellular organelles in whole cells appeared morphologically intact, and the silica 
was confined to the exterior of the cell. Unfortunately, the size of the silica pellicle 
had an average diameter of 20-50 nm and therefore masked any underlying 
ultrastructure of the membrane itself, including fenestrae (Figures 4.4, D). In an 
attempt to visualise fenestrae in the pellets of induced cells, sub-saturating amounts of 
silica were employed so as to enable plasma membrane isolation without complete 
coverage of the surface. Dilutions of the amount of silica even down to 1/10th of the 
concentration used in the standard isolation procedure failed to unmask the underlying 
ultrastructure (data not shown).
4.2.1.3 Quality control of starting material for proteomics
To identify differences between fenestrated and non-fenestrated cells, the highest 
possible levels of induction were required. bEND5 and Py4.1 cells, the two cell types 
that were susceptible to Latrunculin-mediated fenestrae induction were both subjected 
to subcellular proteomics. Each conferred unique advantages to the analysis: The 
highest numbers of fenestrae were attained with bEND5 cells, with the drawback of 
some background fenestrae present in the uninduced state. Py4.1 cells on the other 
hand had no background fenestrae, and although never displayed the high absolute 
values of induction seen in bEND5 cells, showed a better relative induction of 
fenestrae (see chapter 3, Figure 3.9)
To ensure the quality of the material processed for a proteomic comparison, fenestrae 
induction was verified by light microscopy and plasma membrane purification was 
followed biochemically. Coverslips included in the culture dishes were fixed at the
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start of the isolation protocol and immunostained for the diaphragm marker PV-1 and 
tubulin. Consistent with observations from light microscopy (see Appendix I), the 
characteristic PV-1-positive sieve plates, delineated by microtubules, were easily 
distinguishable in all bEND5 and Py4.1 induction attempts (Figure 4.5, A).
For each cell type, plasma membranes of Latrunculin-induced and vehicle-induced 
material were isolated for comparison. For bEND5 cells, an additional control 
referred to as Cl was prepared. This represented cells that were entirely untreated, 
and processed for plasma membrane isolation at the start of the induction (time 0), 
which served to pinpoint exactly any differences due to the vehicle. Aliquots of the 
various subcellular fractions were retained throughout the progress of the purification 
protocol and examined for the enrichment of PV-1 and the depletion of intracellular 
components such as the golgi marker GS28 (Figure 4.5, B).
4.2.2 Fenestrae proteomics
4.2.2.1 Preliminary 2D-gel electrophoresis analysis
To assess the efficacy of 2D-gel electrophoresis in revealing differences between
fenestrated and non-fenestrated plasma membranes, a small-scale analysis was
conducted using silica-isolated material from untreated and induced bEND5 cells.
Proteins were eluted from the silica-isolated membranes, precipitated, and
resuspended in an appropriate buffer for isoelectric focusing, the first dimension of
2D-gel electrophoresis. After a first-round of separation on the basis of their charge,
proteins were further separated in a second dimension, on the basis of their molecular
weight, by SDS-PAGE electrophoresis. Results showed that the technique provided
adequate resolution for identifying single protein spots in the given mixture, while no
adverse effects of precipitation or streaking were encountered. Moreover,
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Figure 4.5 Quality control of isolated plasma membranes. (A) The success of 
fenestrae induction was monitored by the characteristic staining of PV-1 for 
fenestrae patches in areas that exclude microtubules. PV-1 labeling, tubulin 
labeling, and the overlay are shown for a bEND5 cell induced with 2.5 pM 
Latrunculin A for 3 hours. An example of a fenestrae patch is encircled by a 
white line in the overlay. (Bar = 20 pm) (B) The success of the isolation 
protocol was assessed by monitoring enrichment for PV-1 and de-enrichment for 
GS-28 in plasma membrane and nuclei (PM + nu), and plasma membrane (PM) 
fractions versus whole cell homogenates of control (C) and Latrunculin A- 
induced (L) Py4.1 (a) and bEND5 (b) cells. In bEND5 cells the additional 
control sampled at time 0 (Cl) can be distinguished from the vehicle-induced 
sample (C2).
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preliminary differences between the two experimental groups were observed (Figure
4.6, A-B).
4.2.2.2 Large-scale 2D-gel electrophoresis analysis (Collaboration with Charles 
River Proteomics)
Following the preliminary study, the silica-isolation protocol was scaled up to 
generate plasma membranes for a large-scale 2D-gel electrophoresis analysis (Figure
4.6, C-F). Some modifications were included in the electrophoresis protocol for the 
large-scale study, but the flow of the procedure remained essentially unchanged. 
Material from different silica-isolation experiments was pooled together in different 
batches, to provide sufficient amounts of protein for comparisons of a minimum of 
three gels between untreated and induced samples. Protein sufficient for one batch of 
quadruplicate gels was generated for untreated and induced Py4.1 cells, which was 
adequate for a single comparison. Protein sufficient for three batches of triplicate gels 
were generated for untreated and induced bEND5 samples, which combined, 
amounted to nine gels per experimental condition. A schematic of the experimental 
design can be found in Appendix II.
Comparisons between gels of induced and uninduced samples were performed 
separately for each cell type using Progenesis software. The program measured fold 
differences between the average staining intensities of spots in gels of induced and 
untreated samples (Figure 4.7). In addition, p-values for those differences were 
calculated using the Students t-test. A number of spots were observed to significantly 
decrease or increase in intensity; however, with an aim of identifying proteins 
involved in fenestrae biogenesis, only those increasing in the induced samples were 
considered for further study. In the first round of analysis, spots that qualified for one
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Figure 4.6 Representative 2D-gels from the preliminary and large-scale proteomic 
studies. Preliminary comparison of plasma membrane proteins from untreated (A) 
and Latrunculin A-induced (B) bEND5 cells showed that 2D-gel electrophoresis 
provided adequate resolution while no streaking was encounterd. Examples of large- 
scale 2D-gel electrophoresis of plasma membrane proteins from untreated (C,E) and 
induced (D,F) bEND5 (C, D) and Py4.1 (E,F) cells.
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Figure 4.7 Spot intensity calculation using Progenesis Software. (A) shows spot 659 
from the Py4.1 cell analysis, recognized as being 1.772 fold higher in the average (6) 
of the Latrunculin A-induced samples (7,8,9) compared to the average (1) of the 
control samples (2,3,4,5). Possible identities for spot 659 are alpha enolase, 
paralemmin, and kinesin light chain. (B) shows spot 401 from the Py4.1 cell 
analysis, which although recognized as being 3.8 fold higher in the average of the 
Latrunculin A-induced samples (6) compared to that of control samples (1), is 
actually part of a train of spots characteristic of different phosphorylation states of 
the same protein. Possible identities for spot 401 are radixin and moesin.
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or more of the following criteria were selected: a) fold increase in staining intensity 
greater than 2 in the induced sample, b) p-value less than 0.05 for any fold increase, c) 
spot being unique in induced sample. However, as great variation was observed 
across gels originating from different bEND5 batches - most likely reflecting the 
underlying biological variation in the system - a second round of analysis was 
performed: spots were examined for their fold difference and p-value within each of 
the three bEND5 batches of triplicate gels separately. The latter analysis, albeit of 
lower statistical significance, was aimed at unmasking important differences that 
potentially cancelled out from pooling of samples. A summary of all the spots 
selected for mass spectrometry, with their accompanying fold differences and p- 
values is shown in Appendix II.
4.2.2.3 Mass Spectrometry and identity assignment
Excised spots were digested with trypsin and analysed by Mass Spectrometry to 
produce a characteristic peptide mass fingerprint for each spot, provided that 
sufficient protein amounts were present. Each mass fingerprint was then matched 
against a database of fingerprints from theoretical tryptic digests of proteins so as to 
assign a particular protein identity to each spot. Information such as the percent 
coverage of a theoretical protein identity by the tryptic fragments obtained, the 
fraction of tryptic fragments matching that identity, the MOWSE score (algorithm 
evaluating the statistical significance of a match), and the relationship between the 
isoelectric point (pi) and molecular weight of the excised spot and that of the 
theoretical identity, were all considered prior to assigning a particular identity. Often, 
more than one identity was assigned, which could be explained by similarities in 
sequence between potential identities, by coincident patterns of tryptic fragments, or
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Table 4.1 Summary of candidate proteins grouped according to their function. For 
proteins with more than one function, only the best-characterised one is indicated. 
Fold change and accompanying p-value are shown for all the different types of 
analysis performed. Total change refers to the fold change in spot intensity in 
Latrunculin A-induced versus control cells across all gels from the bEND5-cell or 
the Py4.1-cell comparison. Columns L vs C2 (1), L vs C2 (2), and L vs C2 (3) refer 
to fold change in spot intensity in individual batch analyses performed for bEND5 
cells. Note that more than one protein identity can be assigned to one spot (e.g. 
bEND5 400), and the same protein identity can be encountered in multiple spots (e.g. 
bEND5 526 and 527). The fold changes that determined the selection of the 
particular spot for excision and subsequent protein content identification are 
highlighted in yellow.
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Figure 4.8 Categorisation of candidate proteins with respect to their subcellular 
localisation (A) and function (B). For a protein falling into more than one category, 
its value was split between categories. Where multiple isoforms or polypeptide 
chains for the same protein were identified, the protein was counted only once.
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by the presence of more than one protein within a single spot on the gel. In addition, 
separate spots frequently corresponded to the same protein, especially when found in 
clusters representing collections of post-tranlational states of a given protein. 
Identities were obtained for 22 spots, out of a total of 40 spots excised and subjected 
to mass spectrometry. Assigned protein identities for spots in each sample are 
presented in detail in Appendix II, and summarised according to their function in 
Table 4.1. The categories into which candidates fall, with respect to their subcellular 
localisation or function are illustrated in pie-charts in Figure 4.8.
4.2.3 Target validation
4.2.3.1 Immunoblotting for candidate proteins
Selective target validation was pursued for proteins that appeared interesting from
prior knowledge of their function or localisation, provided that antibodies were
available. In a first round of validation, immunoblotting on plasma membrane
fractions was performed with antibodies to candidate proteins. By comparing equal
amounts of protein in untreated and induced conditions, a difference in the protein
levels of cofilin, alpha-enolase, radixin, moesin, annexin II, and hnRNP K was
confirmed (Figure 4.9, A-B). Cofilin, a candidate emerging from the combined
comparison of all three batches of bEND5 samples, was upregulated in all induced
plasma membrane fractions examined. On the other hand, Annexin II, a candidate
from the analysis of the 3rd batch only, was not consistently upregulated. Alpha-
enolase and hnRNP K appeared both to be upregulated, but were only detected when
high amounts of protein were loaded on the gel. Interestingly, although no
upregulation in the induced fraction was seen for the related proteins moesin and
radixin, probing with an antibody that primarily recognizes the phosphorylated
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Figure 4.9 Validation of candidate proteins by Western Blotting. Equal amounts of 
protein from CPM (control cells’ plasma membranes) and LPM (Latrunculin A- 
induced cells’ plasma membranes) were separated by SDS-PAGE electrophoresis 
and probed for the indicated proteins by Western Blotting. Targets from the bEND5 
cell analysis are shown in (A) and from the Py4.1 cell analysis in (B). Enrichment in 
induced cells is confirmed for phosphorylated moesin, hnRNP K, cofilin, and alpha- 
enolase. A comparison of the enrichment in cofilin between the membrane fractions 
of control and induced cells (CPM, LPM) versus that between the whole cell -  
homogenates of control and induced cells (Cw, Lw) is shown in (C). Cofilin 
enrichment is only evident at the level of the plasma membrane. The bands for 
internal membranes (ClM, LIM), and for plasma membrane and nuclei (CPM+N, 
LPM+N) are also indicated.
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version of moesin, showed an increase in the phosphorylated protein. This could 
explain the 2d-gel pattern for the particular spot, which appeared as part of a ‘train of 
spots’ (Figure 4.7, B) and is characteristic of proteins existing in multiple 
phosphorylation states.
Consistent with the hypothesis that plasma membrane enrichment is necessary to 
highlight differences between the samples, cofilin enrichment was only evident in the 
comparison of plasma membrane fractions between induced and uninduced cells, 
while no change was apparent at the level of whole cell homogenates (Figure 4.9, C).
4.2.3.2 Immunolocalisation of candidate proteins
All targets validated by western blotting were subsequently examined for their 
subcellular localisation by immunofluorescence on bEND5 cells induced with 2.5 pM 
Latrunculin A for 3 hours. The characteristic pattern of PV-1 labelling in induced 
cells was used as a reference standard for the presence and location of fenestrae.
The actin binding protein cofilin and annexin II appeared to be associated with the 
thick areas of the cell that act as spacers between fenestrae patches (Figure 4.10, A-F). 
Alpha enolase was concentrated mainly in the perinuclear region in both control and 
induced cells (data not shown). Interestingly, immunolabelling with an antibody that 
recognised both moesin and radixin on a western blot, showed that one or both of the 
ERM (ezrin-radixin-moesin) family members redistributed into the same fenestrae 
patches that were marked by PV-1 (Figures 4.10, G-I). The staining pattern obtained 
with the cross-reactive goat polyclonal anti-moesin antibody was confirmed for 
moesin using a mouse monoclonal anti-moesin antibody. Further confirmation for the 
specificity of the moesin staining was obtained by a peptide competition experiment: 
The labelling for moesin obtained with either antibody could be competed by pre-
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Figure 4.10 Validation of candidate proteins by Immunofluorescence. bEND5 cells, 
induced with 2.5pM Latrunculin A for 3 hours, were stained for PV-1 (A, D, G) and 
the following candidate proteins: cofilin (B), annexin (E), radixin/moesin (H). The 
corresponding overlays (C), (F), (I) show that radixin and/or moesin localise on the 
same fenestrae patches (arrows) that are labeled by PV-1, whereas cofilin and 
annexin are excluded from those regions. Images were obtained using 
epifluorescence microscopy. (Bar = 20 pm)
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Figure 4.11 Competition study for anti-moesin mAb. Specificity for the labeling of 
the anti-moesin mAb (B) is seen by the disappearance of the signal (arrows) after 
preadsorption of the antibody with the peptide against which it was raised (E). Pre­
adsorption with an irrelevant peptide has no effect on the labeling (H). The 
corresponding PV-1 labeling (A,D,G) and overlay of the two signals (C,F,I) are 
shown. Images were obtained using epifluorescence microscopy. (Bar = 20 pm)
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incubating each antibody with the peptide against which it had been raised (Figure 
4.11, A-C and data not shown).
Variable success with the remainder of antibodies in immunofluorescence prevented 
reaching a conclusion for the localisation of all targets. Candidates of interest will be 
pursued in the future, by means of alternative approaches such as cDNA tagging to 
assist visualisation.
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4.3 Discussion
4.3.1 Overview of proteomic results
Despite the recent revolution in the field of genomics, when it comes to the 
characterisation of cell structures, proteomics remains the method of choice. 
Proteomic approaches directly look at the components of a structure, rather than the 
genes that encode them, and can be combined with fractionation techniques to 
specifically focus on the subcellular fraction in question. Success stories in the 
history of ‘subcellular proteomics’ include the proteome characterisations of nuclear 
pore complexes [233] phagosomes [234], mitochondria [235], centrosomes [236], 
chloroplasts [237], nucleoli [238], and others [239-241].
Using the above rationale, this study sought to characterise the components of 
fenestrae from cultured cells in which they are present in high abundance. Since the 
lack of a specific molecular marker hindered the isolation of pure fenestrae for 
characterisation, the approach taken was that of enriching for fenestrated plasma 
membranes and performing a subtractive proteomic analysis against plasma 
membranes from cells without fenestrae. A key element was the use of the cationic 
colloidal silica isolation technique that resulted in significant plasma membrane 
enrichment over the whole cell homogenate. A caveat inherent in the method was the 
masking of any ultrastructure associated with the extracellular leaflet of the plasma 
membrane due to the size of the silica pellicle [228], thus preventing the visualisation 
of presumably enriched fenestrae for quality control purposes. Nevertheless, given 
that in induced cells the majority of the plasma membrane is fenestrated, and that a 
combination of biochemical and ultrastructural evidence indicated that plasma 
membranes were isolated with comparable yields from induced and uninduced cells,
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suggested that the procedure was effective in the isolation of fenestrae. Furthemore, 
the potential loss of fenestrae in the course of the isolation protocol should be 
circumvented, as silica coating reportedly prevents the lateral mobility of proteins to 
which it binds, preserving the spatial and temporal characteristics of membrane 
domains [229, 231, 232]. The compatibility of the silica isolation method with 
proteomics was recently shown in two papers concerned with lung endothelial surface 
heterogeneity [242, 243]. Validation for its effectiveness in this study came with the 
identification of candidate proteins, such as cofilin, whose levels were only altered at 
the level of the plasma membrane, and ultimately with the discovery of fenestrae 
sieve plate components.
In general, subtractive proteomic approaches yield a smaller and more manageable set
of candidate proteins than high-resolution whole proteome analyses. In such a
differential expression approach, the size of the candidate set can vary depending on
the level of differences between the samples under comparison, and the stringency
criteria set by the investigator. In this comparison plasma membranes of identical cell
types differing in their treatment with an actin-disrupting agent, only spots that were
either unique, greater than 2-fold upregulated in the treated sample, or increased in the
treated sample with a confidence interval of p<0.05 were considered, resulting in a set
of 26 unique protein identities. Often, the same spot yielded more than one protein
identity. This can be attributed to the non-absolute method of identity assignment
used that is based on matching mass fingerprints rather than amino acid sequences
against protein databases. When the ambiguity between two or more identities could
not be resolved, they were all deemed possible, taking into account the limitations in
the identity assignment method and the resolving capabilities of the 2d-gel itself.
Overall, out of 26 protein identities, 23 were characterised gene products, 2 had been
previously identified in functional screens (Ras suppressor protein 1, interferon-
143
Chapter 4: Molecular characterisation of fenestrae
activatable protein 205), and one was partially characterised on the basis of structural 
similarity to known proteins (putative RNA-binding protein 3).
4.4.2 Categories of candidate proteins
Categorisation of proteins on the basis of their reported, or in some cases putative, 
subcellular localisation indicated that a total of 60% was associated with the plasma 
membrane and the co-purifying cytoskeleton, and another 32% with various other 
cytoplasmic structures. Within the set of plasma membrane associated proteins, none 
of the proteins had membrane spanning regions, and instead were peripherally 
attached or lipid anchored to the bilayer. Categorisation of proteins with respect to 
their function, indicated that the majority of candidates were involved in membrane 
remodeling or endocytic processes, while a great proportion was also occupied by 
actin binding proteins, cytoskeletal motors, and proteins with roles in transcription or 
translation. Validation of candidates by immunoblotting or immunofluorescence was 
pursued for proteins with interesting function or localisation, but was not always 
possible due to lack of antibody availability or suitability in particular techniques. 
Where validation was possible, all protein changes were confirmed by either or both 
methods, apart from that of annexin II whose upregulation remains questionable. 
When viewed in the context of fenestrae, candidate proteins, validated or not, can be 
split into two categories: those of structural components and those involved in some 
stage of fenestrae biogenesis.
The role of cytoskeletal remodeling in fenestrae formation has been well documented 
by us and others [95, 97, 178, 244, 245], thus the abundance of cytoskeleton 
associated proteins within the candidate list was expected. Cofilin binds to both 
monomeric and filamentous actin and is reported to increase actin filament
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disassembly by depolymerising filaments from their pointed ends and by inhibiting 
spontaneous nucleotide exchange on monomeric GDP-bound actin [246, 247]. 
Twinfilin (or protein tyrosine kinase 9) has a less clear role in actin dynamics, though 
its ability to sequester actin monomers and prevent their nucleotide exchange is 
believed to inhibit monomer assembly [247, 248]. Transgelin is the least characterised 
of the actin binding protein candidates, but reportedly plays a role in cross-linking 
actin filaments into aggregates [249, 250], seemingly opposite to the functions of 
cofilin and twinfilin. These endogenous actin binding proteins could have roles in the 
actin-filament disassembly that is required for fenestrae formation as aids to the 
exogenously added latrunculin A, which presumably drives the process. It is unlikely 
that any of them would be structural components of fenestrae, as exemplified by the 
validation of cofilin as an upregulated candidate in the membrane/cytoskeleton 
fraction, but not in the specific structure of interest.
Myosins and kinesins are molecular motor proteins that move on actin-filaments or 
microtubules, respectively, performing work in a cell [251-253]. Both are found as 
oligomers of heavy and light chains, with heavy chains serving as motor domains and 
light chains having either regulatory roles, in the case of myosins, or determining 
subcellular localisation and cargo selection in kinesins [251-253]. Although only 
light chains were identified in this screen, the entire protein functional unit will be 
considered. In a model of fenestrae biogenesis consistent with a large re-organisation 
in the architecture of a cell, one can foresee the need for organelle movement and re­
localisation. Myosins and kinesins could catalyse this process by driving vesicles and 
organelles to or away from the area that is about to become fenestrated. Latrunculin 
A is reported to induce the internalisation of caveolae and their movement along 
microtubules [254], and whether or not related to fenestrae formation, this could be 
driven by kinesin. Interestingly, the presence of myosin near fenestrae has been
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previously described as part of an actin cytoskeleton ring that surrounds and regulates 
the size of the pore [98].
Apart from cytoskeletal disassembly and organelle movement, an obvious part of 
fenestrae biogenesis is the remodeling of the membrane itself, from a continuous 
structure to that of a discontinuous one, intermitted by numerous pores. Endocytosis, 
as a means of membrane cycling from the plasma membrane to some internal 
organelle is a plausible mechanism for such membrane remodeling, and in this 
context, the tumor promoter Nm23, has been shown to be necessary for dynamin- 
mediated endocytosis of adherens junctions [145]. Paralemmin is another protein 
implicated in plasma membrane dynamics, through its association with the 
cytoplasmic face of membranes at sites of plasma membrane activity and its ability to 
induce cell expansion and process formation [255]. Annexin II, a protein found both 
in the cytoplasm and bound to membranes, is implicated in membrane sorting and 
trafficking through its essential role in the dettachment of multivesicular bodies from 
early endosomes [256]. Interestingly, annexin II was found upregulated in bEND5 
versus Py4.1 cells, in a transcriptional profiling comparison (data not shown). 
Annexin had been identified as a major component of fusogenic membranes [257], 
and in this context could provide an explanation for the increased susceptibility of 
bEND5 cells for fenestrae formation.
Finally, radixin and moesin, representing the ERM family of proteins, can link the 
fundamental processes of actin disassembly and plasma membrane remodeling 
through their role as membrane-cytoskeleton adaptors [258]. Interestingly, 
upregulation for the phosphorylated version of moesin was validated by western 
blotting, and localisation of one or both proteins in fenestrae sieve plates was 
confirmed by immunofluorescence using an antibody of dual specificity. Their
specific role in fenestrae biogenesis will be further addressed in the following chapter.
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Candidate proteins with seemingly irrelevant functions and localisations could be 
contaminants due to the nature of the isolation protocol. The particularly high 
proportion of nuclear proteins can be explained by the inefficient gradient 
centrifugation step employed to separate silica-coated membranes from nuclei. Also, 
polycationic proteins such as RNA binding proteins, could non-specifically adsorb to 
the polyanionic polyacrilic acid crosslinker of the silica after tissue disruption, and co- 
purify with the membrane pellet. No protein should be completely disregarded, 
however, as it is not unusual for proteins thought of as residents o f particular 
organelles, to be later discovered in secondary subcellular compartments. In 
relevance to this analysis, alpha-enolase, a glycolytic enzyme residing in the cytosol, 
has been subsequently found to associate with the plasma membrane and act as a 
receptor for plasminogen [259, 260]. Furthermore, in a recent mass-spectrometry 
study, RNA binding proteins such as hnRNPs were unexpectedly identified as 
components of focal adhesion complexes [261]. In the same study, validation of these 
candidate proteins by immunofluorescence, highlighted a novel function for RNA 
binding proteins as components of spreading initiation centers at the initial stages of 
focal adhesion assembly [261]. One can envision that in the course of fenestrae 
biogenesis, attachments to the substratum undergo remodeling too. The absence of 
the typical vinculin staining that is characteristic of focal adhesions from fenestrated 
cells (data not shown) suggests that focal adhesions need to be disassembled. The 
candidate protein hnRNP K could participate in such a process that would essentially 
be the reverse of its newly reported function.
147
Chapter 4: Molecular characterisation of fenestrae
4.4.3 Integral versus peripheral membrane proteins in fenestrae
The fact that none of the identified proteins had transmembrane domains was 
unexpected, but can be attributed to one or more of the following reasons: (1) 
technical problems associated with 2d-gel electrophoresis of membrane proteins, (2) 
integral membrane proteins being present in the 18 spots that were not identified by 
mass spectrometry, (3) no novel protein components being inserted in the membrane 
upon fenestrae formation. Although 2D-gel electrophoresis provides the highest 
resolution among protein separation techniques, a number of limitations are 
encountered when the technique is applied to membrane proteins [262] . The major 
impediments are the poor solubility of hydrophobic proteins in the chaotrope- 
detergent mixtures of the isoelectric focusing, and the precipitation of some 
solubilised proteins out of solution when they migrate to their isoelectric point. This is 
reflected in published protocols that aim to improve the solubilisation of membrane 
protocols using organic solvents [263, 264] and new detergent mixtures [265-267]. 
Alternatively, the need for solubilisation is often obviated altogether by coupling 1D- 
gel electrophoresis, and occasionally liquid chromatography for increased resolution, 
to mass spectrometry [268-271]. It should be stressed that the most difficult part in 
the solubilisation process of a membrane protein is its dissociation from the 
hydrophobic environment of the lipid bilayer. In the case of silica-coated membranes, 
the proteins are already released from the bilayer upon removal of the silica with 2% 
SDS. Thus, the resolubilisation of the proteins in the isoelectric focusing buffer after 
acetone precipitation should be less of an obstacle. A pellet was obtained after 
resolubilisation, suggesting the presence of some insoluble components, however no 
bands were visible when it was subjected to ID SDS-PAGE analysis (data not 
shown).
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The presence of transmembrane proteins among the 18 unidentified spots is another 
plausible explanation for their absence from the list of candidate proteins. This seems 
less likely from a statistical point of view, as there were no transmembrane proteins in 
22 out of a total of 40 spots, and also none at all in the Py4.1 set, where identities 
were obtained for all spots. Failure to obtain a peptide mass fingerprint is commonly 
due to insufficient protein amounts, therefore scaling up the procedure would be 
required to obtain a definitive answer.
A much more conceivable explanation is the absence altogether of any novel protein 
insertion in the lipid bilayer during fenestrae biogenesis. In the case of a mere lateral 
rearrangement of existing proteins, there would be no differences in protein content 
between the plasma membranes of an induced and an uninduced cell. The high 
membrane curvature at the rim of fenestrae could be due to the recruitment of proteins 
from different parts of the same membrane into a structure that overcomes the 
resistance of mechanically bending the membrane. Alternatively, the observed 
membrane deformation could be due entirely to lipids or the presence of peripheral 
proteins. Different lipid species reportedly favour low or high membrane curvature, 
depending on their geometries or physico-chemical properties [272], and may have a 
heterogeneous distribution to favour budding or fusion [273, 274]. Similarly, 
peripheral membrane proteins can drive membrane curvature, as seen with coat 
proteins on vesicles [275, 276] and dynamin assembly into rings and spirals that drive 
tubule formation [277].
There are many ways in which the current molecular characterisation approach can be 
improved to yield more information. Given the lack of a unique molecular marker for 
the specific purification of fenestrae, the silica isolation approach would still be the 
preferred method for enrichment of the structure. Unfortunately, unlike the isolation 
of caveolae [231, 232], the lack of distinct ultrastructure upon silica binding also
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prevents the selective purification of the structure from the remainder of the 
membrane. Nonetheless, the membrane subfraction can be further fractionated non- 
specifically to enrich for proteins with particular physico-chemical proteins. 
Peripheral proteins are known to be released by sodium carbonate at pH 11.5 [278], 
while organic solvents [279, 280], detergents [239], or chaotropes [239] can enrich for 
subsets of proteins depending on their hydrophobicity. Silica-isolated membranes 
have been previously shown to fractionate into caveolae, other detergent resistant 
membranes, and an insoluble membrane pellet attached to silica, using a combination 
of sonication, potassium phosphate, and detergents [231]. Applied to this system, 
different fractions of the membrane subfraction could be isolated and compared 
separately in 2D-gels that would be less complex and enriched for particular protein 
types. Complexity in such a 2D-gel could be reduced even further, by focusing on a 
narrow pi and molecular weight range. Finally, the most hydrophobic proteins that 
are resistant to solubilisation in the 2D-gel buffer could then be analysed separately on 
a ld-gel.
A variation to the classical subtractive proteomic approach of comparing normal to
disease states is that of differentially analysing cross-contaminated cellular
subfractions, to highlight proteins unique to particular structures. A recent study on
the nuclear envelope proteome, showed the purification and proteomic analysis of
nuclear envelopes in addition to organelles known to co-fractionate with them [281].
Unique nuclear envelope proteins were subsequently identified by subtracting the
organelle-specific proteins from the nuclear envelope data set [281]. An analogous
comparison of silica-isolated plasma membranes contaminated with nuclei against
purified nuclei would pinpoint proteins that are specific to the membrane. To further
simplify this subset of proteins they could be the focus of yet another round of
subtractive proteomics between untreated and induced samples. As there is no single
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approach for the optimal protein characterisation of fenestrae, it seems that a 
combination of strategies should be pursued in order to exhaust their proteome.
This study was the first to use a subtractive proteomic comparison of organelle -  rich 
to organelle - deficient states of the same cell type, in order to define such an 
organelle’s protein complement. It was also the first successful attempt to discover 
and validate proteins of the fenestrae sieve plate. In a similar fashion to PV-1 
however, moesin and radixin are not unique to fenestrae, and may form part of other 
cell structures. Deciphering the relationship of more candidates to fenestrae will be a 
challenge, and may require functional tests in addition to expression validation. In the 
next chapter, the characterisation of moesin and radixin within fenestrae sieve plates 
will be presented, and the biological significance of this novel relationship will be 
addressed.
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5.1 Background
Moesin and radixin, two newly identified components of the fenestrae sieve plate, are 
members of the ERM (ezrin-radixin-moesin) family of proteins, which are known to 
act as adaptors between the cortical cytoskeleton and the plasma membrane [282]. 
The three closely related proteins ezrin [283], radixin [284], and moesin [285], that 
make up the ERM family, along with the related protein merlin [286, 287], belong to 
the larger 4.1 superfamily of proteins, the members of which are characterised by a 
FERM (four-point one, ezrin, radixin, moesin) domain at their amino terminus [286, 
288-290]. The N-terminal domains of ERM proteins are highly conserved with 
approximately 85% homology, and are responsible for interacting directly or 
indirectly with integral membrane proteins [258, 291]. Following the ~300 residue N- 
terminal domain is an extended alpha-helical domain and finally an ~80 residue C- 
terminal filamentous actin (F-actin) binding domain, which represent the less 
conserved regions within the ERM proteins [258, 291]. Merlin, the product of the 
Neurofibromatosis 2 tumor suppressor gene [286, 287], contains an N-terminal FERM 
domain, shares some binding partners with ERM proteins at the plasma membrane but 
lacks an F-actin binding domain at its C-terminus[258]. Nevertheless, it too has been 
reported to interact with F-actin, through actin binding regions within the FERM 
domain [292, 293].
Consistent with the high degree of structural similarity between ERM proteins is their 
reported functional redundancy. Although they show a wide distribution that appears 
to be regulated in a tissue-specific manner [294, 295], a moesin knockout mouse is 
viable with no obvious abnormalities [296], while a radixin deficiency is partially 
complemented by the upregulation of ezrin in a radixin null mouse [297]. To further 
complicate matters, it appears that all ERM proteins are co-expressed in cultured cells
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[282, 291, 294, 298], putting an obstacle to manipulations destined towards 
understanding their function. The use of constitutively active [299-301] or dominant 
negative [302-304] versions of the proteins, however, have shed light onto their 
crucial roles in cell polarity and morphogenesis. ERM proteins have been implicated 
in functions ranging from the determination of cell shape, adhesion, motility, 
cytokinesis, phagocytosis, to integration of membrane transport with signaling 
cascades [258]. The related protein merlin shares a number of the aforementioned 
functions [305].
Regulation of the ERM protein function is thought to occur at the level of their 
conformation, which then translates to a particular subcellular localisation. An 
inhibitory interaction between the FERM domain and the C-terminal domain 
maintains ERM proteins as monomers, and confines them to the cytoplasm [306, 
307]. Interaction with phosphatidylinositol 4,5-bisphosphate (PIP2 ) through the 
FERM domain followed by phosphorylation at a conserved threonine residue in the 
C-terminal domain, are thought to unmask both membrane and actin binding sites 
[308-310]. Inhibitory interactions can occur intermolecularly as well as 
intramolecularly, however the significance of the oligomeric states is currently 
unclear [300, 306, 311]. ERM phosphorylation and phospholipid binding have been 
proposed to lie downstream of the Rho signaling cascade [308, 312-314], while an 
ERM function downstream of Rac has also been reported [315]. ERM proteins have 
also been shown to function upstream of Rho, either as positive [316], or as negative 
[317] regulators, suggesting the presence of a feedback mechanism.
My aim in this study was to characterize these novel components of fenestrae sieve 
plates. In vitro and in vivo evidence was accumulated to support the presence of the 
ERM protein moesin within fenestrae. The subcellular distribution, phosphorylation 
state, and detergent solubility of the protein were assessed in the bEND5 cell line.
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Furthermore, the potential role of moesin in fenestrae biogenesis was addressed 
through a time-course of fenestrae formation and immunoprecipitation experiments.
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5.2 Results
5.2.1 Specificity for sieve plate localisation within the ERM family
The presence of all ERM family members in most cultured cells, and specifically their 
co-existence in the cell lines susceptible to fenestrae formation, prompted an 
investigation into the subcellular distribution of each member (Figure 5.1). 
Latrunculin-induced bEND5 cells were immunostained for ezrin, radixin, moesin, or 
the related protein merlin. To ascertain for fenestrae localisation, anti-PV-1 (MECA- 
32) was used as a counterstain that marks fenestrae sieve plates. Interestingly, and 
despite the reported functional redundancies, the only two ERM members that 
localised to sieve plates were the ones identified in the proteomic study, moesin 
(Figure 5.1, A-C) and radixin (Figure 5.1, J-L). In contrast, ezrin (Figure 5.1, D-F) 
and merlin (Figure 5.1, G-I), appeared to be excluded from the sieve plates, and 
instead were confined to the cytoplasmic spacers between them.
A frequent problem encountered in the study of individual ERM family members is 
the cross-reactivity of the antibodies with different ERM proteins. A combination of 
antibodies that were first assessed by western blotting on bEND5 cell lysates (data not 
shown) was thus employed to draw definitive conclusions for particular ERM 
members. The subcellular localisation of moesin was determined using a rabbit 
polyclonal antibody that recognised both moesin and radixin on a western blot, and 
also a mouse monoclonal antibody that recognised only moesin on a western blot. 
Two independent antibodies were also used in the case of ezrin; a mouse monoclonal 
antibody and a rabbit polyclonal antibody. Both antibodies appeared specific for ezrin 
by western blotting, however slight immunoreactivity with fenestrae sieve plates was 
observed in the case of the mouse monoclonal antibody, especially at high antibody
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Figure 5.1 ERM family distribution within fenestrae patches. bEND5 cells, induced with 
2.5 pM Latrunculin A for 3 hours, were immunostained for moesin (A), ezrin (D), merlin 
(G), and radixin (J) and counterstained for PV-1 (B,E,H,K), to mark the location of 
fenestrae. Overlays of the antibody combinations are shown in C,F,I, and L. Moesin (A) 
and radixin (J) appear to colocalise with the PV-1 staining on fenestrae (B,C) and (K,L), 
respectively, while ezrin (D) and merlin (G) appear excluded from the PV-1 positive 
regions of the cell (E,F) and (H,I), respectively. Epifluorescent images are shown, and 
representative fenestrae patches are marked by arrows. (Bar = 20 pm)
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concentrations. Since the majority of ezrin was confined to the cytoplasmic arms 
around sieve plates, and immunostaining with the rabbit polyclonal antibody showed 
no reactivity with fenestrae, the low labelling obtained with the mouse antibody was 
attributed to cross-reactivity rather than true localisation of ezrin. The subcellular 
localisation of radixin was determined using a goat polyclonal antibody that only 
recognised radixin by western blotting. Finally, an unambiguous classification could 
be performed for merlin, as it is less homologous to the ERM proteins than family 
members are between them, and the rabbit polyclonal antibody against it appeared 
specific for the protein by western blotting.
The specificity displayed by ERM family members and merlin for fenestrae in
cultured endothelial cells was mirrored in an analysis of a fenestrated capillary bed in
vivo. The choriocapillaris of the eye was chosen as a suitable tissue for analysis, as it
contains fenestrae with diaphragms [318, 319] that can be visualised by
immunostaining for the diaphragm protein PV-1 (Stephen Poor, unpublished
observation). In triple stainings of eye sections (Figure 5.2), two distinct tissues were
immediately visible: the retinal pigment epithelium, with immunoreactivity for ezrin
(Figure 5.2 B,F), as previously reported [320, 321], and the fenestrated
choriocapillaris, with immunoreactivity for both moesin [321] and PV-1 (Figure 5.2,
A,C,E,G). A differential interference contrast (DIC) image of an eye section is
included in Appendix III for orientation purposes. The overlay of all three channels,
at both low (Figure 5.2, D) and high (Figure 5.2, H) magnifications, showed
colocalisation of moesin and PV-1 within the same cell type, and exclusion of ezrin.
Very weak immunoreactivity for moesin was detected for some parts of the retinal
pigment epithelium, probably due to cross-reactivity of the rabbit polyclonal antibody
used in the staining. It is noteworthy that the antibody used for the localisation of
moesin displayed cross-reactivity for radixin on a western blot, however the absence
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Figure 5.2 Distribution of ERM family members in vivo. Confocal analysis of mouse 
eye sections triply labeled for moesin (A), ezrin (B), and PV-1 (C). Moesin colocalises 
with PV-1 in the endothelium of the choriocapillaris (arrow), while ezrin is confined to 
the retinal pigment epithelium layer (arrowhead), as seen in the overlay (D). High 
magnification images of the same specimen labeled for moesin (E), ezrin (F), and PV-1 
(G) are shown, along with the overlay (H). Some coincident staining between moesin 
and ezrin is seen in the sclera (asterisk), below the choriocapillaris.
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of any immunoreactivity for radixin in the eye using the radixin -  specific antibody, 
suggested that among the two, moesin was the most likely component of the 
choriocapillaris.
5.2.2 Characterisation of moesin in fenestrae sieve plates
5.2.2.1 Colocalisation studies of moesin with PV-1 and caveolin-1
In light of the distribution of moesin in fenestrated bEND5 cells and the 
choriocapillaris, its reported preferential expression in endothelium in vivo [294, 295], 
and the availability of better antibody reagents for assessing its distribution than in the 
case of radixin, moesin became the focus of further studies.
The first question concerned the specificity o f the association between moesin and 
fenestrae sieve plates. High resolution confocal sections through the plane of PV-1 - 
positive sieve plates showed almost complete colocalisation of moesin with PV-1 
(Figure 5.3, A-F). As seen more clearly in the magnified images (Figure 5.3, D-F), 
moesin was confined to the thin cell areas marked by PV-1, while it was absent from 
the cytoplasmic spacers that separated the sieve plates. In addition, moesin was 
present in filopodia, in agreement with studies in other cell types [298, 302], which 
were not stained by the anti-PV-1 antibody.
Given that PV-1 is a marker for the diaphragms of both fenestrae and caveolae, the
next question was whether moesin also resided in caveolae. Untreated bEND5 cells
were used to address this, as they display a characteristic and recognisable pattern of
caveolae accumulated at the cell edges. In optical sections at the level of caveolae,
moesin appeared to be evenly dispersed around the cytoplasm (Figure 5.3, G), with no
specific enrichment in areas of PV-l-labeled caveolae (Figure 5.3, H-I). At higher
magnification, moesin seemed slightly enriched in the region adjacent to caveolae
160
16.00 pm
161
M N
R
Figure 5.3 (continued from previous page) Colocalisation studies of moesin with PV-1 
and caveolin-1. Moesin (A,D) colocalises with PV-1 (B,E) in fenestrae sieve plates 
(arrows) (C,F) of Latrunculin A-induced bEND5 cells. In untreated bEND5 cells, moesin 
(G,J) does not colocalize with PV-1 (H,K) in caveolae (arrowheads) (I,L). Labeling with 
caveolin-1 (N,Q) confirms that moesin (M,P) is not enriched in caveolae (arrowheads) (O, 
R). Confocal sections were obtained either at the level of fenestrae (A-F) or at the level 
of caveolae (G-R).
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(Figure 5.3, J-L). Further confirmation for the absence of an association between 
moesin and caveolae came from a double immunostaining for moesin and the integral 
membrane caveolar protein caveolin-1 (Figure 5.3, M-R). The same diffuse staining 
of moesin was observed, with no coincidence of fluorescence between the two 
antigens.
5.2.2.2 Post-translational modification and solubility of moesin
The localisation and function of ERM proteins is reportedly dependent on their 
conformation, with active ERM proteins existing in an ‘open’ state, and inactive ones 
existing in a ‘closed’ state. Since binding to PIP2 followed by threonine 
phosphorylation are the hallmarks of such an active form, the phosphorylation state of 
moesin was assessed by immunofluorescence using an antibody specific for the 
phosphorylated version of the protein (Figure 5.4). Moesin appeared phosphorylated 
in filopodia of untreated bEND5 cells, but not at its residence in the cell cortex 
(Figure 5.4, A-D). Coincidence of fluorescence between moesin and its 
phosphorylated version was also observed in fenestrae sieve plates of induced cells 
(Figure 5.4, E-H), suggesting that the protein is phosphorylated in that particular 
subcellular location.
According to the same hypothesis of phosphorylation -  dependent regulation, 
phosphorylated ERMs associate with the actin cytoskeleton and have been shown to 
resist extraction by the detergent Triton X-100. This seemed puzzling, considering 
that fenestrae appeared in the areas of actin disruption, so a differential extraction of 
untreated or induced bEND5 cells was performed, using varying amounts of Triton X- 
100. Equal amounts of detergent soluble and detergent insoluble fractions were 
separated by SDS-PAGE gel electrophoresis, and western blotting was performed
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Figure 5.4 Analysis of moesin phosphorylation in untreated and induced bEND5 cells. 
Untreated (A-D) and Latrunculin A-induced (E-H) bEND5 cells were triple labelled for 
moesin (A,E), phosphorylated moesin (B,F), and PECAM (C,G), with the overlay shown in 
(D,H). Confocal sections were obtained at the level of filopodia (arrowheads) (A-D) and 
fenestrae sieve plates (arrows) (E-F). Moesin appeared phosphorylated in both structures. 
(Bar = 20 pm) 1 5 4
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with antibodies against PV-1, moesin, phosphorylated moesin, and caveolin-1 (Figure
5.5). The diaphragm protein PV-1 appeared almost entirely detergent soluble, in
untreated or induced cells, with Triton X-100 concentrations as low as 0.1%. Using
the rabbit polyclonal anti-moesin antibody, which recognised both radixin and
moesin, the two ERM proteins were shown to be mainly soluble in Triton X-100
detergent. A small amount remained in the insoluble fractions, but the low signal-to-
noise ratio obtained with the antibody precluded the drawing of any meaningful
conclusions. Detergent solubility did not vary as a function of detergent concentration,
and in a similar fashion to PV-1, was independent of the induction state of the cell.
When the phosphorylated version of moesin was probed using the specific antibody
against it, again, the majority of the protein was present in the soluble fraction, an
amount that did not alter in relation to the detergent concentration. Interestingly, when
phosphorylated moesin was compared between untreated and induced cells, it was
immediately apparent that a higher proportion of the protein resisted detergent
solubilisation after induction. As a negative control, membranes were also probed for
caveolin-1, an integral membrane protein which typically resists Triton X-100
solubilisation. In these cells caveolin-1 appeared to partition mainly in the detergent
insoluble fractions, independently of the induction state of the cell, though some was
rendered soluble with concentrations as low as 0.1% Triton X-100.
To examine the subcellular localisation of the insoluble portion of moesin and its
phosphorylated counterpart, induced bEND5 cells were extracted with 0.1% Triton X-
100 prior to fixation, using the same buffers as above, and processed for
immunofluorescence. Cells extracted post-fixation were included for comparison.
Consistent with the biochemical results of the extraction studies, PV-1 was
completely extracted from the sieve plates where it resides in induced cells (Figure
5.6, A-B). Interestingly, the majority of moesin was extracted, but some insoluble
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Figure 5.5 Detergent extraction of untreated and induced cells. Untreated or 
Latrunculin A-induced bEND5 cells were extracted with various concentrations 
of Triton X-100 (0.1, 0.2, 0.5, and 1%). Insoluble material was resuspended in 
the same volume as the soluble fraction, and equal volumes were separated by 
SDS-PAGE electrophoresis. Western blotting, using antibodies against PV-1, 
caveolin-1 , moesin, and phosphorylated moesin, highlighted differences in the 
levels of insoluble phosphorylated moesin between induced and untreated cells.
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material was left behind (Figure 5.6, C-D). Such detergent-resistant regions 
culminated to one or more of the short F-actin filaments that remained after 
latrunculin treatment. The localisation of caveolin-1, in cells fixed prior to and post 
fixation, was used as a control for a protein that for the most part resisted Triton X- 
100 extraction (Figure 5.6, E-F).
Close observation of the phalloidin -  stained actin filaments in cells extracted post­
fixation revealed two separate types of structure: short actin filaments and bundles 
exhibiting bright fluorescence, and a weakly fluorescent structure coinciding with 
fenestrae sieve plates. Phalloidin staining within sieve plates was particularly 
apparent in the preparations counterstained for caveolin-1, an antigen excluded from 
that region (Figure 5.6, E), and in contrast to the bright actin filaments it seemed 
susceptible to extraction by Triton X-100 (Figure 5.6, F). Nonetheless, high- 
resolution confocal sections through an induced cell extracted with Triton X-100 prior 
to fixation, revealed a distorted network of weakly labeled filamentous actin at the 
most ventral region, which was thought to correspond to the plane of sieve plates 
(Figure 5.7, B). A similarly distorted pattern of moesin staining was observed in the 
same optical section (Figure 5.7, A), suggesting that both moesin and actin filaments 
share common solubility properties in the sieve plate vicinity (Figure 5.7, C). 
Colocalisation attempts were inconclusive, as a result of the particularly weak signal 
for the sieve-plate-associated actin, and the likely alteration of the original structure 
by the detergent.
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Figure 5.6 Epifluorescence microscopy on sieve plates after detergent 
extraction. Latrunculin A-induced bEND5 cells were detergent-extracted with 
0.1% Triton X-100, after (A,C,E) or before (B,D,F) paraformaldehyde fixation. 
Cells were labelled for PV-1 (A,B), moesin (C,D), and caveolin-1 (E,F), with 
Alexa 488-conjugated secondary antibodies. F-actin was stained with Alexa 
546-conjugated phalloidin (A-F). Short actin filaments resisting extraction are 
denoted by arrowheads. PV-1 along with moesin in sieve plates (asterisks) are 
extractable at this detergent concentration, while caveolin-1, in the cytoplasmic 
spacers between sieve plates, resists extraction. Light blue asterisks (E) mark 
sieve plates exhibiting weak phalloidin staining (Bar = 20 pm)
Figure 5.7 Confocal microscopy on detergent-extracted sieve plates. bEND5 cells, 
induced with Latrunculin A, were immunostained for moesin (A), using Alexa 546- 
conjugated phalloidin as a counterstain (B). Confocal sections obtained at the level of 
fenestrae sieve plates (asterisks) reveal the partial extraction of both moesin (A) and 
filamentous actin (B). Stress fibre remnants (arrowheads) were completelely resistant to 
detergent extraction, whereas the weakly fluorescent actin filaments within sieve plates 
were extracted in part, with their remnants (thin arrows) exhibiting a distorted filamentous 
pattern (B). A similar pattern was observed in the moesin remnants (thick arrows) (A), 
though colocalisation was difficult to ascertain with the given signal intensities (C).
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5.2,3 Investigation into the role of moesin in fenestrae sieve plates
5.23.1 Actin distribution revisited
The unexpected finding of filamentous actin within fenestrae sieve plates provoked an 
examination of the actin content of untreated and induced bEND5 cells, using a 
variety of probes for actin and different fixation methods (Figure 5.8). Untreated cells 
fixed with methanol or paraformaldehyde, and probed for filamentous actin with 
Alexa 488-conjugated phalloidin, showed a similar pattern of bright stress fiber and 
cortical actin staining, with slightly better structural preservation when 
paraformaldehyde was used (Figure 5.8, A and C). Induced cells stained with 
phalloidin appeared different depending on the fixation conditions: only short
microfilaments were apparent in the cytoplasm of cells fixed with methanol (Figure 
5.8, B), while in addition to such microfilament remnants, a less intense signal 
emanating from sieve plates was visible in the case of paraformaldehyde -  fixed cells 
(Figure 5.8, D). Moreover, the signal was specific for sieve plates, versus their 
cytoplasmic spacers, and for filopodia, and it was absent in induced cells that were 
fixed in methanol and probed with a monoclonal antibody that recognised all forms of 
actin (Figure 5.8, F). Furthermore, probing for globular actin, in paraformaldehyde 
fixed induced cells, using Alexa 488-conjugated Dnase I, confirmed that globular 
actin was absent from sieve plates, and was Instead concentrated in the cytoplasmic 
arms surrounding them (Figure 5.8, H).
Taken together, these results suggested that some form of filamentous, and not 
globular, actin resides within sieve plates. The extraction of these filaments entirely 
by methanol fixation, and partially by Triton X-100 treatment before 
paraformaldehyde fixation, highlighted their different nature compared to the 
insoluble stress fibers, cortical actin, or short filaments after latrunculin treatment.
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Figure 5.8 Visualisation of the actin cytoskeleton in untreated (A,C,E,G) and Latrunculin 
A-induced (B,D,F,H) bEND5 cells. Phalloidin stains filamentous actin in cells fixed with 
methanol (A,B) or paraformaldehyde (C,D), with more detail (arrows) revealed in the 
latter. Anti-actin AC 15 mAb recognizes both globular and filamentous actin in methanol 
fixed cells (E,F). Dnase I stains globular actin in paraformaldehyde-fixed cells (G,H). 
Epifluorescent images are shown. (Bar = 20 pm) , 7
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5.2.3.2 Moesin in a time-course of fenestrae induction
The identification of F-actin elements together with moesin in fenestrae sieve plates, 
along with their common solubility properties, suggested a functional interplay 
between them. The potential role of moesin in linking the F-actin elements with the 
plasma membrane of the sieve plates was assessed indirectly, in a time-course of 
fenestrae induction with latrunculin A. Cells were triply labeled for PV-1, moesin, 
and filamentous actin (Figure 5.9). Under steady state conditions, PV-1 was confined 
to regions associated with caveolae, moesin was distributed throughout the cell with a 
preference for cell edges, while the cytoplasm of cells was spanned by numerous 
stress fibers. No significant colocalisation was observed between PV-1 and moesin or 
moesin and stress fibers. Early in the time-course of induction, stress fibers were 
reduced in number and size. PV-1 moved out of caveolae and migrated to the centre 
and the periphery of the cell, while moesin didn’t appear to significantly alter in 
distribution. When stress fibers were reduced even further, and the cytoplasmic areas 
between them appeared devoid of actin, the first small fenestrae sieve plates began to 
appear, marked by the presence of both moesin and PV-1. The colocalisation became 
more obvious as fenestrae patches became larger and better defined, whilst at the 
same time the presence of a discrete network of actin filaments was apparent in the 
patches. Moesin and F-actin were also colocalised in filopodia emanating from the 
edges of the cell. When the induction stimulus was washed out after a three-hour 
induction, and the cells were re-incubated in normal culture medium for another 
fifteen minutes, a striking pattern was evident: PV-1 moved away from the cell 
periphery, and back towards the centre of the cell; moesin and actin formed a ring at 
the cell cortex, essentially surrounding the PV-1-positive area. When the re­
incubation time following stimulus removal was extended to thirty minutes, the
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Figure 5.10 Time-course of induction by Light Microscopy II. bEND5 cells were induced 
with Latrunculin A for 3 hours, after which the stimulus was removed for 1 hour. Cells 
were fixed at various time-points and immunostained for moesin, PV-1, and caveolin-1, 
with secondary antibodies conjugated to Alexa 488, Alexa 633, and Alexa 546 
respectively. Representative confocal sections are shown for 0, 20, 40, and 120 minutes 
of induction, along with 15 minutes of washing out the stimulus post-induction (180wl5).
Figure 5.9 (previous page) Time-course of induction by Light Microscopy I. bEND5 
cells were induced with Latrunculin A for 3 hours, after which the stimulus was removed 
for 1 hour. Cells were fixed at various time-points, immunostained for PV-1, and moesin, 
with secondary antibodies conjugated to Alexa 488 and Alexa 633, respectively, and 
counterstained with Alexa 546-conjugated phalloidin . Representative confocal sections 
are shown for 0, 20, 40, and 180 minutes of induction, along with 15 and 30 minutes of 
washing out the stimulus after 180 minutes of induction (180wl 5 and 180w30).
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distribution of all three markers resembled steady state conditions. PV-1 became 
concentrated in caveolae, moesin was distributed throughout the cell, and a network 
of stress fibers was beginning to assemble.
In a parallel time-course, cells were triply labeled for moesin, PV-1, and caveolin-1 
(Figure 5.10). In this case, at the steady state, PV-1 was found colocalised with 
caveolin-1 in caveolae, with moesin in the region immediately adjacent to them. 
When induction was initiated, the characteristic pattern of caveolae at the thick edges 
of cells disappeared, and instead PV-1 and caveolin-1 moved towards the centre of 
the cell. PV-1 was also targeted to the periphery of the cell, exhibiting the first signs 
of segregation from caveolin-1. The first patches of fenestrae that appeared in the cell 
periphery saw moesin and PV-1 colocalizing, and caveolin-1 excluded, while mature 
patches were surrounded by caveolin-1 in the cytoplasmic arms that lay between sieve 
plates. Interestingly, within fifteen minutes of washing out the stimulus, PV-1 had 
segregated from moesin, to coincide again with caveolin-1.
5.2.3.3 Immunoprecipitation studies
In view of the intimate spatial and temporal correlation between the presence of 
moesin and PV-1 in sieve plates, a physical association between the two was 
examined through immunoprecipitation experiments. Immunoprecipitations were 
carried out in lysates from untreated and induced bEND5 cells in an attempt to 
highlight differences between a state of potential interaction (fenestrae) and a state of 
definite non-association (caveolae). In addition, immunoprecipitation reactions were 
performed in lysates prepared in a variety of buffers (see Chapter 2), which had been 
previously used successfully in the isolation of ERM complexes [322-324] or were 
effective in solubilizing PV-1 and the majority of the moesin content of sieve plates in
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the detergent extraction studies described earlier. Using the monoclonal anti-MECA- 
32 antibody, PV-1 was immunoprecipitated in untreated and induced conditions, in all 
buffers tested (Figure 5.11). Moesin, however, was not present in the 
immunoprecipitated complex in neither untreated nor induced conditions.
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Figure 5.11 Immunoprecipitation of PV-1 from bEND5 cell lysates. Untreated or 
Latrunculin A-induced bEND5 cells were extracted with 0.1% Triton X-100 or 
RIPA buffer. Extracts were subjected to immunoprecipitation for PV-1 using anti- 
MECA-32 or an irrelevant antibody, anti-VE-PTP (VP). Immunoprecipitates were 
separated by SDS-PAGE electrophoresis, next to equal volumes of insoluble and 
soluble material generated after extraction with the specific buffer. Western blotting 
for PV-1 showed an enrichment of PV-1 in the immunoprecipitate, while no 
enrichment was observed for moesin after stripping and reprobing the same 
membrane. No difference was observed between untreated and induced cells.
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5.3 Discussion
5.3.1 Moesin as a constituent of fenestrae sieve plates
Fenestrae sieve plates are specialised membrane structures, whose molecular 
composition has attracted considerable interest, but in the absence of appropriate 
study tools remained elusive. Following a subcellular proteomic analysis that 
culminated in the recognition of the ERM proteins moesin and radixin as sieve plate 
components, this chapter focused on characterising the specific association between 
moesin and fenestrae.
The distribution of ERM family members in the bEND5 cell line was assessed using 
combinations of antibodies to detect each ERM protein, in an effort to minimise 
ambiguities arising from antibody cross-reactivity. Despite the presence of all ERM 
family members plus merlin in bEND5 cells, and their reported functional 
complementation in vitro [291, 325], only moesin and radixin localised to sieve 
plates, while ezrin and merlin appeared confined to the cytoplasmic areas surrounding 
them. The differential distribution of ezrin and moesin in bEND5 cells came as a 
surprise, as studies in a variety of fibroblast or epithelial cells had shown that ERM 
proteins are co-expressed and co-exist in cell surface structures, with the exception of 
radixin which is a unique component of adherens junctions and focal contacts [282, 
284, 298, 325]. The cell surface structures where ERMs have been previously 
localised include microvilli, filopodia, uropods, ruffling membranes, retraction fibers 
[282, 298, 325, 326], all of which, like fenestrae, are membrane specialisations arising 
from cytoskeletal remodeling. Interestingly, moesin in bEND5 cells appeared 
specifically enriched in fenestrae and not in the related structure of caveolae, 
consistent with the absence of such an association in previous ERM localisation
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studies [327]. The subcellular distribution of ERM family members in Py4.1 cells 
was somewhat puzzling, as although moesin was present in the fenestrae sieve plates, 
it was not restricted to that area, also residing in the cytoplasmic arms between sieve 
plates (data not shown). Differences in the endogenous complement of ERM proteins 
could account for this discrepancy, with moesin compensating for some other ERM 
function associated with the area between the patches. As the sieve plate definition 
using immunocytochemistry was not as clear in the Py4.1 cells compared to the 
bEND5 cells, investigations on this cell line at the light microscopy level were not 
pursued further.
The differential specificity of family members for fenestrae in bEND5 cells is 
suggestive of distinct functions, and is likely to be physiologically relevant. In 
sections of mouse eyes, moesin was co-expressed with PV-1 in the fenestrated 
choriocapillaris, whereas ezrin expression was limited to the retinal pigment 
epithelium [320, 321]. Previous analyses on the tissue distribution of ERM proteins 
showed that all family members had a wide pattern of expression, but ezrin and 
radixin displayed a preference for epithelium, while moesin was predominantly found 
in endothelium [294, 295]. Within the endothelium, moesin had been shown to be 
expressed in both small and large vessels, radixin had been described as being only 
weakly expressed in vessels, and ezrin as being absent from the endothelium of 
arterioles, venules, or capillaries [295]. Moreover, the case for moesin was 
strengthened as its expression had been documented in tissues where fenestrated 
capillary beds are known to exist, such as liver, pancreatic, intestinal, and kidney 
endothelia [294, 328]. All of these tissues excluded ezrin, which reportedly is 
confined to tissues immediately adjacent to moesin-positive fenestrated endothelia: 
the retinal pigment epithelium [320, 321] adjacent to the choriocapillaris, and the
glomerular podocytes [329-331] adjacent to the glomerular endothelial cells [332].
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Findings in the in vitro induction system, combined with previously published data, 
indicate that moesin and ezrin are expressed in morphologically similar, yet distinct 
structures. Integrated within the same organ, such structures may act in a co-operative 
and complementary fashion to promote physiological functions.
5.3.2 Moesin modification and interactions
In light of the well-recognised role of ERM proteins as adaptors between the plasma 
membrane and the cytoskeleton in cell-surface structures [282, 333], it was plausible 
to consider a similar role for moesin within the context of fenestrae. Consistent with 
such a role, moesin in sieve plates is part of a specialised structure of the plasma 
membrane. On the other hand, this structure was thought to lack any underlying 
cytoskeleton as its formation has been intimately linked to microfilament disassembly. 
The recent observation of weak phalloidin reactivity for fenestrae sieve plates, 
however, not only highlighted an unexpected structure and localisation for F-actin, but 
also reconciled the paradox of moesin localisation in a cytoskeleton deficient region. 
Moreover, phosphorylated moesin is reportedly found predominantly in cell-surface 
structures [312, 334], and investigations into the phosphorylation state of moesin by 
immunocytochemistry suggest that the protein is phosphorylated within the context of 
fenestrae. According to the conformational regulation hypothesis an intramolecular 
association maintains ERM proteins in a ‘closed’ and inactive state [335, 336], and 
phosphorylation at a conserved threonine residue is required to relieve this inhibition 
[308, 309]. Phosphorylated moesin is therefore expected to be in an ‘open’ state, and 
interacting with both the membrane and the cytoskeleton of fenestrae sieve plates. 
Further evidence for increased moesin phosphorylation in the membrane and 
cytoskeleton subcellular fractions, upon fenestrae formation, came from 2D-gel
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electrophoresis (see Chapter 4) and detergent extraction studies, respectively. In 
agreement with the biochemical data, immunofluorescence on detergent extracted 
cells revealed a partially resistant loose network of actin filaments and a similar 
network of moesin, in areas expected to accommodate sieve plates. However, Co­
localisation was difficult to ascertain, given the distortion of the structures by the 
extraction, and their partial susceptibility to detergent solubilisation. Collectively, 
these data point towards an active involvement of moesin in fenestrae microdomains, 
rather than a random distribution of dormant, ‘closed’, moesin in a cell area that acts 
as a sink for proteins with aberrant distribution under the conditions created by 
Latrunculin induction.
The N-terminal FERM domain of ERM proteins has been recognised as responsible 
for membrane binding through direct or indirect interactions with membrane 
components. A direct association has been observed between ERM proteins and 
integral membrane proteins such as CD44 [323, 337], the ICAM family of adhesion 
molecules [326, 338, 339], the sodium-hydrogen exchanger isoform 1 [340], the T- 
cell mucin CD43[341], the podocyte sialomucin podocalyxin [330, 342], and others 
[258], through interactions with their cytoplasmic domains [339]. Indirect 
associations with membrane proteins are mediated by cytoplasmic scaffolding 
proteins consisting of multiple substrate-interaction domains, such as the ERM- 
binding phosphoprotein 50/regulatory co-factor of the sodium-hydrogen exchanger 
isoform 3 [343] and others [258]. The obvious candidate for moesin’s binding 
partner on the membrane was the only published component of diaphragmed fenestrae 
to date, the protein PV-1. Immunoprecipitation studies were carried out using a panel 
of buffers that had been shown to successfully preserve the interaction between ERM 
proteins and CD43 [322], CD44 [323], Dbl [324], or were effective in solubilizing 
PV-1, entirely, and moesin, partially, from the fenestrae sieve plates. Moesin was
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absent from PV-1 immunoprecipitates, in all conditions tested, suggesting either the 
failure to preserve the interaction with the detergents in question or the absence of 
such an interaction altogether. A recent attempt to cross-link PV-1 with other proteins 
in situ, similarly failed to identify any protein that could associate with PV-1 [71]. It 
is of interest to note that the presence of moesin has been documented in non- 
diaphragmed fenestrated capillary beds such as the glomerular endothelium [295], 
where it would be expected to exist independently of PV-1. Whether PV-1 is 
necessary only for the targeting of moesin to fenestrae sieve plates, in agreement with 
a speculative role for the diaphragm in the development of glomerular endothelial 
fenestrae, or whether PV-1 and moesin merely coincide in the same structure with no 
physical interaction are open questions. Moreover, given the differential specificity of 
moesin for fenestrae and not caveolae, if  a physical association indeed exists, it is 
expected to be dependent on phosphorylation or other post-translational 
modifications, which could favour or inhibit particular conformations and molecular 
interactions.
Finally, ERM proteins bind membrane lipids, and specifically PIP2 [344], an 
association deemed essential for membrane localisation of ERMs [345] as well as for 
their conformational activation [310, 346, 347]. PIP2 would be a valid candidate for 
attracting moesin to the membrane of fenestrae sieve plates, alone, or in co-operation 
with a yet unidentified protein.
5.3.3 Actin filaments within fenestrae patches
The observation of filamentous actin in fenestrae sieve plates was validated in a study 
using different actin probes and fixation methods. Actin was confirmed to be in a 
polymerised state, through its interaction with the F-actin binding protein phalloidin
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but not the G-actin binding protein Dnase I. Methanol fixation or 0.1% Triton X-100 
detergent extraction prior to paraformaldehyde fixation, however, solubilised or 
distorted the filamentous actin in sieve plates, suggesting a different nature to that of 
short stress fiber remnants, which remained intact.
The precise structural arrangement of the filamentous actin component in fenestrae 
sieve plates remains a mystery. Based on the reported sieve plate dimensions in vivo, 
quoting a cytoplasm thickness of 40 nm and a distance between individual fenestrae 
of 60 nm [59], only some actin filament networks or intermediate filaments, among 
cytoskeletal polymers, could be accommodated. Within the family of actin filament 
networks, actin filaments can be found in long, unbranched parallel bundles, as occur 
in filopodia, or in branched structures typical of lamellipodia [348]. The two 
possibilities could be distinguished by ultrastructural methods, or by probing for actin 
binding proteins that would be specific for each structure, such as a-actinin or filamin 
[348].
Initially this filamentous actin structure and localisation was surprising, considering 
the prerequisite of cytoskeletal disruption for fenestrae formation in our system. 
Moreover, the continual presence of Latrunculin is expected to inhibit actin 
polymerisation by sequestering actin monomers [185, 186]. Nonetheless, as this 
assay does not provide information on the developmental stages a fenestrae patch 
goes through before it reaches maturity, one cannot unambiguously determine the 
timing of actin’s appearance within sieve plates. ERM proteins have been implicated 
in actin polymerisation [315, 349] and recently also in de novo actin assembly on the 
surface of isolated phagosomes [350]. One explanation could therefore involve 
moesin in promoting actin nucleation on the cytoplasmic surface of the membranes in 
fenestrae sieve plates. The effect of moesin could perhaps override the function of 
latrunculin, resulting in the polymerisation of actin both within fenestrae patches and
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cell-surface filopodia. On the other hand, in view of the actin-binding properties of 
ERM proteins, the reverse could be true, and this type of actin filaments could act to 
recruit moesin.
Finally, whether filamentous actin plays a role in propelling membrane fusion during 
fenestrae formation, as reported for the terminal phases of exocytosis and some 
intracellular fusion events [103, 193, 197, 198], or merely provides accessory 
structural support is an open question. Irrespective of whether it plays a structural or 
a functional role, the physiological relevance of filamentous actin within fenestrae 
sieve plates awaits validation. Cytoskeleton rings, composed of actin and myosin 
[98], and maintained after cytochalasin B or latrunculin A treatement [95], have been 
documented to surround fenestrae in sieve plates of liver endothelial cells ex vivo, but 
remain poorly defined. No report has addressed the cytoskeletal content of fenestrae 
capillary beds in vivo to date.
5.3.4 Moesin’s putative role in fenestrae biogenesis
The triple stainings for PV-l/moesin/actin and moesin/PV-1/caveolin-1 in a time- 
course of induction were useful in drawing correlative relationships between putative 
partners in fenestrae formation. With the onset of actin remodeling, a spatial and 
temporal correlation between PV-1 and moesin was observed along the periphery of 
the cell, which culminated in their complete coincidence upon formation of well- 
defined fenestrae patches. In the same time-frame, PV-1 was seen to gradually 
segregate from the caveolar protein caveolin-1, until they became completely 
separate, in fenestrae patches and cytoplasmic arms between sieve plates, 
respectively. The situation was rapidly reversed following the removal of the 
stimulus: within the first fifteen minutes, PV-1 had segregated from moesin, and
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colocalised again with caveolin-1. At this stage, moesin appeared as a ring at the cell 
cortex, surrounding a thick filamentous actin structure. Consistent with its 
aformementioned role in actin nucleation [315, 350], it could promote the 
development of stress fibers, that were observed in abundance during the next stage, 
thirty minutes after stimulus removal. The characteristic pattern of sieve plates was 
sometimes associated with immunoreactivity for either PV-1 or moesin. This 
observation, together with the strict colocalisation of moesin and PV-1 in fenestrae, 
and not caveolae or any other undefined intermediate, rules out a tentative role for 
moesin as the carrier of PV-1 from one cell structure to the other. On the other hand, 
at time-points preceding clear fenestrae assembly or disassembly, caveolin-1 and PV- 
1 do appear to colocalise at the centre of the cell, in a different structure than that of 
characteristic pattern of caveolae at the edges of cells. These could represent cell- 
surface peri-nuclear caveolae, or alternatively an intermediate structure between the 
two extremes of fenestrae and caveolae, occuring at the cell-surface or internally. 
Caveolae are known to move towards the centrosomal region of the cell upon 
Latrunculin A treatment [254], and once internalised they could join the endocytic 
pathway, whereupon segregation of PV-1 from caveolin-1 would be achieved. As to 
the path of moesin towards and away from fenestrae, perhaps more insight could be 
gained through following its activation state by probing for its phosphorylation or its 
localisation relative to PIP2 .
Ultimately, to draw causative relationships between moesin and fenestrae,
perturbation of its function is required. To overcome the functional redundancy
stemming from the presence of all ERM members in mammalian cells, a number of
studies have made use of constitutively active or dominant negative ERM constructs.
Site-directed mutagenesis at a conserved threonine residue, in both ezrin and moesin,
have produced pseudophosphorylated variants of the proteins that lead to the
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formation of lamellipodia, membrane ruffles, and microvilli-like structures in 
epithelial or COS7 cells [299-301]. Alternatively, the expression of the N-terminal 
FERM domain of either ezrin or moesin alone, lead to the mislocalisation of all 
endogenous ERM proteins and to altered responses upon growth factor stimulation in 
epithelial cells [302-304]. Efforts to use such constructs to promote or inhibit 
fenestrae formation in our in vitro model have been hampered by technical difficulties 
at the level of DNA introduction into cells: cells transfected with any plasmid, are 
altered in shape, and preclude fenestrae formation. Alternative approaches for the 
expression of proteins that perturb ERM function in bEND5 cells should help clarify 
whether moesin plays a role in fenestrae biogenesis.
At present, speculations on moesin’s role can be made from looking at the reported 
functions of ERM proteins in model organisms. Due to functional redundancies 
among family members, specific roles have been assigned in the cases o f organisms 
containing only one ortholog of the ERM family or tissues exhibiting specific 
expression of only one ERM protein. An in vivo role as modulators of signaling 
pathways has been suggested from studies of the drosophila ERM ortholog Dmoesin 
[317], but the majority of observations point towards structural roles in tissue integrity 
and polarity [297, 351-353]. Mouse ezrin and the c.elegans ERM ortholog erm-1 
have been deemed essential for epithelial tubulogenesis through their actions as 
scaffolds with static and/or dynamic effects on the apical membranes that are facing 
lumina [352, 353]. Radixin has been deemed essential for the maintenance of cochlear 
sterocilia in mice [297], and Dmoesin as essential for the assembly of the 
photoreceptor rhabdomere in drosophila [351].
Considering its dual binding properties, moesin could act as a coordinator within
fenestrae biogenesis, translating the modulation of the cytoskeleton to a remodeling of
the plasma membrane. Alternatively, an architectural contribution of moesin in
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fenestrae sieve plates could involve a role in restricting particular proteins to 
specialised membrane microdomains, as occurs in the T cell synapse [322] and the 
podocyte foot processes [330]. Finally, moesin could play a scaffolding role in 
providing the cytoskeletal support of the fenestrated area, or in maintaining the close 
apposition between the apical and basal plasma membranes through its 
oligomerisation properties. Interestingly, the overwhelming majority of specialised 
cell-surface structures that are associated with ERM proteins share the common 
property of negative membrane curvature. Intestinal microvilli, stereocilia, podocyte 
foot processes, and the membrane lining fenestrae, all bear a sharp negative curvature. 
In contrast, caveolae or clathrin-coated pits, specialised membrane domains with 
positive curvature, have never been found associated with ERM proteins, despite their 
connection with cytoskeletal elements. Furthering our knowledge into the 
relationship between such curvature and ERM function could potentially highlight yet 
unappreciated roles for moesin in the context of fenestrae.
Lastly, if moesin is indeed found to play a role in fenestrae biogenesis, determining 
whether such a role is indispensable will be important. Clues from a moesin knockout 
mouse suggest that loss of moesin does not result in any abnormality, without the 
compensatory up-regulation of ezrin or radixin [296]. Nonetheless, precise 
phenotypic analysis is required before reaching definitive conclusions, as evidenced 
by a recent study on the radixin deficient mouse showing that radixin was only 
essential in the maintenance of stereocilia, whose development could be rescued by 
the compensatory up-regulation of ezrin [297].
In the first cell biological approach to understanding fenestrae, a novel component of
fenestrae sieve plates has been characterised. The connection between the membrane-
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cytoskeleton adaptor moesin and fenestrae establishes a conceptual framework that 
unifies actin filaments, actin binding proteins, and membrane proteins of the sieve 
plate, within the context of a highly specialised feature of endothelial cells. This bears 
significant functional implications, and opens new avenues in the study of this 
organelle’s biogenesis. A number of questions that require ultrastructural or 
functional approaches to be definitively addressed remain open, however an important 
step towards the visualisation of fenestrae by light microscopy has been 
accomplished: The classification of fenestrae on the basis of immunoreactivity for 
PV-1, a marker with dual specificity for caveolae and fenestrae, can be made less 
ambiguous in combination with anti-moesin labelling, which is specific for the latter. 
Moreover, moesin immunoreactivity could be useful in probing for non-diaphragmed 
capillary beds, which as suggested in the literature, lack PV-1, but contain moesin.
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6.1 Background
Vascular permeability, similar to blood vessel growth, is thought to be governed by 
the co-ordinated and competing actions of Receptor Tyrosine Kinases (RTKs) and 
Receptor Protein Tyrosine Phosphatases (RPTPs) [28, 354, 355]. Extensive 
experimental evidence has implicated the VEGF-A and Angiopoietin (Ang) signaling 
cascades in the regulation of permeability, through the activation of the endothelial 
cell-specific RTKs, VEGFR-2 and Tie-2 respectively [28].
Among the tyrosine phosphatases present in endothelial cells [28], the recently 
characterised Vascular Endothelial Protein Tyrosine Phosphatase (VE-PTP) is 
specifically expressed in this tissue [159]. VE-PTP has been detected in the 
vasculature of embryos, as early as embryonic day E9.5. In situ hybridisation analysis 
revealed restricted expression of VE-PTP to endothelial cells lining larger, smooth 
muscle cell invested vessels [159]. In the adult, strong expression for VE-PTP has 
been reported in the brain, lung, and kidney, by Northern blotting [159].
A role for VE-PTP in the control of paracellular permeability has been supported by 
evidence of an interaction with the junctional protein VE-Cadherin [161]. VEGF- 
driven tyrosine phosphorylation of the adherens junction components is known to 
destabilise the integrity of endothelial cell contacts, leading to an increase in 
paracellular permeability [114, 158]. VE-PTP has been shown to reverse VEGFR-2- 
mediated tyrosine phosphorylation of VE-cadherin, and to increase the integrity of the 
endothelial monolayer in a cell-based assay [161].
An association between VE-PTP and the seemingly opposing Tie-2 pathway of 
endothelial barrier regulation has also been suggested. Although its mechanism of 
action remains poorly defined, the angiopoietin/Tie-2 signalling cascade has been 
implicated in the regulation of vascular integrity, and in blocking the vascular
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permeability induced by VEGF [28, 356, 357]. Modulation of Tie-2 by VE-PTP was 
suggested from co-precipitation experiments, however, no functional effect stemming 
from the interaction has been shown [159].
Early embryonic lethality in mice with targeted disruption of many components in 
VEGF and Ang signaling cascades [112, 358-362] has hampered the analysis of the 
precise physiological function of these pathways during later stages of vascular 
development and adulthood. To circumvent these problems I opted for a conditional 
overexpression system to perturb the function of VE-PTP in a tightly controlled 
spatial and temporal manner. Such qualities are fulfilled by the tetracycline- 
responsive binary expression system, which is based on the E.coli tetracycline 
resistance operon (Figure 6.1) [176, 363-365]. The system relies on two parts; a 
driver transgene harbouring a recombinant tetracycline transactivator (tTA), and a 
responder transgene harbouring the gene of interest under the control of the 
tetracycline operon (tetO). When a driver line of mice is crossed to a responder line 
of mice, induction of expression of the gene of interest is achieved as a result of the 
high affinity of the tTA transcription factor for the tetO response element. Spatial 
control of gene expression is ensured by placing the tTA gene cassette downstream of 
tissue-specific promoters [366-371]. Temporal control of gene expression is achieved 
through the use of the antibiotic doxycycline, which can reversibly suppress the 
binding of tTA to the tetO element, thereby preventing induction of the gene of 
interest [176, 364, 365].
In an attempt to analyse the role of VE-PTP in regulating paracellular permeability in 
vivo, I sought to create responder mouse lines that would be crossed to an existing 
endothelial-specific driver line. This chapter describes the generation and 
characterisation of TetO-VE-PTP responder lines, using transgenes that are likely to 
promote gain or loss of VE-PTP function. A number of responder founder lines were
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Figure 6.1 The tetracycline-responsive regulatory system for transcriptional 
transactivation. (A) The tetracycline transactivator of transcription (tTA) is encoded 
by a chimeric construct of the E.coli TnlOtetR gene (purple) and the VP16 
transactivation domain (orange). In the absence of Doxycycline (Dox), tTA dimers 
bind to the tetracycline operon, consisting of seven tandemly repeated 19-bp tetO 
sequences (tet07), and activate transcription of the gene of interest (target ORF) from a 
minimal promoter (TATA). When bound to Dox, tTA undergoes a conformational 
change that prevents it from binding tet07. (B) In the reverse tTA (rtTA) system, the 
tetR gene has been mutated so that tTA binds to tet07 only in the presence of Dox. 
Only upon binding of Dox, does tTA undergo the necessary conformational change 
that allows it to bind to tet07 to activate transcription. (ORF, open reading frame; pA, 
polyadenylation site; TSP, tissue specific promoter). (Reproduced from Ref. 377)
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screened by means of an approach centred on measuring RNA transcript levels for the 
TetO-VE-PTP transgene. Two founder lines were identified as potential models to 
further explore the effects of modulating VE-PTP function
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6.2 Results
6.2.1 Subcloning of TetO-VE-PTP transgenic constructs
Responder line constructs were designed to produce wildtype or dominant negative 
versions of the VE-PTP protein. Three separate versions of the VE-PTP cDNA were 
used: 1) wildtype, full-length cDNA, 2) VE-PTP extracellular (EC) domain mutant, 
and 3) VE-PTP catalytic domain trapping mutant (R/A).
Overexpression of the full-length VE-PTP transgene is expected to increase the levels 
of VE-PTP protein in endothelial cells, and as shown for other phosphatases, amplify 
an already existing phenotype [372, 373]. Given that VE-PTP and VE-Cadherin 
interact via the 17th membrane proximal FNIII domain and the 5th membrane proximal 
cadherin domain respectively [161], the VE-PTP EC mutant is expected to interfere 
with the extracellular domain interactions of VE-PTP and possibly obstruct binding of 
the wildtype phosphatase to VE-cadherin [374]. The R/A trapping mutant can bind to 
the substrate and, whilst unable to perform catalysis, does not release it, potentially 
preventing the recruitment of the wildtype phosphatase or other signaling molecules 
downstream [159]. cDNAs for full-length or mutant VE-PTP were subcloned 
downstream of a tetracycline response element linked to a cytomegalovirus (CMV) 
minimal promoter [176]. An artificial intron and a polyadenylation signal were added 
to the 3’ end of the cDNA for optimal expression (Figure 6.2, A).
Before injecting the constructs into fertilised oocytes it was critical to ensure that VE- 
PTP protein could be expressed. To determine protein expression, a commercially 
available MEF 3T3 Tet-Off cell line, expressing the tTA, was transfected with the 
constructs for VE-PTP full-length, and VE-PTP R/A, and expression of the protein 
was assessed by immunofluorescence using a rabbit anti-serum (Figure 6.3). A
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Figure 6.2 Generation and genotyping of TetO-VE-PTP responder mice (A) Schematic 
of driver and responder transgenes. Grey and orange regions in the driver transgene 
denote the Tie2 first intron and an enhancer element, respectively. Responder 
transgenes for VE-PTP full-length (FL), extracellular domain only (EC), and trapping 
mutant (R/A) are depicted. The black region in responder transgenes represents a 
chimaeric intron. Arrows denote PCR primers used to genotype transgenic animals. (B) 
Genotyping results for a wildtype (a) and a responder transgenic (b) mouse, using a dual 
PCR to amplify the transgene (340bp), and the endogenous (200bp) copies of VE-PTP. 
The two amplifications share the same reverse primer, but differ in their forward 
primers. The transgene-specific primer is shown in (A), while the endogenous-specific 
primer anneals in a 5’untranslated region present only in the endogenous copy.
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Figure 6.3 VE-PTP induction in vitro. MEF 3T3 cells expressing the tTA 
transactivator were transfected with plasmids containing CMV-VE-PTP (A) TetO- 
VE-PTP (B,D), and TetO-VE-PTP R/A (C). Doxycycline (2 pg/ml) was included in 
the culture medium in (D) to suppress the tTA-driven transcription. Immunolabeling 
for VE-PTP (green), and the golgi marker GM130 (red) showed that VE-PTP is 
constitutively expressed in (A), induced in (B) and (C), and repressed in (D). Confocal 
sections were obtained at the level of the golgi. (Bar = 20 pm)
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plasmid harbouring CMV-driven full-length VE-PTP was used as a positive control 
for VE-PTP expression, and the antibiotic doxycycline was omitted or included in the 
culture medium to allow or suppress, respectively, the tTA-driven induction of VE- 
PTP. The VE-PTP EC construct was not included in the experiment as its 
presumptive nature of a soluble protein, secreted into the medium, would be expected 
to preclude detection by immunofluorescence. The expression of both VE-PTP full- 
length and VE-PTP R/A was induced in the absence of doxycycline (Figure 6.3, B-C). 
Moreover, expression was suppressed when doxycycline was included in the culture 
medium (Figure 6.3, D and data not shown). Considerable cell death was observed 
among the population of MEF 3T3 transfected cells, consistent with previous 
observations during full-length VE-PTP overexpression in CHO or COS cells. The 
surviving transfected cells expressed VE-PTP on their plasma membrane, but had 
altered morphology and sometimes appeared retracted from the substratum.
6.2.2 Generation of TetO-VE-PTP responder mice
Following confirmation of transgene expression, the three TetO-VE-PTP transgenic 
cassettes were excised from their respective cloning vectors and injected into 
pronuclei of mice from two different backgrounds, namely C57BL6/J and B6CBAF1 
x FI hybrid. ‘Responder’ founders were obtained for all transgenes, as assessed by 
PCR (Figure 6.2, B), and all but one of the identified founder animals transmitted the 
transgene to their progeny. The total of 16 founder animals that were capable of 
transmitting the transgene, once bred to C57BL6/J or B6CBAF1 x FI hybrid mice, 
produced normal litter sizes of about 8 pups, with the exception of founder line 
3650B2. This line was very difficult to breed, and its litters consisted of 3-5 animals 
on average. Overall, the presence of the responder transgene alone did not appear to
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have a negative impact on mouse development. The problems encountered within 
founder line 3650B2 could be due to a disruption of a normal cellular function caused 
by transgene insertion or to uncontrolled expression of the transgene itself, but were 
not investigated further.
6.2.3 Screening responder founder lines for VE-PTP expression
6.2.3.1 Screening for inducibility ex vivo
The first attempt to screen between the different founder lines was based on selecting 
for VE-PTP inducibility without breeding to the driver lines. This entailed isolating 
mouse embryonic fibroblasts (MEFs) from E l4.5 mice and transfecting them with an 
rtTA expressing construct (pTetOn). rtTA, the reverse tetracycline transactivator, 
differs from tTA by only four amino acids, and in contrast to the latter, drives 
expression of the target gene upon addition of doxycycline to the medium (Figure 6.1) 
[364]. As a positive control, MEFs were co-transfected with the plasmid containing 
the TetO-VE-PTP transgene in addition to the rtTA plasmid. Immunofluorescence 
analysis using rabbit anti-VE-PTP antiserum revealed that stably integrated transgenes 
could be induced to express VE-PTP ex vivo in the presence of an exogenous 
transactivator element (Figure 6.4, B). Moreover, this expression was contingent 
upon the presence of doxycycline (Figure 6.4, B), as no expression was observed in 
the absence of the antibiotic (Figure 6.4,A). As expected, co-transfected cells 
exhibited higher levels of protein expression due to the presence of multiple copies of 
the transgene following transient transfection, compared to stable integration in the 
genome as occurs in the transgenic MEFs (Figure 6.4, C-D).
A number of responder lines were found to sustain the induction of VE-PTP ex vivo.
Nevertheless, given that considerable cell death was observed, induction was weak in
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Figure 6.4 VE-PTP induction cx vivo. Mouse embryonic fibroblasts (MEFs) isolated 
from responder TetO-VE-PTP founder lines were transfected with a plasmid expressing 
the reverse tetracycline transactivator (rtTA) (A,B), and cultured in the absence (A) or in 
the presence (B) of doxycycline (2 pg/ml). Immunolabelling for VE-PTP (red channel) 
and GM130 (green channel) demonstrated that VE-PTP is expressed only when 
doxycycline is included in the medium (A,B). MEFs co-transfected with the rtTA plasmid 
plus the plasmid used in the generation of the TetO-VE-PTP lines, and cultured with 
doxycycline, were used as a positive control (C,D). Confocal sections were captured at 
the level of the golgi (A-C), or the plasma membrane (D). VE-PTP labeling throughout 
the plasma membrane is observed, with an enrichment in peripheral areas.
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surviving cells, and the response was often inconsistent even within the same founder 
line, the strategy was abandoned in favour of in vivo screening for induction.
6.2.3.2 Screening for induction in double transgenic embryos
Screening for induction in vivo was deemed to be the ultimate selection method as it 
assesses the capability of transgene induction from a given integration site, within the 
context of relevant levels of the tTA driver in the organism. The screening rationale 
was aimed at identifying responder lines capable of (a) high transgene expression, and 
(b) regulated transgene expression by the tTA.
Unsuccessful attempts to detect the endogenous VE-PTP protein in tissues, using the 
available antibody tools, precluded a screening approach based on assessing protein 
levels. An RNA-based screening method was deemed preferable as it conferred the 
additional advantage of monitoring the induction of all three transgenes: full-length, 
VE-PTP EC, and VE-PTP R/A transcript levels in the cell could all be measured, 
avoiding complications associated with the detection of secreted VE-PTP EC by an 
antibody. Moreover, unique elements in the untranslated regions of the endogenous 
and transgenic VE-PTP transcripts provided a means of differentiating between the 
two versions.
A Tie2-tTa driver line of mice (provided by Dr. Urban Deutsch, Theodor Kocher 
Institute, Bern, Switzerland), capable of driving uniform vascular endothelial-specific 
tTA expression in embryos [375], was crossed to each of the responder founder lines, 
and embryos were harvested at El 1.5. At this embryonic stage the Tie2 promoter is 
highly active [375, 376], and Lac Z staining of El 1.5 embryos which were double 
transgenic for the Tie2-tTA transgene and a TetO-Lac Z responder transgene 
exhibited strong Lac Z expression throughout the vasculature (Figure 6.5, A).
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Figure 6.5 Strategy for VE-PTP transcript analysis in vivo. Tie2-tTA drivers are 
confirmed as capable of driving transcription of a LacZ reporter gene in the 
endothelium at El 1.5 (A). Schematic of Real-time PCR primer and probe set positions 
(B). Primers are denoted by black or red arrows, and probes by grey lines. Probes and 
reverse primers are common for endogenous and transgene VE-PTP transcripts, but 
forward primers (red arrows) are unique to each construct. RT-PCR primers for 
transgene VE-PTP were designed in the same region as for Real-time PCR. For 
simplicity, only one version of the three transgene constructs is shown, and introns are 
omitted from the endogenous copy.
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Double transgenic embryos from crosses between the Tie2-tTA driver line and each 
TetO-VE-PTP responder line were assessed for the levels of TetO-VE-PTP transcript 
by RT-PCR. By comparing TetO-VE-PTP transcript levels of double transgenic 
embryos to those of littermates carrying only the responder transgene, the regulation 
of transcription by tTA was also assessed. In order to distinguish the transgene 
version of VE-PTP transcript from the endogenous version, primers were designed to 
amplify a region unique to the transgene, located at the 5’end (Figure 6.5, B). Given 
that the 5’end of the TetO-VE-PTP transgene RNA did not differ from the DNA that 
encoded it, a number of controls were included to ensure that the observed signal was 
attributable to the presence of an mRNA transcript. An RT-PCR reaction using 
material from a cDNA synthesis without reverse transcriptase was run in parallel to 
each reaction carried out with cDNA synthesised in the presence of the enzyme. In 
addition, two transcripts were amplified in the same RT-PCR reaction: p97 and TetO- 
VE-PTP. The primers for p97 spanned an intron, giving rise to a PCR product of 
higher molecular weight when DNA, versus RNA, was amplified. Overall, a 
number of founder lines capable of VE-PTP transcription were identified (Figure 6.6). 
Among these, some founder lines also exhibited regulated transgene transcription by 
tTA, as assessed by the presence of higher levels of VE-PTP transcript in double 
transgenic embryos compared to those in single transgenic littermates for the 
responder transgene. Some uncontrolled transcription in single transgenic embryos 
was evident, while genomic DNA was sometimes observed and was taken into 
account in the interpretation of each signal.
To confirm and also obtain a quantitative estimate of the observations from RT-PCR,
the analysis was validated by Real-time quantitative PCR (TaqMan). This method
ensures increased accuracy, as two primers and one probe must specifically anneal to
each cDNA for detection. Moreover it adds quantitative value, as relative product
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3530A -/v 3530A t/v 3597AB t/v 3597AB-/v 3650C t/v 3529A -/v 
— +  — +  -  +  -  +  -  +  -  +
3529A t/- 3530A t/v 3530A -/v 3650B1 -/v 4052A -/v 4052A t/v
+  -  +  -  +  - + - + -  +
Figure 6.6 Screening through TetO-VE-PTP founder lines by RT-PCR. TetO-VE-PTP 
and p97 transcripts were amplified in the same reaction, from RNA that was reverse 
transcribed with the inclusion (+) or the omission (-) of reverse transcriptase. A 153 bp 
fragment was amplified in samples containing the TetO-VE-PTP transcript, while a 470 
bp fragment from the constitutively expressed p97 gene was amplified in all samples. 
The presence of a 153 bp band for TetO-VE-PTP or a 670 bp band for p97 (after 
inclusion of an intron) in the (-) lane was indicative of a contribution by genomic DNA. 
The founder lines and genotypes are indicated on top of each gel picture. The 
nomenclature used for each founder line consists of a four-digit number plus one or two 
letters, collectively indicating each event of oocyte transfer into a pseudopregnant 
female. Numbers following letters in the nomenclature distinguish different founders 
stemming from the same oocyte transfer event. The genotype of the animals is 
abbreviated using the following scheme: t = Tie2-tTA transgene, v = TetO-VE-PTP 
transgene. Accordingly, double transgenic animals are denoted as t/v, while single 
transgenic animals for the driver transgene or the responder transgene are denoted as t/- 
and -/v, respectively. Molecular weight markers and the identity of the obtained bands 
are indicated.
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levels are assessed in the linear phase of the PCR reaction, prior to the saturated end­
point. Following the same rational to the RT-PCR screening, a primer and probe set 
was designed to amplify a region unique to the transgenic version of VE-PTP (Figure 
6.5, B). In addition, a primer and probe set specific for the endogenous version of 
VE-PTP, as well as another set specific for the Tie2-tTA transcript, were used to 
determine the endogenous VE-PTP and driver tTA levels, respectively (Figure 6.5, 
B). As a control for the presence of genomic DNA contamination, PCR reactions 
using RNA that had not undergone reverse transcription were included in the analysis. 
In a first round of quantitative PCR analysis, all founder lines were analysed for the 
transcription of VE-PTP, and lines with no or insignificant amplification of the TetO- 
VE-PTP transcript (namely 3598C, 4052A, and 3664B) were eliminated (data not 
shown). Subsequently, a second round of analysis was carried out, where 
representative samples from all remaining founder lines were compared side by side, 
in the same Taqman run (Figure 6.7). For each founder line, a double transgenic 
embryo was assessed, and where possible, its TetO-VE-PTP single transgenic 
littermate was included for comparison. This allowed ranking the founder lines 
according to their levels of TetO-VE-PTP transcript, and also quantitatively assessing 
how much of the observed levels were due to uncontrolled transcription, even in the 
absence of the driver transgene. It was immediately apparent that the founder lines 
harbouring the highest levels of VE-PTP transcript (3529A and 3650C) were not 
inducible, as samples displayed similar levels in the presence or the absence of the 
tTA driver (Figures 6.7, A and data not shown).
Founder lines displaying the highest levels of regulated transgene VE-PTP
transcription were selected for each of the three types of TetO-VE-PTP transgene, to
undergo yet a third-round of transgene expression evaluation (Figure 6.8). Given that
an over-expression approach depends on flooding the system with a protein that will
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Figure 6.7 Screening through TetO-VE-PTP founder lines by Real-time PCR 
(TaqMan). TetO-VE-PTP transcript levels in representative El 1.5 embryos from 
different founder lines were measured in a single Taqman experiment. Transcript levels 
are expressed as a fold induction over a sample with very low amounts of transcript, 
namely 3530B t/v. (A) differs from (B) in lacking the samples with the highest 6 
scores, to highlight differences at low transcript levels. The genotypes and founder 
lines of the animals are denoted beneath the graph, according to the scheme described 
in Figure 6.6.
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Figure 6.8 TetO-VE-PTP transgene normalised to endogenous VE-PTP. Transcript 
levels for transgene and endogenous VE-PTP in each El 1.5 embryo were measured 
in the same TaqMan experiment. For each embryo sample, the transgene transcript 
levels were normalised against the endogenous VE-PTP transcript levels. The fold 
induction of normalised TetO-VE-PTP transcript levels in double transgenic 
embryos versus their single transgenic littermates is plotted for selected founder 
lines. A fold induction value of 1 indicates no difference between the normalised 
TetO-VE-PTP transcript levels of littermates. Founder lines along with the type of 
TetO-VE-PTP construct they harbour are denoted.
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enhance or override the normal cellular counterpart, an attempt to predict in which 
founder line it would be more likely for the transgene to have an impact was initiated 
by comparing the levels of transgene VE-PTP transcript to those of endogenous VE- 
PTP. To this end, transcript levels for transgene and endogenous VE-PTP were 
measured in double and single transgenic littermates. Levels of transgene VE-PTP 
transcript were subsequently normalised to the corresponding levels of the 
endogenous transcript for each embryo. It was reasoned that high normalised 
transgene levels in the double transgenic embryos, compared to single transgenic 
embryos from the same litter, were indicative of a strong presence of the transgene 
VE-PTP. Thus, it was anticipated that a strong presence of the transgene VE-PTP in a 
given line would be accompanied by greater consequences than in lines with less of a 
significant presence. Founder lines 3530A, 3597AB, and 3650B3 exhibited the 
greatest difference in the normalised transgene levels between littermates. In contrast, 
no difference in the normalised transgene levels was observed among the littermates 
of line 3596B1 or within the non-inducible lines 3529A and 3650C.
Finally, levels of the tTA transcript were measured between littermates of different 
founder lines. As expected, the tTA driver was expressed in all animals of the 
appropriate genotype (Figure 6.9). Some differences in tTA transcript levels between 
founder lines and within littermates were noted, however, no correlation between the 
driver transcript levels and the attained responder transcript levels was observed. 
Collectively, the above observations (summarised in Table 6.1) suggested that 
founder lines 3530A, 3597AB, and 3650B3, for TetO-VE-PTP full length, EC only, 
and R/A mutant, respectively, were the most promising for further study.
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Figure 6.9 Tie2-tTA transcript levels. Driver transgene transcript levels in 
representative El 1.5 embryos from different founder lines were measured in a single 
Taqman experiment. Transcript levels were expressed as a fold induction over sample 
3530B. The genotypes and founder lines of the animals are denoted beneath the graph 
according to the scheme described in Figure 6.6.
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R an k  according 
to transgene  
transcript 
lev e ls
com parison within founder lines:
T etO -V E -PT P
construct
Founder line
uncontrolled  
transcription in
-/v
normalized 
transgene  
induction in t/v 
o v e r -/v
Phenotype
trends
3529A 1st YES N O N O
3530A 4th SLIGHT 376x YES
3530B 10th N O N .D . N O
fuD length 3541B 8th YES N .D . N O
3595A 11th N O N .D . N O
3596B1 3rd YES N O N O
3596B 2 6th YES N .D . N O
3597A B 5th N O 352x YES
EC only
3598B 1 7th N .D . 1.4x N O
3598C - - - YES
4 052A - - - N O
3650B 1 12th N O N .D . N O
R/A mutant
3650B 3 9th YES 6.5x N O
3650C 2nd YES N O N O
3664B - - - N O
Table 6.1 Summary of Real-time PCR and morphological observations. TetO-VE- 
PTP founder lines are ranked according to their transgene transcript levels measured 
in a parallel comparison within a single TaqMan experiment. Uncontrolled 
expression in -/v refers to transgene transcription in a single transgenic animal for 
the responder transgene, in the absence of the tTA transactivator. Normalised 
transgene induction in double transgenic (t/v) versus their single transgenic (-/v) 
littermate refers to an empirical estimate of the increase in transgene levels, 
described in Figure 6.8. Phenotypic trends observed in El 1.5 embryos are indicated 
for the appropriate founder lines. The most promising founder line for each different 
TetO-VE-PTP construct is highlighted in yellow. The nomenclature for founder 
lines and genotypes follows the scheme described in Figure 6.6. N.D. stands for not 
determined.
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6.2.4 Further analysis of selected founder lines
In order to validate the induction at the protein level, double transgenic embryos from 
inducible and non-regulatable lines were processed for western blotting and 
wholemount immunostaining using a monoclonal anti-VE-PTP antibody. Although 
the antibody readily recognised VE-PTP in immunoblotting from cell extracts and 
immunocytochemistry [161], previous attempts to detect endogenous VE-PTP protein 
in tissues had been met with little or no success (personal communication; Dr. Urban 
Deutsch). In an attempt to detect potentially increased levels of total VE-PTP protein, 
that would fall within the range of sensitivity for the particular antibody, inducible as 
well as non-regulatable lines were processed. Nonetheless, no protein was apparent in 
any experimental sample (data not shown), suggesting that VE-PTP protein levels in 
wildtype, inducible, or non-regulatable lines were below the threshold of protein 
recognition by the antibody, in immunoblotting or wholemount 
immunohistochemistry assays alike.
Despite the inability to assess VE-PTP protein induction, phenotypic trends observed 
in founder lines capable of high and regulated VE-PTP transgene transcription, were 
suggestive of a perturbation at the protein level. Double transgenic animals in lines 
3530A and 3597AB were often developmentally delayed, compared to their 
littermates, and exhibited enlarged pericardia with haemorrhage (Figure 6.10). 
Moreover, the sub-Mendelian ratios of double transgenic offspring in a litter from 
either line (Table 6.2) were indicative of embryonic lethality. Observed defects 
ranged from subtle to very dramatic, suggesting a dose-dependency on VE-PTP in the 
severity of the phenotype exhibited.
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Figure 6.10 Abnormalities in double transgenic embryos. El 1.5 double transgenic 
(t/v) and single transgenic (-/v) littermates from 2 different litters (A and B) of a cross 
between Tie2-tTA driver and TetO-VE-PTP 3597AB responder lines. The double 
transgenic embryos in both litters were developmentally retarded in comparison to 
their littermates, displayed haemorrhages (arrowhead) and enlarged pericardia 
(arrows). The partially dissected yolksac of the double transgenic embryo in (A) is 
marked by an asterisk.
Founder line E10.5 El 1.5 P7
3530A 11.1% (n=9) 17.9% (n=28) 11.1% (n=18)
3597AB 33% (n=6) 20%(n=25) 7.7% (n=13)
Table 6.2 Genotype records for crosses between the Tie2-tTA driver line and the 
3530A or 3597AB responder lines. 10.5-11.5 old embryos, and 7-day old pups were 
genotyped for the presence of both transgenes. The percentage of double transgenic 
animals in a litter, and the total number of animals assessed (n) are indicated.
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6.3 Discussion
6.3.1 System overview
Conditional gene expression in mice is a popular tool for dissecting the precise roles 
of genes in complex physiological processes [377]. Among binary overexpression 
systems based on transcriptional transactivation [363, 378, 379], the tetracycline- 
resistance system has seen the widest use in the study of spatially- and temporally- 
specific gene function [366, 370, 371, 380-385].
A conditional and endothelial cell-specific overexpression system in the analysis of 
VE-PTP function was thought to confer a number of advantages. First of all, tight 
control of the onset and location of gene expression should provide a means for 
studying the VEGF and Ang signalling cascades in vivo. Conventional knockout or 
transgenic approaches, aimed at elucidating the precise physiological functions of 
components in these pathways, have been limited due to early embryonic lethality 
[112, 358-362]. In addition to obviating lethality, the ability to switch expression on 
or off, should allow one to specifically focus on multiple stages of vascular 
development or disease. Finally, using one system, but varying the transgenic 
construct, should enable the study of both gain and loss of function of VE-PTP.
6.3.2 Selection of responder founder lines
In consideration of the above, the ideal responder line should be silent for the 
transgene it harbours, until crossed to the driver line, whereupon it should sustain high 
levels of expression upon induction. Given that inducible lines are often a minority 
among responder lines [386], a number of oocytes are typically injected, generating a
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number of potential founder lines. Among the resulting 16 responder founder lines, 
the 15 responder lines that were capable of efficient germline transmission of the 
transgene, were sorted according to their mRNA transcript levels for TetO-VE-PTP. 
The different responses observed can be used to classify responder mice into three 
broad categories: 1) Founder lines that did not show expression of the TetO-VE-PTP 
transgene, 2) Founder lines that displayed non-regulatable TetO-VE-PTP transgene 
expression even in the absence of the transactivator, and 3) Founder lines that 
expressed no, or very little, TetO-VE-PTP transgene in the absence of the 
transactivator, but could support an induction in its presence.
A critical determinant in the ability of a promoter-less transgene to remain silent, 
induced only in the presence of a transcriptional transactivator, is the site of 
chromosomal integration [363, 365, 387]. Transgenes can integrate into the genome 
near endogenous promoters leading to their constitutive transcription in the absence of 
the tTA transactivator. Alternatively, integration sites can be surrounded by silencer 
elements that preclude transcription, even in the presence of the tTA transactivator. 
Stimulatory or suppressive signals in the genome have also been attributed to factors 
affecting the three-dimensional structure of chromatin, such as acetylation or 
methylation [388]. Non-regulatable expression, or absence of expression altogether 
have been previously reported for other responder lines [367, 371, 381, 385].
The two founder lines that displayed the best induction properties (3530A, 3597AB), 
showed minimal transgene expression in the absence of a tTA transactivator, and an 
increase in transgene expression on the order of 10-25 fold upon transcriptional 
activation. They also exhibited the greatest difference between normalised transgene 
transcripts of double transgenic embryos and their single transgenic littermates, an 
empirical measurement devised to predict the effectiveness of transgene induction. 
Normalizing the relative transgene levels to those of endogenous VE-PTP was
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deemed more relevant than measuring total (transgene and endogenous) levels, as the 
latter could be misleading in the case of high endogenous levels in a non-transgenic 
animal. Normalised transgene levels were increased on the order of 300-400 fold in 
the presence of a transactivator. In agreement with the observations at the RNA level, 
founder lines 3530A and 3597AB were accompanied by trends of a phenotype in 
double transgenic embryos.
The two non-regulatable VE-PTP responder lines (3529A, 3650C) displayed the 
highest levels of TetO-VE-PTP transcript among founder lines, without exhibiting any 
obvious morphological or behavioural defect. A number of interpretations could 
account for the above observation. One explanation is consistent with the specificity 
of VE-PTP expression for the vasculature [159]. Substrate specificity for vascular 
targets could preclude an adverse phenotype in a situation of ectopic expression. 
Another explanation could be the inability of the particular transcripts to be translated 
into protein. Lastly, the possibility of full-length (line 3529A), or R/A mutant (line 
3650C), VE-PTP overexpression not leading to an overt phenotype should be 
considered. However, in view of the toxicity associated with VE-PTP overexpression 
in vitro and the observed phenotype trends in the founder lines displaying inducible 
VE-PTP expression, the last interpretation seems the least likely of all.
6.3.3 Preliminary phenotypic analysis
The phenotypic trends associated with overexpression at the RNA level, coupled to 
the ability of protein translation ex vivo, constitute indirect evidence for the expression 
of VE-PTP protein in tissues. For future reference, one way to have circumvented the 
problem of VE-PTP protein detection in vivo could be the inclusion of a tag in the 
transgene cassette to aid visualisation by either means.
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Defects observed in the embryos of lines 3530A and 3597AB were associated with a 
decrease in embryo size, enlarged pericardia, and haemorrhages. Embryonic lethality 
was inferred from sub-Mendelian ratios of double transgenic offspring. It should be 
stressed that phenotypes were not exhibited in all double transgenic embryos of the 
selected lines, and phenotype manifestation varied in severity. The variability could 
reflect differences in the levels of VE-PTP overexpression attained between, or even 
within, litters of the same founder line. Variations in the expression of responder 
transgenes between littermates has been previously noted [363]. However, in contrast 
to reports linking variation in responder gene expression to the levels of the 
transactivator [387, 389], no correlation was observed among the tTA and TetO-VE- 
PTP transcript levels among littermates with identical genotype (Figures 6.9).
Heart phenotypes are a common occurence in many mutants of components of the 
vasculature [112, 358-360, 362]. Further studies are necessary to distinguish true 
endothelial defects from secondary myocardial defects in a dying embryo. If the 
phenotypes are indeed related to the perturbation of VE-PTP in the vasculature, they 
could be conceptually linked to the dual functions of its substrate VE-cadherin in 
permeability and endothelial cell assembly during angiogenesis [17, 112, 120, 165]. 
Alternatively, or in conjunction with effects on VE-cadherin, modulation of the Tie-2 
pathway could result in defects in vascular remodelling and permeability [28, 390]. 
Detailed analysis, however, is required to define the onset and nature of the observed 
phenotypes, as well as the differences between the effects of full-length or mutant 
overexpression. Finally, the ultimate assessment for the suitability of the selected 
responder lines as components of a binary overexpression system will be the 
suppression of transgene expression and associated phenotypes, upon administration 
of doxycycline.
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In conclusion, I have generated tools to perturb VE-PTP function in vivo. These 
consist of two responder transgenic lines for full-length and extracellular domain VE- 
PTP, which sustain transgene induction, and exhibit defects associated with 
overexpression. Combined with a driver line that restricts expression to the 
vasculature, the significance of VE-PTP function perturbation can be assessed within 
the context of endothelial barrier assembly, maintenance, and breakdown.
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Concluding remarks and future outlook
As is the case for most research endeavours, this scientific study has opened more 
questions than it has answered. Nonetheless, the novel tools generated, and the new 
concepts formulated should help guide future research in the area of vascular 
permeability. A number of possible directions are discussed below.
With this work, one of the major obstacles to studying fenestrae was surmounted, as a 
method was developed to reproduce fenestrae in abundance, in vitro, using a 
combination of predisposed cell lines and microfilament disruption agents. This in 
vitro culture system can serve as a platform to address questions concerning the 
biogenesis, composition, regulation, and function of fenestrae. Future studies may 
benefit from rendering the culture system conditions more close to the situation in the 
organism, as the physiological relevance of the extreme phenotype displayed by 
induced endothelioma cells is currently unknown. Triggering fenestrae induction 
through the use o f growth factors or extracellular matrix components, should allow 
drawing more accurate parallels between capillary beds in vivo and the in vitro model. 
The first successful use o f the in vitro model towards understanding fenestrae biology 
was in the subcellular, subtractive proteomics study. A number of components 
involved in membrane and cytoskeletal remodelling were identified, which can be 
accommodated within a unifying conceptual framework for the biogenesis of 
specialised membrane structures. Evidence presented in this thesis favours a model in 
which actin remodelling, PV-1 relocalisation, and the cross-linking actions of ERM 
proteins collaborate in orchestrating the biological response of fenestrae formation. 
Future studies aimed at perturbing the function of ERM proteins and altering the
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reorganisation properties of microfilaments, should shed light on their precise 
contributions and help transform a speculative model into a substantiated theory.
The identification of a novel fenestrae sieve plate component may be of future 
practical use in the fields of diagnosis and treatment of vascular disease. Preliminary 
evidence from the physiological tissue distribution of moesin and PV-1 suggests that 
the two antigens, together, are promising as a composite biomarker for identifying 
fenestrae. Further efforts are required to establish the presence of moesin and PV-1 in 
fenestrae of the neovasculature, and to assess their suitability as indicators of 
structures contributing to leakage. Furthermore, recognition of a functional 
interaction between moesin and the fenestrae sieve plate would provide a new target 
for therapies aimed at controlling aberrant permeability.
The creation of a mouse model for VE-PTP function modulation in the endothelium 
constitutes the first step in an effort to understand phosphatase regulation of 
paracellular permeability in vivo. An assessment of paracellular permeability, by 
measuring leakage of dyes or tracers, in the new models of VE-PTP gain or loss of 
function should help define the physiological role of VE-PTP within the endothelial 
barrier. Finally, combining the TetO-VE-PTP transgenic mice with experimental 
conditions of endothelial barrier dysfunction such as the retinopathy of prematurity 
(ROP) model or tumor models could highlight roles for VE-PTP within pathological 
paracellular permeability.
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Appendix I Light Microscopy Assay using the diaphragm marker PV-1. In 
untreated cells PV-1 colocalises with the caveolar marker caveolin-1 (A,upper 
panel), while upon fenestrae induction, it distributes into two distinct areas: a 
caveolin-1-positive and a caveolin-1-negative area (A, lower panel). Such 
caveolin-1-negative areas are also devoid of labelling for the organelle-binding 
dye DiOC6 (B, lower panel), or tubulin (C, lower pannel), and are thought to 
represent fenestrae sieve plates. (D) A triple immunostaining of induced cells 
for PV-1, tubulin, and PEC AM shows that the distinct areas of PV-1-positive and 
tubulin-negative labelling are not a generalised phenomenon of the plasma 
membrane, which can be labelled throughout its surface area for PECAM. 
Confocal sections were obtained at the level of organelles or fenestrae sieve 
plates, for untreated and induced cells respectively. Representative fenestrae 
sieve plates are encircled by dotted lines in each panel of induced cells.
The Light Microscopy Assay was developed by Katrin Deinhardt, a former PhD 
student at the Endothelial Cell Biology Laboratory, currently at the Molecular 
Neuropathobiology Laboratory, Cancer Research UK. Part of this work was 
presented as a poster at the 42nd Annual Meeting of The American Society for 
Cell Biology, held in December 2002.
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Appendix II (i) Experimental design for large-scale proteomic study
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Appendix II (ii) Intensities of spots excised for mass spectrometry
Spot DO total LvsC2 p-value L vs C2 (1) p-value L vs C2 (2) p-value L vs C2 (3) p-value
138 1.883 0.1927 9.224 0.03162 -1.392 0.6478 1.495 0.1227
146 1.71 0.1852 3.28 0.1096 1.199 0.571 1.381 0.004115
153 -1.176 0.3662 - Unknown -1.381 0.3138 1.266 0.157
215 1.358 0.377 1.074 0.543 -1.24 0.02935 1.641 0.0105
(A 233 1.826 0.02507 2.103 0.001633 2.447 0.1313 1.58 0.081041 237 1.364 0.1417 1.595 0.02001 1.445 0.3797 1.273 0.45351
c
304 1.671 0.02125 -1.064 0.8038 2.148 0.1855 3.067 0.01115
334 1.193 0.3104 1.052 0.7728 - Unknown 1.396 0.01084
MO 400 -1.012 0.9481 1.03 0.353 -1.394 0.1313 1.416 0.01322
a 406 1.229 0.2688 1.52 0.00371 1.042 0.7731 1.372 0.1275
•5
> 414 1.927 0.007195 3.415 0.1368 1.135 0.4678 2.675 0.009798
1 473
- Unknown 3.99 0.008421 - Unknown - Unknown
§" 478 1.488 0.001198 1.345 0.09975 1.517 0.1585 1.842 0.122
486 - Unknown 19.635 Unknown - Unknown - Unknown
517 1.251 0.03035 1.611 0.003646 - Unknown 1.334 0.03847
521 1.16 0.945 4.502 Unknown - Unknown 1.373 0.02015
526 1.689 0.0001765 -1.274 Unknown 1.503 0.03269 2.373 0.01236
527 1.548 0.002631 1.265 0.2492 1.423 0.01114 2.269 0.02215
65 1.247 0.4155 -1.846 0.05807 1.494 0.0008652 1.052 0.001266
125 1.928 0.1568 1.332 0.05748 1.255 0.04611 1.669 0.6696
155 -1.264 0.7714 - Unknown -1.264 0.3465 1.463 0.0003429
188 1.315 0.5625 1.397 0.01912 - Unknown - Unknown
5/3 200 1.448 0.001263 1.36 0.1691 1.492 0.1217 1.509 0.1035
C 239 1.256 0.2898 -1.771 Unknown 1.293 0.7221 1.462 0.02508
-o 271 - Unknown - Unknown only i i  L - Unknown
1 292 1.145 0.3585 -1.08 0.5231 1.025 0.8736 1.404 0.015431 366 2.973 0.1192 - Unknown 1.442 0.000735 - Unknown
”3 399 -1.008 0.08448 1.484 0.01762 - Unknown 1.766 0.1215o
•5 402 1.348 0.06779 1.847 0.008672 1.172 0.1845 1.146 0.7076
410 1.144 0.3432 1.357 0.04608 -1.227 0.5891 1.395 0.1706
1 411 1.385 0.1231 1.071 0.5587 1.049 0.4479 2.401 0.02249Gy 443 1.426 0.07064 2.311 0.01659 -1.116 0.7321 1.404 0.4977
450 1.164 0.1214 2.12 0.02537 -1.857 0.5471 2.524 0.2858
479 1.875 0.02106 2.043 0.3201 -1.007 0.1216 - Unknown
488 3.264 0.00418 3.019 0.0222 1.839 0.1587 - Unknown
491 1.475 0.5093 - Unknown - Unknown 2.205 0.01431
Fold changes for excised spots from Py4.1 cell analysis
Spot no total LvsC p-value
401 3.811 0.003184
I  ^1 658 2.038 0.002161ft ft! 659 1.772 0.02662
793 2.258 0.004779
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Appendix II (iii) Protein identity assignment
bEND5 cells upregulated spots:
G e l# Spot#
(Gel)
Protein
Name
A ccession  # Species
MW
(Kda) Pi
#
peptides
matched
MOWSE
Score
% sequence 
covered by 
matching
373
373
235
Alpha
enolase
P17182.40
Mus
musculus
46.9 6.4 6 60 22.4
257
Eukaryotic 
initiation 
factor 4A - 
like
08BVY3.23
Mus
musculus
46.7 6.64 9 102 28.95
Probable
ATP-
dependent
heliease
Mus
musculus
46.8 6.33 9 102 28.95
373 233
Alpha
enolase
P17182.40 Mus
musculus
46.9 6.4 10 124 34.64
552 486
Co film, non- 
muscle 
isoform
P18760.16
Mus
musculus
18.5 8.25 5 47 45.78
552 527
M yosin light 
chain alkali, 
smooth- 
muscle
064119.35
Mus
musculus
16.8 4.46 6 61 45.33
552 304
Actin
monomer-
binding
protein
080X09.24
Mus
musculus
40.1 6.35 6 57 24.86
552 414
14-3-3
protein
zeta/delta
P35215.28
Mus
musculus
27.7 4.73 5 41 28.16
552 526
M yosin light 
chain 
alkali(MLC3 
SM)
064119.35
Mus
musculus
16.8 4.46 5 42 34.67
473 478
M yosin  
regulatory 
light chain 2- 
A
PI 3832.13
Rattus
Norvegicus
19.7 4.65 11 152 63.16
M yosin  
regulatoiy 
light chain 2- 
B
PI 8666.32
Rattus
Norvegicus
19.6 4.76 8 91 40.94
BATCH ANALYSIS-1
406 237
Interferon- 
activatable 
protein 205 
(IFI-205)
008619.35
Mus
musculus
47 8.4 4 12 8.94
224
470 406
Ras 
suppressor 
protein 1 
(Ksu-1)
001730.29
Mus
31.5 8.86 5
-------------
31 19.49
406 473
Similar to 
transgelin 2
091VU2.19
Mus
musculus
22.3 8.43 5 35 31.16
406 517
Putative 
RNA- 
binding 
protein 3
089086.38
Mus
musculus
16.5 7.04 3 11 28.76
BATCH ANALYSIS -3
470 138
Heterogen eo 
us nuclear 
ribonucleopr 
otein K
08BG08.23
Mus
musculus
48.4 5.69 5 33 14.35
557 138
Heterogen eo 
us nuclear 
ribonucleopr 
otein K
08BG08.23 Mus
musculus
48.4 5.69 14 180 35.76
Heterogen eo 
us nuclear 
ribonucleopr 
otein K
060577.40
Homo
Sapiens,
Rattus
50.9 5.25 13 163 30.6
541 146
Heterogen eo 
us nuclear 
ribonucleopr 
otein K
060577.40
Mus
musculus
50.9 5.25 5 27 11.64
557 146
Heterogen eo 
us nuclear 
ribonucleopr 
otein K
060577.40
Mus
musculus
50.9 5.25 13 165 31.25
Heterogen eo 
us nuclear 
ribonucleopr 
otein K
08BG08.23
Mus
musculus
48.4 5.69 14 182 36.45
541 153
60 kDa heat 
shock  
protein, 
mitochondria
P19226.36
Mus
musculus,
Rattus
Norvegicus
60.9 5.92 7 68 15.71
541 215
ATP 
synthase  
beta subunit
09CW A2.17 Mus
musculus
56.9 5.44 8 89 22.85
1
557 215
ATP  
synthase  
beta chain
P56480.41 Mus
musculus
56.2 5.19 13 175 34.78
541 334
Annexin II 
(Lipocortin
ID
P07356.07
Mus
musculus
38.5 7.69 4 18 11.24
225
557 334
Annexin II 
(Lipocortin
U)
P07356.07 Mus
musculus
38.5 7.69 4 19 14.5
557 400
Eukaryotic 
translation 
initiation 
factor 4H
O9W UK2.40 Mus
musculus
27.3 6.95 10 96 35.08
M usculin
(M yogenic
repressor)
088940.40 Mus
musculus
21.5 9.45 6 44 28.36
541
------------- 1
517
Putative 
RNA- 
binding  
protein 3
089086.38 Musmusculus 16.5 7.04
---------
4 31 30.07
470 517
Putative 
RNA- 
binding  
protein 3
089086.38 Mus
musculus
16.5 7.04 6 67 53.59
Putative 
RNA- 
binding  
protein 3
089086.38 Mus
musculus
16.5 7.04 5 37 39.22
N u cleosid e  
diphosphate  
kinase B
001768.25 Mus
musculus
17.3 7.21 5 38 40.79
557 517
Putative 
RNA- 
binding  
protein 3
089086.38 Mus
musculus
16.5 7.04 5 41 33.99
N u cleoside  
diphosphate  
kinase A
PI 5532.14 Mus
musculus
17.1 7.1 5 36 38.16
N u cleoside  
diphosphate  
kinase B
P22392.19 Homo
Sapiens
17.2 8.56 4 21 31.58
37.5
557 521
N u cleoside  
diphosphate  
kinase A
PI5532.14 Mus
musculus
17.1 7.1 7 58
N u cleosid e  
diphosphate  
kinase B
001768.25 Mus
musculus
17.3 7.21 11 125 69.74
541 521
N u cleosid e  
d iphosphate  
kinase B
Mus
musculus
17.3 7.21 3 5 23.68
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Py4.1 cells: upregulatedspots
G el#
Spot#
(Gel)
Protein
Name
A ccession # Species
MW
(Kda) Pi
# peptides 
matched
MOWSE
Score
% Coverage
561 401
Radixin P26043.22 Mus
musculus
68.4 5.82 11 120 21.78
Moesin P26041.28
Mus
musculus
67.5 6.23 19 246 31.6
561 658
Elongation 
factor 1- 
gamma
09D8N0.40 Mus
musculus
50 6.33 13 151 27
Alpha
enolase
P17182.40 Mus
musculus
46.9 6.4 18 240 46.42
561 793
Protein 
tyrosine 
kinase 9
091YR1.19
Mus
musculus
40 6.26 8 90 32.29
561 659
Alpha
enolase
P04764.05
Mus
musculus
46.9 6.18 7 80 27.71
Paralemmin Mus
musculus
41.5 4.79 5 42 21.41
Kinesin light 
chain KLCt
09ESH7
Rattus
norvegicus
55.8 6.16 5 46 19.01
227
RPE
retina
vitreous
retina
sclera
Appendix III Differential interference contrast (DIC) microscopy on eye 
sections. Low (A) and high (B) magnification images show the topology of the 
sections and the different layers included: retina, retinal pigment epithelium 
(RPE), choriocapillaris (CC), sclera. (Bars = 100 /mi and 20 /mi, respectively)
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